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Chapter 1 
Introduction 
8 Chapter I 
Less than a decade ago Murry et al reported that infarct size in dogs sUbjected to a 40 min 
coronary artery occlusion was 29% of the anatomical area at risk. \Vhen the 40 min occlusion 
was preceded by 4 cycles of 5 min coronary artery occlusion and 5 min of reperfusion infarct size 
was only 7% III (Figure I). This protective effect of brief periods of reversible myocardial 
ischemia was tenned "ischemic preconditioning" and has now been confll1ued in a large number 
of other laboratory animals including pigs, rabbits and rats !2l, 
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Figure I. Ischemic preconditioning protocol used by Murry et a/[l] in an in vivo dog model. Closed bars are periods 
of ischemiC stress applied by occluding the coronary artery of which the distibution zone became the area at risk 
(gray and black area in the heart). Infarct size (black area in the heart) was determined by histochemical techniques 
and is expressed as the percentage infarcted area of the area at risk. 
In chapter 2 we will review the experimental evidence of the protective effect of ischemic 
preconditioning and outline the problems that exist in obtaining clinical evidence for this 
phenomenon. 
It has been reported that not only total[I,3-10) but also partial[ll, 12] coronary artery occlusions can 
precondition the myocardium. Thus, Ovize et aftllJ observed in dogs myocardial necrosis after 
a 60 minute total coronary artery occlusion was less when coronary blood flow was reduced by 
50% for IS minute preceding that 60 minute coronary artery occlusion. In that study 15 minute 
of complete reperfusion between the partial coronary artery occlusion and the sustained total 
coronal), occlusion was necessary to obtain the reduction in infarct size. In contrast, we observed 
earlier in pigs that a 70% coronary flow reduction that lasted 30 min protected the myocardium 
during a subsequent 60 min total coronary artery occlusion without the need of intervening 
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reperfusion.112] These findings appear contradictory but could also suggest that the severity and 
duration of the flow reduction playa critical role in eliciting protection. Although ischemic 
preconditioning has been the topic of many studies, none of these investigated whether the 
protection by ischemic preconditioning was the same for the inner and outer myocardial layers 
across the left ventricular wall. It is well established that a partial coronary artery occlusion 
afiects perfusion of the subendocardial layers more severely than that of s1.1bepicardiallayers.ll3-18] 
11ms, differences in severity of ischemia across the left ventricular wall could produce different 
degrees of protection for different myocardial layers. 
To address these questions we investigated in chapter 3 (i) whether the protection by partial 
coronary artelY occlusions depends on the severity and(or) duration of the flow reduction and (Ii) 
the transmural distribution of this protection. These issues are of particular clinical interest, since 
preconditioning with partial occlusions mimics more closely the condition of patients suffering 
from coronary artery disease than the abmpt brief total occlusion and reperfusion sequences. To 
compare the protective effects of the partial and total coronary artery occlusion stimuli we also 
analyzed the subendocardial and subepicardial distribution of in:h'lfct size of pigs preconditioned 
with a brief total coronary artery occlusionYIJ 
Myocardial protection can be produced by a variety of stimuli causing myocardial ischemia. 
Thus, one or more brieftotaW] or partial18, II, 12] coronary artery occlusion(s) limit(s) infarct size 
produced by a sustained period of ischemia. Moreover, infarct size can also be limited by brief 
ischemia in adjacent myocardium[191, Thus a temporary interruption of oxygen supply either 
within or outside the myocardial region of interest can lead to protection. Recent studies suggest 
that stimuli that do not cause ischemia may also protect the myocardium, Thus, Ovize et aIPO} 
reported that an increase in left ventricular wall stretch produced by acute volume overload 
protected the myocardium against infarction during a subsequent 60 min coronary artery 
occlusion, Also two consecutive 2 min periods of rapid ventricular pacing in open-chest dogs 
reduced the incidence of ventricular arrhythmias during and inunediately following a subsequent 
25 min coronary artery occlusiotP1l, In chapter 4 we describe the effect -of rapid ventricular 
pacing on infarct size development produced by a sllstained coronary artery occlusion, 
Ischemic preconditioning has been described not only for the myocardium,[l] but also for the 
kidney,[22] skeletal muscle,I231 braitP~l and liver.[25} Furthermore, Przyklenk et 0/[19] reported that 
a brief coronmy artery occlusion preconditioned not only the myocardium within but also outside 
its perfusion territory ("remote" but intracardiac ischemic preconditioning). It is uhknown, 
however, whether remote organ ischemia can protect the myocardium against infarction. 
Therefore, we examined in chapter 5 whether brief remote organ ischemia prior to a 60-minute 
coronary artery occlusion limited myocardial infarct size. For this purpose, we produced transient 
ischemia in the small intestine or left kidney by occluding the anterior 
10 
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Figure 2. Background of protection by ischemia in organs other than the heart, Ischemic preconditioning is not an 
organ specific phenomenon and its protective effect is not limited to the area that has become ischemic but also 
expands to the 'virgin' adjacent area. In chapter 5 we investigated the effect of brief ischemia in other organs on 
myocardial infarction. LAD=left anterior descending coronary artery; LCX=iefi circumflex coronary artery. 
mesenteric artery or the left renal artery in rats and examined its effect on myocardial infarct 
size (Figure 2). Since body temperature may influence infarct sizcf26,27] and cardioprotection by 
the adenosine deaminase inhibitor pentostatin was only observed in the presence of mild 
hypothennia128] studies were performed at two temperatures. Because results indicated that brief 
mesenteric artery occlusion provided cardioprotection at both temperatures, mesenteric artery 
occlusion was selected to examine the mechanism of protection by remote organ ischemia. To 
investigate whether a neurogenic pathway was involved we repeated the studies after ganglion 
blockade with hexamethonium. To determine whether activation of the neurogenic pathway 
occurred during remote organ ischemia or the subsequent 10 minutes of reperfusion, we also 
detel111ined infarct size after 60M minute coronalY artery occlusion in the presence of permanent 
mesenteric ariery occlusion. 
Introduction II 
In chapter 5, we showed that myocardial infarct size produced by a 60-minute coronary artery 
occlusion in rats was not different when the experiments were performed at normothermia 
(36.5"C-37.S0C) or hypothermia (30°C-3J°C) [29[. This finding is at variance with previous 
studies in rabbits [26J and swine [27J in which infarct size produced by 30J26J and 45-minute [27) 
coronary artery occlusion coronary artery occlusion was smaller at lower body temperatures. 
Reasons for the apparent discrepancy could be differences in species or the duration of the 
coronary artery occlusion. In chapter 6 we therefore investigated the importance of the duration 
of coronary artelY occlusion on the infarct size limiting effect ofhypothennia. Since hypothermia 
was associated with bradycardia, which could possibly limit infarct size per se pOJ, we studied an 
additional group of hypothermic rats in which heart rates were increased to heart rates at baseline 
of the normothermic animals. 
Initially, studies searching for the mechanism of ischemic preconditioning focussed on time 
characteristics and on extracellular endogenous and exogenous factors that either mimicked or 
inhibited the phenomenon. Protection proved to occur during two distinct episodes: a classical 
preconditioning period (first window of protection (FWOP)) that lasted 2 to 3 hours after the 
preconditioning stimulus was applied [1.21, and a second window of protection (S\VOP) between 
24 and 72 hours [31- 331. The meehanisms of protection for these two windows are most likely not 
the same. Endogenous factors rapidly produced agonists may activate intracellular pathways 
during P\VOP, while the slower process of in duet ion of heat-shock proteins may be involved 
during the S\VOP. Initially, attention focussed on activation of adenosine AI-receptors [34.35) or 
K\TP chalillel opening [36,37], as the mechanisms for protection during FWOP. More recently 
activation of protein kinase C has received wide attention /3S] (Figure 3). Prior to reviewing the 
role of protein kinase C in chapter 7, we introduce the biochemical properties of protein kinase 
C and discuss the limitations of the techniques used to investigate its role in ischemic 
preconditioning. Finally, the evidence that activation of protein kinase C and the intracellular 
signalling pathways leading to its activation playa pivotal role in the mechanism of ischemic 
preconditioning is summarized. 
In chapter 8 we investigated the role of protein kinase C in ischemic preconditioning and the 
protection obtained by remote organ ischemia (chapter 5). 
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Less than a decade ago Murry el al reported that infarct size in dogs subjected to a 40 min 
coronary artery occlusion was 29% of the anatomical area at risk. When the 40 min occlusion 
was preceded by 4 cycles of 5 min coronary artery occlusion and 5 min of reperfusion infarct size 
was only 7% {II, This protective effect of brief periods of reversible myocardial ischemia was 
termed "ischemic preconditioning" and has now been confirmed in a large number of other 
laboratory animals including pigs, rabbits and rats Ill. 
Protection by preconditioning has not only been connected with infarct size limitation but 
also with enhanced recovery of regional cardiac contractile function and anti-alThythmic activity 
P,4J. Because in large animal species the incidence of reperfusion arrhythmias is highest after 
coronary artery occlusions lasting between to and 30 min (which are too short to lead to 
infarction) the effect of ischemic preconditioning on in£1rct size, reperfusion arrhythmias and 
recovery of contractile function are usually studied in separate models. The anti-arrhythmic 
component of preconditioning has been convincingly demonstrated only in the rat; in other 
animal species this effect is less prominent [11. 
In this overview we will restrict the experimental evidence of the protective effect of 
preconditioning to infarct size limitation and outline the probJems that exist in obtaining clinical 
evidence for this phenomenon. However, clinical studies exclusively dealing with aspects of 
preconditioning in models of reversible ischaemia will also be discussed. 
Features of experimental studies on ischemic preconditioning with infarct size as endpoint 
Four distinct phases can be characterized in ischemic preconditioning experiments (i) the 
preconditioning stimulus, (ii) the intervening reperfusion period, (iii) the sustained coronary 
artery occlusion, which is followed by (iv) a sustained reperfusion period at the end of which the 
anatomical area at risk and infarcted area are determined. Important features of each of these 
phases have been summarized in Table I and will be discussed briefly. 
The preconditioning stimulus. Single or multiple brief total coronary artery occlusions 
varying from 2 to 10 min in duration have been used to precondition the myocardium, The 
minimum stimulus (threshold) to elicit preconditioning is not sharply defined but no data are 
available to suggest that occlusions less than 2 min can trigger preconditioning. However, two 
different subthreshold stimuli can produce preconditioning. Thus, Yao and Gross reported that 
while a brief coronary artery occlusion and low dose of the K+ATPchannel activator Bimakalim 
(see mechanisms) had no effect on infarct size when given separately, combined administration 
of these stimuli in dogs resulted in significant infarct size limitation [51. Not only total coronary 
artery occlusions, but clinically even more relevant, also partial coronary artery occlusions can 
precondition the myocardium [6.71. Ovize el af have described that cyclic coronary flow variation 
produced by a fixed stenosis and endothelial injury also preconditioned myocardium [81. Most 
investigators have used an impaired blood supply to induce preconditioning, but preconditioning 
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Table 1. Important features of preconditioning in experiments with infarct size as endpoint and 
the problems obtaining evidence in man. 
Features o/precollditlollillg III experlmeuts 
Precollditioulllg stilllll/US 
Ischemic 
single or multiple total coronary artel}' occlusions 
lasting from 2 to 10 min (supply ischemia) [1,2,7} 
severe partial coronary artery occlusions (supply 
ischemia) [6,7} 
moderate partial coromll}' artery occlusions + 
adrenergic stimulation (demand ischemia) [9} 
moderate fixed stenosis + endothelial injury [8} 
Non-ischemic 
heat stress (heat shock proteins) 
brief total occlusion of coronal}' artery supplying 
adjacent myocardium (remote preconditioning) {IOJ 
left ventricular volume loading {13 J 
transient hypoxia 
transient occlusion of renal artery? (remote 
'preconditioning') [II, 12} 
Pharmacological slIbstances 
adenosine, K\TP channel openers, protein kinase C 
activators [27,30-33} 
decreased threshold for ischemic preconditioning by 
subthreshold K\TPchannel activation [5} 
Illten'enillg (reperjilsloll) perioli 
mandatory following total occlusion (self evident) 
I min· 2 hours first window of protection 
[1,18] 
24 hours· ? second window of protection 
[15,16] 
not necessary following severe partial occlusions {7J 
Sustailled corolUu)' artery occlusloll 
duration limited to 90 min (species specific) [I] 
Slts/ailled reperjilSioll 
mandatol}' following the sustained coronary artel}' 
occlusion (selfe"ident) 
Otlter aspects of precollditionillg 
controversy about the loss of the protective clfect of 
preconditioning during first window (gradual decrease 
or "all or nothing" phenomenon) [20,21 I 
preconditioning can be reinstated after the protection 
is lost (22] 
tolerance develops with chronically applied 
preconditioning stimuli (24] 
preconditioning has been demonstrated in hypertrophic 
hearts (26} 
Problems illlllall ill obtailllllg e~'itfellce 
unknown if the duration and severity of anginal attacks 
arc sufficient to precondition the myocardium 
unknown if silent ischemia can precondition the 
myocardium 
unknown ifhibemation leads to preconditioning 
unknown if exercise stopped at the earlieast sign of 
ischemia can precondition myocardium 
unkno\\n ifdilated hearts in heart failure arc or can be 
preconditioned 
medication and other fonns of stress may interfere with 
the potential protective enect of the brief ischemic 
periods {treatment with K \TP channel openers for 
angina pectoris or treatment with K \TP channel 
blockers (Glibenclamide) for diabetes mellitus type II} 
reperfusion following anginal attacks may be 
incomplete and variable in duration 
occlusion that produces infarction may be incomplete 
and variable in severity 
collateral bloodflow to the area at risk is unknown 
onset and duration of occlusion cannot be accurately 
defined 
onset of reperfusion cannot be accurately defined 
reperfusion may be incomplete due to pre-existent 
coronary artel}' stenosis 
Detemlination of infarct size 
"infarct size" should be related to the anatomical 
area at risk; area at risk is usually not determined 
cnzyme leakage, preservation of left ventricular 
function or survival arc often used as endpoints; 
these may not accurately reflect the extcnt of the 
infarcted area 
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can also be obtained by increasing oxygen in the face of a maintained oxygen supply[91, Evidence 
is accumulating that the myocardium can also be preconditioned by ischemia in a remote region 
of the left ventricle. Thus, Przyklenk et at reported that a brief total coronary artery occlusion 
preconditions not only the myocardium within its perfusion territory but also protects the 
myocardium outside its territory [10], Another example of such remote ischemic preconditioning 
is the reduction in myocardial infarct size when a renal artery is transiently occluded prior to the 
coronary artery occlusion {II, 121, The concept of cardiac protection without the need for ischemia 
is forwarded. Ovize et a/In] described that stretching the myocardium by volume loading reduces 
infarct size during a subsequent coronary artery occlusion. TIlls could provide an explanation tor 
the remote ischemic preconditioning experiments by Przyklenk ef al as severe regional ischemic 
contractile dysfunction leads to stretching of the adjacent nonRischemic myocardium {IO}. \Ve have 
shown that 30 min of rapid ventricular pacing also preconditions the myocardium (Chapter 5). 
Tills protection did not involve ischemia as high energy phosphates were not depleted during the 
ventricular pacing period, while systolic segment shortening recovered immediately (no stunning) 
and reactive hyperemia was absent after ventricular pacing was terminated. The mechanism 
involved activation of K+ATP channels as pretreatment with the K+ATP channel inhibitor 
glibenclamide prevented the protection by ventricular pacing. 
The intervening repel/usioll period It is self evident that an intervening reperfusion period is 
mandatory when myocardium is preconditioned with a total coronary artery occlusion as 
otherwise the period of sustained ischemia would merely be prolonged. Ischemic preconditiOlllng 
is a transient phenomenon as with reperfusion periods exceeding two hours the protective effect 
has dissipated 1141. However, when the duration of the intervening reperfusion period is increased 
to 24 hours the myocardium may again become preconditioned (15, 161. The evidence for this 
reappearance of protection is yet not as convincing as that for the classical preconditioning 1171. 
The necessitity of an intervening reperfusion period has been a point of discussion when 
myocardium is preconditioned by a partial coronary artery occlusion. Ovize et al could not trigger 
preconditioning with a 50% flow reductiou Iastiug 15 miu unless a period of complete 
reperfusion was allowed 161. In contrast. we found that a 70% flow reduction which was 
maintained for 30 min preconditioned myocardium without an intervening reperfusion period P}. 
\Vhether myocardium can be preconditioned when reperfusion during the intervening period 
after a brief total coronary artery occlusion is incomplete has not yet been investigated. These 
data would be of significant clinical importance as they are likely to mimic more closely the 
clinical situation than the abmpt occlusioIlRreperfusion protocols. 
The sustained total corOJ1wy arlelY occlusion. Studies in dogs suggest that with sustained 
coronary artery occlusions lasting longer than 90 min the protective effect of the preconditioning 
stimulus is lost !II. The protective effect of preconditioning should therefore be considered to be 
a shift in the time course of infarct size development {I,18}. 
The sllstained repeJ:filsion period Ischemic preconditioning could merely postpone myocardial 
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cell death during the early reperfusion period similarly to what has been described for a number 
of phannacological agents. That the protective effect of preconditioning persists and is not only 
a delay of cell death during the repemlsion period follows from studies that allowed 3-4 days of 
reperfusion prior to infarct size determination [1,19J. 
Other .features a/preconditioning. Some studies suggest a gradual disappearance of the 
protection effect already during the first hour of the intervening reperfusion period [20J, Our 
studies support the hypothesis that in the individual animal the protection does not wam off 
gradually but is more consistent with an Hall or nothingH phenomenon [211. 
A stimulus given immediately after preconditioning is lost will reinstate the cardioprotective 
action [221, but a stimulus given while the myocardium is still protected does not prolong the 
protective effect beyond that produced by the initial stimulus [231, Since patients may have 
multiple episodes of ischemia each day for a prolonged period of time, the question arises 
whether the protective action of ischemic preconditioning persists when multiple sequences of 
brief occlusions and reperfusions are continued for a period of hours to days, Cohen et al 
addressed this issue in awake rabbits subjected to 5 min occlusions at 30 min intervals for 8 
hours [241, After 3 to 4 days these repetitive occlusions did not protect the myocardium but after 
a stimulusM free period preconditioning could be recaptured with a single 5 min occlusion. 
Although it is unlikely that such a large array of multiple occlusions occurs in patients these data 
indicate that repetitive ischemia in patients could lose its protective effect, particularly as it is 
possible that preconditioning may already be lost after a smaller number of ischemic episodes, 
Many patients that encounter myocardial infarction are older than 50 years and are likely to 
have heal1s which are quite difterent from the normal hearts in which ischemic preconditioning 
has been demonstrated. The Framingham study revealed that left ventricular hypertrophy occurs 
in 12M40% of subjects older than 50 years [251. This would increase its potential clinical relevance 
if ischemic preconditioning could be demonstrated in hearts with left ventricular hypertrophy, 
Speechly-Dick el a{ indeed showed that rats with left ventricular hypertrophy can be 
preconditioned with a single 5 min coronary artery occlusion [261, 
Possible mechanisms of preconditioning 
Ischemic preconditioning has been demonstrated in several species which lack a significant 
coronary collateral circulation, and thus recmitment of co Hat era I blood flow by the brief ischemic 
periods can be excluded as a potential mechanism for ischemic preconditioning [271. Murry et al 
[II and others /2S1 reported reduced rates of glycolysis and high energy phosphate depletion, better 
preservation of pH and myocardial ultrastmcture during the sustained coronary artery occlusion 
of preconditioned hearts, The reduced rate of energy utilization was initially believed to result 
from a decrease in myocardial energy requirements secondary to the depressed contractile 
function produced by the brief period of reversible ischemia (Le. myocardial stUlUling), However, 
Matsuda ef al demonstrated that the myocardium remained protected when systolic segment 
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shortening in stunned myocardium was recruited by infhsion of dobutaminc within the allocated 
2 hours interval between the short and the longlasting coronary artcry occlusions ml, indicating 
that myocardial stunning is not a prerequisite for triggering cardioprotection. 
It was not until Downey and co-workers proposed a role for adenosine that a large number of 
studies began to focus on (sub)cellular mechanisms [301, Mechanisms that arc currently ascribed 
a pivotal role in ischemic preconditioning include adenosine, K+ A1P channel activation, and G-
protcinlProtein kinase C activation. For a detailed description of these mechanisms the reader is 
referred to one of many extensive reviews [2)0-331, 
Evidence for the existence of ischemic preconditioning in patients 
No clinical study can meet the strict conditions outlined for the experimental studies in Table 
1. Consequently, direct evidence for the occurrence of ischemic preconditioning with infarct size 
as endpoint is not available. A main source of error lies in the inability to accurately define the 
onset, duration and the completeness of the different occlusion and reperfusion phases as these 
do not necessarily coincide with the onset or relief of anginal pain or changes in the 
electrocardiogram. The extent of coronary collateralization is another important determinant of 
infarct size, which CaiUlot be quantified with sufficient degree of accuracy. Another shortcoming 
of clinical studies is the inability to accurately determine infarct size, for which often indirect 
measures (enzyme leakage, survival or left ventricular function) have to be relied 011. The area 
at risk is most often not determined which makes it impossible to relate the amount of necrosis 
to the area at risk. Finally, patients may be on medication that is capable of mimicking or 
inhibiting ischemic preconditioning (aminophylline, K+ATP channel modulators). Because 
reperfusion is mandatory following the sustained period of ischemia for preconditioning to be 
able to limit infarct size, shldies performed during the pre- and thrombolytic eras should be 
differentiated (Table 2) [lH51. 
Because of these limitations we also review studies in which multiple periods of ischemia 
have been investigated usually as part of a diagnostic or therapeutic intervention. If the 
mechanisms responsible for ischemic preconditioning (infarct size limitation) arc the same as the 
mechanisms responsible for myocardial adaptation (lesser signs of ischemia during the second 
of two periods of reversible ischemia) this would provide strong, though indirect, evidence that 
ischemic preconditioning may occur in the human heart. 
Several patient categories have been identified in which myocardial adaptation might exist 
{.f6A71, These include patients who have experienced two or more episodes of reversible ischemia, 
secondary to exercise stress tests, atrial pacing stress tests and percutaneous transluminal 
coronary angioplasty (Table 3) [48-651, Patients undergoing arterial cross-clamping as part of 
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cardiac surgery, and in-vitro studies in samples obtained from human hearts may provide 
additional evidence for ischemic preconditioning in man [66.68], 
Table 2. Evidence for ischcmic preconditioning to il'l'cvcrsiblc damage in man using 
indirect measurements of infarct size as endpoint. 
Allgina preceding il/farclioll 
Positi~'e results 
Without reperjusioll 
Referel/ces 
globallregionai wall function. ejection fraction [34·36J 
With I'epeljusioll (acute PTCA, thrombolysis) 
enzyme leakage [37J, [38J (T1MI-4) 
hypokinetic area/area beyond the stenosis [37] 
("IA/AR) 
heart failure, shock 
reocclusions 
short ternl survival 
Negalb'e results 
Without I'eperjusioll 
incidence of subendocardial infarction 
recurrent ischemia. infarct extension 
recurrent myocardial infarction 
heart failure 
short tenn survival 
long tenll survival 
With reperjusioll (acute PTCA, thrombolysis) 
recurrent angina and infarction 
residual stenosis 
heart failure 
Killip class 
[38J (T1MI-4) 
[39](TAMI) 
[39J (TAMI) 
[40J 
[46J (MiLlS) 
[4 I 1 (Framingham) 
[41J (Framingham) 
[40J 
[41] (Framingham) 
[42J (T1MIII) 
[42J (T1MIII) 
[43J 
[44J (ITPA/SMT) 
short teml sUfvival [42J (T1MIII), [43, 44] (ITPA/SMT), [45J 
long tenn survival [43] 
TAMI -l1lrombolysis and Angioplasty in Myocardial Infarction 
MILlS = Multicenter Investigation of the Limitation of Infarct Size 
TIMI = Thrombolysis in Myocardial Infarction 
ITPAiSMT = Intemational Tissue Plasminogen Activator i Streptokinase Mortality Trial 
PTCA = percutaneous transluminal coronary angioplasty 
lA = infarcted area 
AR = area at risk 
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Angina prior 10 an acute myocardial infarction Positive as well as negative results, which 
cannot be explained by the absence or presence of reperfusion by thrombolysis or acute 
percutaneous transluminal coronary angioplasty, have been reported in patients with angina prior 
to infarction (Table 2). Importantly, none of the studies reported positive results on long term 
survival. Tilis may be attributed to a greater prevalence of severe coronary artery disease and 
other risk factors such as age, smoking and presence of hypertension in the non-survivors. 
Because of the frequency of ischemic episodes prior to the occurrence of myocardial infarction 
it cantlot be excluded that in a number of patients tolerance to ischemic preconditioning had 
developed {241. Based on the currently available evidence it is premature to conclude that angina 
prior to myocardial infarction limits infarct size. Until more sensitive measures of infarct size and 
area at risk become available, and the incidence and duration and severity of occlusions can be 
more accurately determined, this question will likely remain unanswered. 
Repeated episodes of ischemia. In a large number of patients the first anginal attack in the 
morning is more severe than those occurring during the later hours of the day ('warm Upl 
phenomenon). A circadian variation in the autonomic tone may explain this observation 169J, but 
an alternative explanation could be that the less severe signs of ischemia during these later 
episodes are the result of adaptation triggered by the first episode. Exercise-induced ischemia is 
also less severe during the second of two identical exercise tests when these exercise tests are 
separated by a short recovery period [48.50J. It is unclear if exercise when stopped at the earliest 
signs of myocardial ischemia (as is often the case) is suntcient to protect the myocardium against 
irreversible damage during a subsequent myocardial infarction. 
Atrial pacing stress test. Early on it was recognized that the metabolic, electrocardiographic 
and functional responses to two pacing stress tests were not always reproducible when repeated 
at a short time interval. Several studies showed that the time to onset of angina was prolonged, 
while other signs of ischemia were less during the second test (Table 3), which is compatible 
with the hypothesis of myocardial adaptation. It is unknown whether pacing~induced ischemia 
may be too brief in duration and not sevcrc enough to elicit ischemic preconditioning. 
Angioplasty procedures. Several studies have reported that during the second balloon inflation 
signs of ischemia are less severe than during the first inflation (Table 3): Failure to observe 
adaptation might be due to the myocardium already being in an adapted state because of previous 
ischemic episodes [23] or had become resistant [24J. In addition, the duration of inflation might have 
been too short (60 sec) or the intervening reperfusion too long to trigger adaptation. Kerensky 
et al [62J reported that after pretreatment with intracoronary adenosine, the magnitude of ST-
segment changes during the first and second inflation was no longer different. Their findings 
could suggest that adenosine pretreatment already adapted the myocardium prior to the first 
inflation analogous to its protective effect on inf.:1rct size. Pretreatment with glibenclamide 
abolished the attenuation of intracoronary electrocardiographic changes during the second 
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Table 3. Myocardial adaptation to repeated episodes of reversible ischemia in man. 
Adaptation to angilla 
E.:wrcise stress lesl (" Warm tip" alld "Walk Ihrougll 1/ phellomelloll) 
decreased intensity of pain 
increased time to onset of pain 
less ST segment changes 
decreased anaerobic myocardial metabolism 
decreased myocardial 0l-demand (systemic hemodynamics) 
decreased myocardial 02-consumption 
increased coronary bloodflow 
Alrial paciltg stress test 
Positive results 
decreased intensity of pain 
increased time to onset of pain 
less ST segment changes 
decreased anaerobic myocardial metabolism 
decreased myocardial 02-coilsumptioll 
decreased myocardial 02-demand (systemic hemodynamics) 
Negatil'e results 
similar intensity of pain 
similar time to onset of pain 
similar ST segment changes 
similar anaerobic myocardial metabolism 
similar myocardial O~-collsumption 
similar myocardial 02-demand (systemic hemodynamics) 
Angiop/asl)' procedures 
Positive results 
decreased intensity of pain 
less ST segment changes 
decreased anaerobic myocardial metbolism 
improved global hemodynamics 
Negative results 
similar ST segment changes 
similar global hemodynamics 
similar anaerobic myocardial metabolism 
Aorlic ('ross clamp during caf(/iac surgery 
slowing of high energy phosphates degradation 
III )'ilro studies 
/solated h,IllUIII rigllt atrial tmbecu/(fe 
References 
[48J 
[49,50J 
[49,50J 
[50] 
[48,49J 
[50J 
[49J 
[51,52J 
[51 J 
[52-54J 
[52-54J 
[52J 
[53, 54J 
[55J 
[55] 
[51J 
[55J 
[55J 
[51] 
[56-60J 
[56-58J, [60-62J 
[57J 
[57,58J 
[63-65J 
[59J 
[65] 
[66J 
less deterioration of contractile function [67] 
HUll/till I'ellfricular mYllcyles 
decretlsed cell death, decreased H~, preserved aerobic myocardial metabolism [68] 
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balloon inflation [60], suggesting that activation ofK\TP channels was involved in this study. 
Studies in human myocardial samples. Yellon et af [66J randomly assigned patients to a 
sustained period of global ischemia consisting of 10 min cross-clamping without (control) and 
with two preceding sequences of 3 min cross-clamping and two min of reperfusion 
(preconditioning). AIP levels were decreased after the preconditioning protocol when the 10 min 
cross-clamping period was started but by the end oftllis period AIP levels in the preconditioned 
group were higher than in the control group. These observations are in agreement with the 
original observations by Murry et at who showed that ischemic preconditioning slows energy 
metabolism during a sustained coronary artery occlusion [I]. 
\Valker et al 167l suspended right atrial trabeculae in an organ bath and preconditioned one 
group with 3 min of pacing (180 pulses/min) while Sl'perfusing the trabeculac with a hypoxic and 
substrate-free buffer. As an intervening reperfusion period the trabeculae were paced at 60 
pulses/min for 10 min in a reoxygenated buffer with substrate. The preconditioned group and a 
control group were then subjected to pacing (180 pulses/min) for 90 min during superfusion with 
a hypoxic and substrate-free buffer and by 120 min ofreoxygenation and pacing at 60 pulses/min. 
At the end of this period recovery of function was twice as in the preconditioned group period 
large as in the control group. 
Summary and Conclusion 
Direct clinical evidence for the classical preconditioning phenomenon with infarct size 
limitation as endpoint cannot be obtained but a number of patient groups have been identified 
in which adaptation to ischemia has been demonstrated by enhanced recovery of function or 
preservation of high energy phosphates in models of repeated ischemia such as atrial pacing 
stress tests, percutaneous transluminal coronair angioplasty and aortic cross-clamping during 
cardiac surgery. Evidence is accumulating that mechanisms which are operative in experimental 
ischemic preconditioning (infarct size limitation) are also operative in these clinical models of 
repeated reversible ischemia. Insight into the mechanisms responsible for ischemic 
preconditioning could potentially help to develop pharmacological agents which mimic 
preconditioning. This is especially attractive as several of the ischemic episodes maybe too short 
or not severe enough to trigger preconditioning. By a synergistic or additive action combination 
of such a stimulus and low dose of pharmacological agent might result in a protective action. If 
these agents were also to be used for treating cardiovascular conditions, such as the K\TPchatmel 
activator nicorandil for the treatment of angina pectoris, the cardioprotective effect could be a 
beneficial side effect. The cUlTentIy available protein kinase C activators are oncogenic, but with 
the recognition and better understanding of the different subtypes possibly involved in 
preconditioning, new protein kinase C activators may become available without these side-
effects. On the other hand, hearts of patients who regularly experience episodes of ischemia may 
be in a more or less permanent state of preconditioning afforded by one of these stimuli or have 
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developed tolerance. In this situation it is not unlikely that (additional) protection by a 
pharmacological agent cannot be accomplished at that time. It is reassuring, however, that in the 
animal preconditioning can be reinstated immediately after the cardioprotection is lost and that 
it can also be demonstrated in hearts with pathologic conditions such as hypertrophy. 
Finally, in view of the observations that cardioprotection may also be produced by transient 
ischemia in other organs and even some forms of stress which do not lead to myocardial 
ischemia, it could be envisioned that ischemic preconditioning is only one component of a 
general form of cardioprotection. 
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Endocardial and epicardial infarct size after preconditioning by a partial coronary 
occlusion without intervening reperfusion. 
Importance of the degree and duration of flow reduction 
Monique M.G. Koning, MD, PhD; Ben C.G. Gho, MD; Erik van Klaarwater, MSc; 
Dirk J. Duncker, MD, PhD; Pieter D. Verdonw, PhD. 
Backgroulld Recently, we reported that a partial coronary artery occlusion immediately 
preceding a sustained coronary artery occlusion limited infarct size. Vole now investigated 
whether the protection by partial coronary artery occlusions (i) depends on the severity and(or) 
duration of the flow reduction and (ii) varies in the different myocardial layers. 
Melilods ami Results In 71 open·chest pigs (eight groups) left ventricular area at risk (AR) 
and infarct area (IA) were determined for the endocardial (I1\ndo and ARendo) and epicardial 
halves (IA"i and AR",), In control animals [60 min total coronary artery occlusion (TCO) 
followed by 120 min reperfusion (Rep)) there were highly linear relations between IA and AR 
in the endocardium (FO.98, p<O.OI) and epicardium (1~0.97 ,p<O.OI), which could be described 
by 11\"" ~ I.OIAR.,,,,, - 4.5 and by IA",i ~ 0.88AR.,pi - 3.6, respectively. In animals that underwent 
a 10 min TCO + IS min Rep prior to the 60 min TCO + 120 min Rep, IA in both myocardial 
layers were again highly linearly related with AR, with less steep slopes for both the endocardium 
(0.63) and epicardium (0.57) (both p<O.OI). Two groups of pigs were subjected to either a 30 or 
90 min 70% reduction in coronary blood flow (FR) immediately preceding the 60 min TCO + 
120 min Rep, without intervening reperfusion, A 30 min 70% FR decreased IA to the same 
degree in the endo- and epicardial half. A 90 min 70% FR resulted in protection in the 
epicardium (p<0.0 I) but not in the endocardium, most likely because 90 min 70% FR without 
60 min Teo already caused infarction which was more severe in the enda- than in the 
epicardium (p<0.01). Endocardial and epicardial IA after either a 30 or 90 min 30% FR prior to 
the 60 min TCO was not different from that in the control group, indicating that this mild flow 
reduction failed to limit irreversible damage. 
COllclusions Thirty or ninety min of severe (70%) but not mild C30%) coronary flow 
reductions protected against myocardial infarction. The protection by a 70% FR was influenced 
by the duration of FR as a 30 min 70% FR similarly decreased IA in the endocardial and 
epicardial halves, while 90 min 70% FR preferentially limited IA in the epicardial half. These 
fhidings suggest that perfusion abnormalities immediately preceding an infarction could be an 
important source of infarct size variability in patients. 
Keywords myocardial ischaemia, myocardial infarct size, systolic segment shortening, pig, 
anesthetized, coronary blood flow. 
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Recently, it has been reported that not only total[I-9] but also partial[IO,IIJ coronary artery 
occlusions can precondition the myocardium, Thus, Ovize et aP IO] observed in dogs that the 
development of myocardial necrosis during 60 min total coronary artery occlusion was attenuated 
when coronary blood flow was reduced by 50% for 15 min preceding the sustained coronary 
artery occlusion, In that study 15 min of complete reperfusion between the graded coronary artery 
stenosis and the sustained total coronary occlusion was necessary to. obtain the reduction in 
infarct size, In contrast, we observed in pigs that a 70% coronary flow reduction that lasted 30 
min protected the myocardium during a subsequent 60 min total coronary artery occlusion 
without the need ofintenrening reperfusionP I] These findings appear contradictory but could also 
suggest that the severity and duration of the flow reduction playa critical role in eliciting 
protection. Although ischaemic preconditioning has been the topic of many studies, none of these 
investigated whether the protection afforded was the same for the different myocardial layers 
across the left ventricular wall. It is well established that a partial coronary artery occlusion 
affects perfusion of subendocardial~ more severely than of subepicardial layers.{1l-17] Thus, 
differences in severity of ischaemia across the left ventricular wall could produce different 
degrees of protection for different myocardial layers. 
To address these questions we investigated (i) whether the protection exerted by partial 
coronary artery occlusions depends on the severity and(ar) duration of the flow reduction and (ii) 
the transmural distribution of this protection. These issues are of particular clinical interest, since 
preconditioning with partial occlusions mimics more closely the condition of patients suffering 
from coronary artery disease than the abmpt brief total occlusion and reperfusion sequences. To 
compare the protective effects of the partial and total coronary artery occlusion stimuli we also 
analyzed the subendocardial and subepicardial distribution of infarct size of pigs preconditioned 
with a single 10 min total coronary artery occlusion.[IO] 
Methods 
Experimental Design 
All experiments were performed in accordance with the "Guiding principles in the care and 
use of animals" as approved by the Council of the American Physiological Society and under the 
regulations of the Animal Care Committee of the Erasmus University Rotterdam, 
Experimelltal Grollps (figllre I) 
The results of eight groups of animals are presented. A total of79 animals entered the study, 
of which 20 animals underwent a single 60 min total coronary artel), occlusion (TCO), followed 
by 120 min of reperfi.sion (Rep) (Group I), while II animals underwent a 60 min TeO preceded 
by a single 10 min TCO + 15 min Rep (Group 2). Four groups underwent a partial coronary 
artery occlusion of either 30 min [Group 3 (n~1 0) and Group 6 (lF8)] or 90 min [Group 4 (n~9) 
and Group 7 (n~8)], before the ar1ery was occluded completely for 60 min without intervening 
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reperfusion. The partial occlusions were chosen such that coronary blood flow was reduced by 
either 70% (Groups 3 and 4) or 30% (Groups 6 and 7) of baseline. When necessary, small 
adjustments were made in the volume of the balloon to keep the flow at its reduced value during 
the partial coronary artery occlusion period. In all animals the ischaemic myocardium was 
reperfused for 120 min following the 60 min total coronary artery occlusion. Because it is 
conceivable that episodes of ischaemia lasting longer than 30 min already lead to necrosis before 
the 60 min Teo period, two groups of animals underwent 90 min of either 70% FR (Group 5, 
n~8) or 30% FR (Group 8, n~5) followed by 120 min Rep withollt the 60 min TCO. Transmural 
infarct size data of 12 animals afthe control group and 10 animals that were preconditioned with 
a single 10 min total coronary artery occlusion, as well as 7 animals with a 30 min 70% FR have 
been presented in an earlier study. (II) 
EXPERIMENTAL GROUPS 
Group _____ =6iolmliniiiTICiiO~ _ ___.:1~2~O,/m,i/n Rep 1 (n~19) Controt . _ 
Stimuli 
2 (n= 10) 10 min TCO + 15 min Rep ___ -.fI7l:L__.I ••• L ___ ,,/ ,>'/'----__ 
3 (n~9) 30 min 70% FR ____ .G1;r;·.xoz> ••• L ___ ----,'/ ,/'----__ 
, r 
4 (n=7) 90 min 70% FR cl/'5vZ"Z/2·,:S;:v§v'5'Zc2<j, ••• L ___ --,'/ //'----_---" l..! ) r 
5 (n=7) 90 min 70% FA [7-,,·2:/,27;)/':;/,,·.;';",2/;)/;], lL ______ --,'/ ,/'----_---" 
7 r 
6 (n=7) 30 min 30% FA 
7 (n=7) 90 min 30% FA 
8 (n=5) 90 min 30% FR 
[2] :::: FR :::: Flow Reduction 
-----===-.... L-----7///--~ 7 r-
=
====-___ -,</ L-/ --" 
, ~ 
~===~--------7/ L/ __ --' 
"'- 7 /' 
time (min) 
• = TCO = Total Coronary Artery Occlusion 
Figure 1. Experimental protocols of the 8 groups of animals in which the distribution of infarction size was 
detemlined. TIle 60 min total coronary artel), occlusion (60 min TeO) has been indicated in black. flow reductions 
have been indicated with a cross-hatch pattern, Teo = total coronary artery occlusion, Rep = reperfusion, FR = flow 
reduction, The number of animals which completed the experimental protocols has been presented in parentheses, 
Surgical Procedures 
Domestic Yorkshire-Landraee pigs (IF79, 25-35 kg, HVC, Hedel, The Netherlands) were 
anaesthetised with pentobarbital and instrumented for measurement of arterial blood pressure and 
control of arterial blood gases,[lg] After administration of pancuronium bromide (4 mg i.v., 
Organon Teknika B.V., Boxtel, The Netherlands), a midline thoracotomy was performed and an 
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electromagnetic flow probe (Skalar, Delft, The Netherlands) was placed around the ascending 
aorta to measure cardiac output. In the control animals the left anterior descending coronary 
artery (LA DCA) or its diagonal branchcs supplying the left ventricular anterior wall were 
dissected free from the surrounding tissue to allow placement of a microvascular clamp. The 
anatomic location of the occlusion site was varied to create areas at risk of different sizes. {II] In 
the animals which underwent a partial occlusion preceding the total coronary artery occlusion, 
a proximal segment of the LADCA was dissected free for the placemcnt of a probe for pulsed 
Doppler flow velocimehy (Oystal Biotech, Hopkinton, MD, U.S.A.) and an inflatable balloon 
(R.E. Jones, Silver Spring, MD, USA) to occlude the vessel in two stages. In the animals of 
groups 4-8, the great cardiac vein was catmulated to allow selective sampling of venous· blood 
draining the myocardium perfused by the LADCA. 
Regiolla/ll1yocardial COlltractile FUllction 
A pair of ultrasonic crystals (Sonotek Corporation, Del Mar, CA, USA) was positioned into 
the subendocardial layers of the left ventricular myocardium in the distribution legion of the 
LADCA for the measurement of segment sh0l1ening by sonomicrometry (Triton Technology, San 
Diego, CA, USA). From the segment length tracings the segment lcngth at the start of ejection 
(EL, onset of positive ascending aortic flow) and the length at thc cnd of systole (ESL, positive 
aortic flow crossing the zero flow line) were determined and regional segment sh0l1ening during 
ejection was computed as: 
SS(%) ~ 100 x (EL - ESL)IEL, 
while post-systolic segment shortening was computed as: 
PSS(%) ~ 100 x (ESL -minimal segment length)/EL. 
Experimelltal Protocols 
After completion of the instrumentation, a stabilization period of at least 30 min was allowed 
before the animals were subjected to the experimental protocols. Systemic haemodynamic 
variables and regional segment length changes were recorded throughout the experimental 
protocols. \Vhen necessary, in the animals subjected to the partial coronary altery occlusions 
(Groups 3-8) small adjustments were made in the volume of the balloon to keep the flow at its 
reduced value during the partial coronary artery occlusion period. In case of ventricular 
fibrillation defibrillation was started within 30 s, using DC countershocks (15-30 Watt). If 
defibrillation was successful within 1 min animals were allowed to complete the experimental 
protocol, since this procedure does not produce irreversible damage. Animals in which 
defibrillation could not be accomplished within I min were excluded from further study. 
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Area at Risk alld Illfarct Area 
Validation of the methods to determine the area at risk and infarct area has been described 
extensivelyp,J9,20] Briefly, following reocclusion of the LADCA the area at risk was identified 
by an intra~atrial injection of 15 ml of a 10 % (w/w) solution of tluorescein sodium (Sigma 
Chemical Co, St. Louis, USA). Ventricular fibrillation was produced with a 9V battery and the 
heart was excised. Both atria, the right ventricular free wall and the left ventricular epicardial fat 
were removed. The left ventricle (LV) was filled with alginate impression material (Bayer 
Dental, Leverkussen, Gennany), cooled in crushed ice and sliced parallel to the atrioventricular 
groove into 5 segments. The cut sur£1ce(s) of each segment and the demarcated areas at risk CAR) 
were then traced onto a transparent acetate sheet under an ultraviolet light. The viable 
myocardium was then stained deeply purple by incubating the segments for 20 min in 0.125 g 
para-nitrobluetetrazolium (Sigma Chemicals Co., St. Louis, USA) per litre of phosphate buffer 
(pH 7.1) at 37°C and the non-stained pale infarcted tissue was traced onto the acetate sheet. The 
surface of each ring was subsequently subdivided into a subendocardial (inner) half and a 
subepicardial (outer) half by drawing a line which divided the myocardial wall into two layers 
of equal thickness. Division into two layers was done as it provides information on the 
transmural distribution of infarct size, yet preserving sufficient accuracy of infarct size 
determination in the two halves. Surface areas of the subendocardial and subepicardial halves, 
and of the subendocardial and subepicardial areas at risk and infarct areas (IA) were determined 
and averaged for the basal and apical side of each individual ring. Then the fraction of the ring 
that was infarcted and at risk was multiplied by the weight ofthe ring to yield the weight of the 
infarct area and area at risk for that ring. The weights of the subendocardial and subepicardial 
halves and the total weight of each ring were then summed to yield the LVendo• L Vepi and total LV 
masses. The weights of the endocardial, epicardial and total areas at risk of each ring were 
summed to yield the total AR.:lldo, ARepi and total AR masses; the weights of the endocardial, 
epicardial and total infarct areas of each ring were summed to yield 11\ndo, IAepi and total IA 
masses. Endocardial, epicardial and total IA and AR data were expressed as a percentage of 
LVelldo, LVepi and total LV masses, respectively. 
Data Analysis alld Presentation 
In earlier studies we observed that in pigs the relation between IA and AR is highly linear but 
not proportional i.e. the linear regression line has a positive intercept on the AR-axis. 11 Because 
this makes the IN AR ratio dependent on the absolute AR, infarct size data arc presented by 
plotting the IA as a function of AR. Linear regression analysis was performed to determine the 
relation between endocardial and epicardial IA and AR in the control group and the 'animals 
preconditioned with 10 min Teo + 15 min Rep. For the animals that underwent the two-stage 
coronary artery occlusion the individual data are presented. Intergroup differences in 11\000' Il\pi' 
or total IA were analyzed. with AR.:lldo' ARepi or total AR as respective covariatcs, by analysis 
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of covariance (AN COY A) followed by modified Bonferroni procedure to correct for multiple 
comparisonsYI] Intragroup differences between IA.:ndo and IAepi were, analyzed with AR.:ndo and 
ARepi as respective covariates, using ANCOV A for repeated measures. The incidence of 
ventricular fibrillation was analyzed by Fisherts exact test. Haemodynamic data were analyzed 
with two-way (experimental group and time course) ANOYA followed by paired t-test 
(intragroup comparison) or unpaired tRtest (intergroup comparison). A p value of less than 0.05 
was considered statistically significant (twoRtailed). Data are presented as mean(SEM). 
Results 
Mortality alld Exclusiolls 
In both the control group (60 min TCO, Group I) and the 10 min TCO + 15 min Rep group 
(Group 2), onc animal was excluded because defibrillation was unsuccessful during the 60 min 
TCO. Two animals which underwent a 30% FR [one pig for 30 min (Group 6) and the other for 
90 min (Group 7)] could also not be defibrillated during the 60 min TCO period. Two animals 
died because defibrillation was unsuccessful during 70% FR (15 min and 20 min after onset of 
the flow reduction in Groups 4 and 5, respectively), while one animal in Group 5 was excluded 
from study because of technical failure of the balloon occluder. One animal was excluded from 
Group 4 because of incomplete reperfusion due to vasospasm after 60 min TCO. Infarct sizes 
have therefore been presented for 71 of the 79 animals that entered the study. 
Velltricular Fibrillatioll (Table 1) 
During the 60 min TCO ventricular fibrillation occurred in 8 of the 20 control animals, and 
in 5 of the II animals that had been subjected to 10 min TCO + 15 Rep (p~NS). Animals that 
fibrillated during 60 min TCO had larger areas at risk than animals that did not fibrillate (35±3% 
vs 19±2%, respectively. p<O.Ol). A 30 min 70% FR also failed to exert a protective effect on the 
incidence of ventricular fibrillation during the subsequent 60 min TCO (area at risk 27±2%) but 
ventricular fibrillation was absent (0 of 8, p<0.05 vs control group) in the animals that were 
preconditioned with 90 min 70% FR (area at risk 38±3%). In contrast, the incidence of 
ventricular fibrillation during the 60 min TCO in the groups preconditioned with either a 30 or 
90 min 30% FR (area at risk 35±2%) was not different from the control group. Thus, while the 
protective effect of a 90 min 70% FR could not be explained by differences in area at risk, the 
findings indicate that severity and duration of the partial flow reduction critically determine its 
protection against ventricular fibrillation duration a sustained ischaemic episode. Upon 
reperfusion ventricular fibrillation was rare, which is in agreement with studies showing that 
ventricular fibrillation occurs predominantly after TCOts with a duration between 10 min and 30 
min. [22,23J 
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Table 1. Ventricular fibrillation in all experimental groups 
Groups Preconditioning slimulus 60 min Teo Reperjllsioll 
(I) Control 8(20)' 2(19)' 
(2) 10 min Teo + 15 min Rep + 60 min Teo 2(11 )" 5(11)' 3(10)" 
(3) 30 min 70% FR +60 minTeD 0(9) 3(9) 0(9) 
(4) 90 min 70% FR +60min TCO 1(9) 0(8)' 0(7) 
(5) 90 min 70% FR 1(8) 0(7) 
(6) 30 min 30% FR + 60 min TCO 3(8)' 2(8)' 1(7) 
(7) 90 min 30% FR + 60 min TeO 0(8) 6(8) 0(7) 
(8) 90 min 30% FR 0(5) 0(5) 
Between parentheses are the total numbers of animals per group at that moment still in the study. Teo - Total 
coronary artery occlusion, Rep = Reperfusion, FR = Coronary Flow Reduction, • one pig fibrillated during both 
60 min TeO and Reperfusion, b one pig fibrillated during both the preconditioning stimulus and Reperfusion, Cone 
pig fibrillated during both the preconditioning stimulus and 60 min TeO, ·p<0,05 vs Control 
In/arct Area - Area at Risk Relatioll in COlltrol Pigs aud Pigs Preconditioned witlt a Sillgle 
10 mill TeO (figure 2) 
In the control group there was a linear relation (r=O.98, p<O.OOI) between Il\ndoand AR(ndo 
which could be described by I1\,do ~ 1.0 I AR,"dO - 4.5. In Ihe epicardial half of Ihe left ventricle 
we also observed a linear relation (1"""0.97 , p<O.OOI) which could be described by I1\pi ~ 
O.88AR"pi - 3.6. ANCOV A (with AR"oJo and AR"pi as respeclive eovariales) revealed that 11\,do 
was slighlly larger than 11\" (p<0.05). 
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Figure 2. Individual data points detennining the relation betwecn infarcted area and area at risk in the transmural 
left ventricular wall (left pane\). epicardium (middle panel) and endocardium (right panel), expressed as a 
percentage of left ventricular (LV), endocardial (L V.d .,) or epicardial mass (LV.vJ, respectively. Shown are the 
regression line and individual data points in thc control group (60 min total coronary occlusion, TCO)(open circles) 
and the individual data points in the animals preconditioned with 10 min TCO + 15 min Rep prior to the 60 min 
Teo (closed circles). Infarct size limitation aftbrded by the \0 min TCO + 15 min Rep was of similar magnitude 
in the cndo- and epicardium. 
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Preconditioning With 10 min TeO + 15 min Rep decreased infarct size in both the inner and 
outer half ofthe left ventricle. The infarct areas in the endocardium and epicardium were again 
linearly related with the areas at risk: 11\,do ~ 0.63AR",o - 3.19 (FO.79; p<O.OI) and 
11\" ~ 0.57 AR"p' - 3.38 (FO.94; p<O.OI). ANCOVA (with ARe"""or ARep,as covariates) indicated 
that both 11\"", and 11\" were smaller in the 10 min TCO + 15 min Rep group compared to the 
control group (both p<O.OI). The degree of protection afforded by 10 min TCO + 15 min Rep 
was nearly identical for the imler and outer halves of the left ventricle (F~0.68; p~0.42). 
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Figure 3. Individual data points detemliuing the relation beh\'een infarcted area and area at risk in the transmural 
left ventricular wall (left panel), epicardium (middle panel) and endocardium (right pane!), expressed as a 
percentage of left ventricular (LV), endocardial (LV end,,) or epicardialillass (LVe,.), respectively. Shown are the 
regression line and individual data points for the control group (60 min total coronary occlusion, TCO)(open 
circles), and individual data points for animals subjected to a 30 min 70% coronary flow re'duction (FR) followed 
by60 min TCO (closed squares), a 90 min 70% FR followed by 60 min TCO (closed triangles pointing upward), 
and a 90 min 70% FR without the 60 min TCO (open triangles pointing downward). Note that a 70% FR which 
itself resulted in significant infarction after 90 miu, still provided protection against the irreversible damage 
produced by 60 min TCD. 
Illjarct Area - Area at Risk Relatioll ill Pigs UlIllergoillg Two Stage Corollary Artery 
Occlusioll 
70% Flow Reductioll (figure 3) 
Transmural lnjil/'ci Size. When the 60 min TCO was preceded by a 30 min 70% FR, 
transmural infarct size was significantly smaller compared to the control group. Extending the 
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duration of the 70% FR to 90 min produced similar protection against infarction compared to the 
30 min 70% FR animals. A 90 min 70% FR without the 60 min TCO already resulted in some 
myocardiaillecrosis. Nonetheless the individual transmural data points of animals subjected to 
a 90 min 70% FR and 60 min Teo remained below the regression line of the control group 
(p<0.0 I) indicating protection against irreversible myocardial damage produced by the 
subsequent 60 min TCO. 
Distribution of Infarct Size. The 30 min 70% FR decreased infarct size in both endo- and 
epicardial halves compared to the control group (p<0.0 I). The protection tended to be greater in 
the epicardium than in the endocardium but this failed to reach statistical significance (p~0.16). 
When the duration of the 70% FR was extended to 90 min, infarct size limitation in the outer half 
of the left ventricle was similar to that observed with the 30 min 70% FR. Infarct size was also 
reduced in the endocardium (p<0.05 vs control group), but the degree of protection produced by 
the 90 min 70% FR was greater in the epicardium than in the endocardium (p<O.O I). The 90 min 
70% FR alone resulted in infarction in both endo- and epicardium, with the greater infarct size 
in the endocardium (p<0.01 endocardium vs epicardium). The addition of a 60 min TCO 
increased infarct size slightly further in both endocardium (p<0.05) and epicardium (p<0.0 I), so 
that the amount of additional necrosis produced by the 60 min TCO was not different for the 
endocardium and the epicardium (p~0.20). 
30% Flow Reduction (figure 4) 
Transmural Infarct Size. Transmural infarct size in animals subjected to a 30 min 30% FR 
prior to the 60 min TCO was not different from that of the control group (figure 4). Extending 
the period of flow reduction to 90 min did also not alter infarct size produced by a 60 min TCO, 
indicating that exposure to such mild flow reductions fails to limit irreversible ischaemia damage 
during a subsequent 60 min TCO. A 90 min 30% FR without the 60 min TCO did not produce 
myocardial necrosis (figure 4). 
Distribution of Infarct Size. Endocardial and epicardial infarct sizes in animals subjected to 
the 30 or 90 min 30% FR prior to the 60 min TCO were not different from those of the control 
group (figure 4). The 90 min 30% FR alone did not produce myocardial necrosis in either the 
outer or inner half of the left ventricle. 
Systemic Haemodynamic Variables and Segment Sltortening (Table 1/) 
Baseline values (n~71) of heart rate (l10±2 beats min· I), mean arterial blood pressure (89±1 
mmHg), cardiac output (2.9±0.1 L min· l ) or the product of heart rate and systolic arterial pressure 
(l2200±270 beats nmlHg min· l ) were not statistically different between the eight experimental 
groups. In all groups the 60 min TCO tended to increase heart rate, but this reached levels of 
statistical significance only in groups 3,4 and 7. Although in most groups cardiac output was 
significantly lower at the end of the 60 min Teo compared to baseline levels, mean a011ic 
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Figure 4.lndividual data points detemlining the relation between infarcted area and area at risk in the transmural 
left ventricular wall (left panel), epicardium (middle panel) and endocardium (right panel), expressed as a 
percentage of left ventricular (LV), endocardial (LV.od~) or epicardial mass (LVopJ' respectively. Shown are the 
regression line and individual data points for the control group (60 min total coronary occlusion, TCO)(open 
circles), and individual data points for animals subjected to a 30 min 30% coronary flow reduction CFR) followed 
by 60 min TCO (closed squares), a 90 min 30% FR followed by 60 min TCO (closed triangles pointing upward), 
and a 90 min 30% FR without the 60 min TCO (open triangles pointing downward). Note that a 30% FR which 
itself did not result in significant infarction after 90 min, failed to protect against the irreversible damage produced 
by 60 min TCO. 
pressure was generally maintained. The preconditioning stimuli had only minor effects on heart 
rate or mean aortic blood pressure. In the 10 min TeO + 15 min Rep group, the preconditioning 
stimulus produced significant decreases in cardiac output (l4±3% from baseline, p<O.O I) and a 
reduction in segment shortening in the LADCA perfused area (to 61±6% of baseline, (p<O.Ol)), 
with no effect on heart rate or central arterial blood pressure. Similarly, the 70%FR produced a 
16±2% decrease in cardiac output and decreased segment shortening to 13±5% of baseline. In 
contrast, a 30% FR produced a significant decrease in segment shortening (to 63±8% of 
baseline), with negligible effect on global cardiac pump function. 
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Table II: Systemic hacmodvnamics! global and regional Ill~focardial function in group:s 1-8. 
Baseline End·stimulus 60min TeO 120min Rep 
Group I (0=19) 
HR 114±3 120±5 119±5 
MAP 89±1 89±2 88±2 
CO 3.0±0.2 2.5±0.I' 2.4±0. I' 
ss I 5.5±!. I 0.9±0.5' 1.8±0.5' 
Group 2 (n~IO) 
HR 107±6 108±4 113±4 117±7 
MAP 90±2 90±2 86±3 83±3 
CO 3.2±0.2 2.8±0.I' 2.3±0. I' 2.2±0.1' 
SS 20.7±1.9 11.7±1.4' 1.7±1.2' 2.0±I.I' 
Group 3 (n~9) 
HR 91±7 92±6 103±6' 134±7' 
MAP 90±2 88±3 90±1 83±3 
CO 2.7±0.2 2.4±0.2' 2.3±0." 1.8±0. I' 
SS 18.4±1.4 2.7±1.3' -0.4±0.8' -1.2±0.7' 
Group 4 (0=7) 
HR III±II 119±13 126±13' 144±IO' 
MAP 90±2 86±3 81±4' 78±4' 
CO 2.8±0.2 2.2±0.2' 2.1±0.2' 1.7±0.1' 
SS 15.9±1.5 0.9±0.9' -0.3±0.2' 0.0±0.6' 
Group 5 (0=7) 
HR 100±4 102±4 126±II' 
MAP 85±2 78±4 71±6 
CO 2.7±0.2 2.2±0.2' 1.9±0. I' 
SS 16.4±3.0 2.4± 1.9' 1.4±1.2' 
Group 6 (1\=7) 
III< 127±11 120±12 131±12 155±II' 
MAP 91±2 84±3' 78±4' 73±3' 
CO 3.2±0.3 2.8±0.3' 2.4±0.2' 2.3±0.3+ 
SS 17.6± 1.5 1O.1±3.I' 1.7±1.1' 1.4±0.9' 
Group 7 (n=7) 
HR 113±8 112±8 125±9' 133±9' 
MAP 84±3 83±3 79±3 77±5 
CO 2.4±0.2 2.3±0.1 1.9±0.9 1.7±0.2' 
SS 17.7±1.I 14.5±1.0+ -0.1±0.3' 0.4±0.5' 
Group 8 (n=5) 
IIR 115±7 120±6 136±9' 
lvlAP 89±4 85±6 90±5 
CO 3.1±0.2 2.8±0.3 2.8±0.3 
SS 13.1±2.7 7.1±3.3' 8.0±2.0 
TCO -Total coronary artery occlusion, Rep-Reperfusion. HR-heart rate (bpm), MAP-mean aortic pressure 
(mmHg), CO=Cardiac output (Umin). SS=segment shortening during left ventricular ejection (%). Data are mean 
±SEfvl. ·p<O.05. ·p=O.07 vs Baseline. See figure 1 for description of the groups. 
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Relation to InfarCt Size. Analysis of covariance with the infarct area as depen~ent factor, the 
experimental groups as independent factor, and the area at risk and rate pressure-product (either 
at baseline or at the onset of 60 min TCO) as covariates did not reveal a significant correlation 
between the product of heart rate and systolic arterial pressure and infarcted area (p>O.l 0). 
Similar results were obtained when heart rate or systolic arterial pressure were entered as separate 
covariates into the ANCOV A. 
There was no correlation between the loss of systolic wall thickening produced by the 
preconditioning stimuli and the infarct size. Similarly, we did not observe a correlation between 
ejection segment shortening at the end of 120 min Rep and IAiAR ratio, indicating that ischaemic 
preconditioning did not lead to improved functional recovery during the first 120 min of 
reperfusion. In contrast, a modest but significant (r=0.49, p<O.OI) inverse correlation was 
observed between the magnitude of post-systolic shortening (a marker of myocardial tissue 
viabilityY241 of the anterior wall at the end ofreperfusion and transmural IAiAR. 
Respollses o/Regiollal Myocardial Per/I/siol/, Metabolism al/d COl/troctife FI/I/ctiollto Partial 
Corollary Artery Oec/I/siol/s. (figl/re 5) 
The 30% and 70% reductions in coronary blood flow resulted in decreases in myocardial 
oxygen consumption as the increase in oxygen extraction, which was significantly greater in the 
70% FR than in the 30% FR animals, was clearly insufficient to compensate for the decreases 
in coronary flow. The decreases in flow were accompanied by a flow reduction dependent 
increase in the arterio-coronary venous pH difference, which is in this model highly linearly 
related to lactate release due to increased anaerobic metabolismPS] Another indication of 
ischaemia was the flow reduction dependent loss of segment shortening and appearance of post-
systolic shortening. All variables remained constant between 15 min and 90 min of 30% FR and 
70% FR, with the exception of the arterio coronary venous pH difference which recovered 
towards baseline levels. This suggests that despite ongoing hypoperfusion, anaerobic metabolism 
could have been due to the loss of myocytes allowing the remaining myocytes to shift from 
anaerobic to aerobic metabolism. However, necrosis is unlikely to occur within 30 min, at which 
time significant recovery of the pH difference was noted. Furthermore, in ~he 30% FR animals 
no necrosis occurred, thus excluding myocyte dropMout as a mechanism for the metabolic 
adaptations in that group. 
Discussion 
This study has presented several new findings. I) Infarct size limitation afforded by a single 
10 min total coronary miery occlusion and 15 min reperfusion preceding a 60 min total (jOfonary 
aliery occlusion is distributed homogeneously across the left ventricular wall in pigs. 2) Infarct 
size was also limited by a 30 Of 90 min 70% FR prior to a 60 min Teo without the need for 
intervening reperfusion. The transmural distribution of this protection depended critically on the 
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Figure 5. Alterations in perfusion, metabolism and contractile performance in the distribution area of the left 
anterior descending coronary artel), produced by 30% (circles) and 70% (squares) coronary blood flow reductions 
(FR). Data have been pooled for all animals undergoing either 30% FR (n=J9) or 70% FR (n=14). %6. CBF = 
coronary blood flow, MV02 = myocardial oxygen consumption, ~ = fractional myocardial oxygen extraction 
computed as the arteria· coronary venous oxygen content difference divided by the arterial oxygen content, 
L\pH=diffcrence in pH of the arterial and local coronar), venous blood, SS = fractional segment shortening during 
left ventricular ejection, PSS = post-systolic segment shortening. *p<0.05 vs baseline, tp<0.05 70% FR vs 30% 
FR, 
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duration offIow reduction. Thus, whereas a 30 min 70% FR produced similar decreases in infarct 
size in the inner- and outer half of the left ventricle, a 90 min 70% FR resulted in preferential 
epicardial infarct size limitation. 3) Protection against myocardial infarction or ventricular 
fibrillation was not afforded by either a 30 or 90 min 30% flow reduction. 4) The incidence of 
ventricular fibrillation during the 60 min total coronary artery occlusion was not altered by the 
30% flow reduction but was significantly reduced when a 90 min 70% FR preceded the sustained 
ischaemia period. The implications of these findings will be discussed in detail. 
Trallsmllral Distriblltioll of lllfarct Size ill COlltrol Pigs alUl ill Pigs sllbjected to a Brief Total 
Coronary Artery Occlusion. 
In the present study we found a linear relation between IA and AR (both expressed as percent 
of left ventricular mass) with a positive intercept on thc AR-axis, which was similar for the 
endocardial and epicardial half of the Icft ventricle in pigs subjectcd to a 60 min TCO. In 
anaesthetized and awake dogs, IA and AR arc also linearly related with a positive intercept on 
the AR_axis,f26-281 but in contrast to swine, the AR-intercept in dogs is considerably higher in the 
epicardium than in the cndocardiumY81 The consequent heterogeneity of transmural infarct size 
distribution in dogs is likely in part due to the transmural gradient of collateral blood flow in thc 
dog heart. But also in pigs, in which total coronary artcry occlusions result in transmurally 
homogeneous blood flow reductions, infarction progresses from inncr to outer iayer,[29,30] possibly 
due to higher energy demands in the itUler layers. In agreement with these findings we observed 
that for a given area at risk the infarct area produced by 60 min total coronary artery occlusion 
was larger although only slightly (but significant by ANCOV A) in the endocardial than in the 
epicardial half ofthe left ventricle. 
In pigs preconditioned by a 10 min TeO + 15 min Rep the relation between infarct area and 
area at risk was linear, with a similar AR-intercept but with a lower slope than for the animals 
in the control group. The decrease in slope was similar in the endo- and epicardium indicating 
that in pigs the protection afforded by the 10 min occlusion was identical in the imler and outer 
half of the left ventricle. 
Partial Corollary Artery Occlusioll,' Importallce of Degree ami Duratioll of Flow Reduction 
for Illfarct Size Limitation. 
In the present study the myocardial protection was not different after 30 min or 90 min 
exposure to the coronary flow reductions, but critically depended on the degree offlow reduction. 
Thus, a 70% reduction of coronary flow preceding the 60 min TeO reduced infarct size, whereas 
a 30% reduction in coronary m1ery flow did not protect the myocardium. Recently, Ovize et apJO] 
reported that moderate myocardial ischaemia in dogs caused by a 50% reduction in myocardial 
blood flow lasting for 15 or 25 min failed to reduce infarct size during a subsequent 60 min TeO 
unless intervening reperfusion was allowed. The present study suggests that a partial coronary 
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artery occlusion, immediately preceding a sustained coronary artery occlusion, can afford 
protection provided that the degree of tlow reduction is sufficiently severe. 
The protection produced by the 30 min 70% FR did not differ between endo- and epicardium. 
However, when the duration of70% FR was extended from 30 min to 90 min, infarct size after 
the 60 min Teo was significantly larger in the endocardial than in the epicardial half of the left 
ventricle. A 90 min 70% FR witholl/ the 60 min TCO produced larger infarct size in the 
endocardium than in the epicardium, which likely results from the more severe flow reductions 
in the inner- than in the outcr layers distal to a coronary artery stenosis. The additional necrosis 
produced by the 60 min TeO was not different for the endocardium and epicardium. Thus, the 
observation that a 90 min 70% FR resulted in less infarct size reduction (compared to the control 
group) in the endocardium than in the epicardium was due to a greater degree of irreversible 
damage in the endocardium already produced by this duration of severe flow reduction. However, 
of greater importance is the observation that despite the production of significant endocardial 
necrosis by the 90 min 70% FR itself, endocardial infarct size after the subsequent 60 min TeO 
was still less than endocardial infarct size in the control group. 
\Vhile ischaemia was not severe enough to produce myocardial necrosis after 90 min, a 30% 
reduction coronary blood flow did produce ischaemia as indicated by a 39±6% decrease in 
systolic segment shortening. It is well established that metabolism of an ischaemic segment 
changes continuously during a fixed reduction in coronary blood flow, while contractile function 
remains depressed. Studies from several laboratories, including our own, have shown that 
myocardial lactate production and efflux of potassium ions increase during the early period of 
a fixed flow reduction, but that there is a llonnalization of ischaemia~induced metabolic changes 
as the hypoperfusion is pro!ongedPI.J5J Specifically, a 30~40% coronary blood flow reduction in 
pigs produces metabolic abnormalities (increase in myocardial lactate content and production and 
a decrease in myocardial phosphocreatine levels) that reach a nadir at approximately 15 min after 
the onset of flow reduction followed by significant recovery towards baseline within 60 
min.[17,29.3JJ Thus, lack of necrosis after 90 min of 30% FR despite continuing myocardial 
hypoperfusioll and hypotllllction could be due to metabolic adaptations. This also supported by 
the observations regarding the 30% FR in the present study. Thus, the arteria-coronary venous 
pH difference increased during the early (15 min) phase of 30% FR, but partially recovered 
during the remainder of the 90 min period. The metabolic recovery also suggests that a period 
of 30% flow reduction in pigs lasting longer than 90 min is not likely to produce myocardial 
necrosis. 
Ninety min of 30% flow reduction alone did not result in necrosis in either epi~ or 
endocardium, whereas 90 min of70% flow reduction produced necrosis in both the endocardium 
and epicardium . .In the present study we did not measure the transmural distribution of 
myocardial blood flow but previous studies, including from our own laboratory, reported that a 
70% coronary flow reduction in pigs is associated with approximately 80% reduction in blood 
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flow to the inner half and approximately 60% reduction in blood flow to the outer half ofthe left 
ventricle. [14, IS) In contrast, a 25-30% reduction in total myocardial flow resulted in approximately 
20% flow reduction to the epicardial half and approximately 40% flow reduction to the 
endocardial halfJl2. 13, 17, 35] Thus. the observation that a 90 min 30% FR did not produce 
endocardial necrosis but a 90 min 70% FR produced epicardial necrosis is likely the result of the 
more severe epicardial flow deficit during 70% coronary artery flow reduction than the 
endocardial flow deficit associated with 30% flow reduction, 
Iscllaemic preconditiollillg alld l'entricular fibrillatioll during subsequent sustailled ischaemia 
Studies in rats rep0l1ed that single or multiple brief total coronary artelY occlusions decrease 
the incidence of ventricular fibrillation during a subsequent sustained period ofischaemiaP6, J7] 
Also. a preliminary study in pigs reported that a single 5 min total coronary artery occlusion 
followed by 30 min of reperfusion reduced the incidence of ventricular fibrillation during a 30 
min occlusion. iJ7) In contrast, we failed to observe a decrease in the occurrence of ventricular 
fibrillation during the 60 min TCO when preceded by a 10 min TCO + 15 min Rep. An 
explanation for the different results in our study and that of ParraH and Vegh[35] is not readily 
found but could be due to a number of factors such as different durations of the preconditioning 
stimulus and the intervening reperfusion periods and the areas at risk. In the present study a 
partial coronary artel)' occlusion immediately preceding the sustained period of ischaemia 
(analogous to Harris! two-stage coronary artery occlusionj3S] significantly suppressed the 
occurrence of ventricular fibrillation provided that the duration and severity of flow reduction 
were sufficient. These findings are in agreement with earlier studies from our laboratory that 
partial flow reductions can decrease the incidence of ventricular fibrillation during a sllstained 
coronary artery occ1usionP2] 
To study the effects of preconditioning on infarct size, a 60 min total coronary artcry 
occlusion was used that resulted in significant myocardial necrosis. Since ventricular fibrillation 
during reperfusiol1 in pigs occurs predominantly after occlusions of 10-30 min [22, 23) these 
arrhythmias were rare in the present study. Consequently, the eff1cacy of preconditioning on 
fibrillation during reperfusion could not be assessed. 
Methodological COllsideratiolls 
In the present study experiments were performed in pigs. Pigs lack a significant innate 
coronary collateral circulation, which results in less variability in infarct size due to collateral 
blobd flow during the sustained coronal)' artery occlusion. compared to species such as the dogP' 
39] In agreement with this we observed a very tight relationship between AR and IA. Another 
advantage of the lack of collaterals is that the reductions as measured with a flow probe on a 
proximal coronary artery reflects the flow in the myocardium, thereby allowing more stringent 
control of the level of flow reduction. 
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In the present study infarct size produced by a 60 min coronary artery occlusion was 
determined in myocardium rcperfused for two hours using paraMnitrobluetetrazolium sodium. In 
viable myocytes paraMnitrobluetetrazoliulll is reduced to form a dark purple diformazan 
precipitate by intracellular diaphorases that use NADH or NADPH as electron donors,lzol False 
positive staining is minimized by allowing myocardial reperfusioll to facilitate washout ofNADH 
and NADPH from necrotic myocardium. Schaper e/ aP9] reported that only 30 min of reperfusion 
is sufficient for accurate detection of infarct size. Homeffcr et alf40) also evaluated para-
nitrobluetetrazolium staining for the detenllination of myocardial infarct size in pigs and reported 
that infarct size produced by 15, 30 or 90 min coronaty artery occlusion was not different when 
either 2 or 48 hours of reperfusion were allowed. Fujiwara e/ afl411 showed that detennination of 
infarct size produced by a 60 min total coronary artery occlusion in porcine myocardium 
reperfused for I hour was identical to infarct size detennined after 3 and 7 hours of reperfusion. 
In the latter study, histochemical analysis of infarct size correlated weB with histological 
measurements. The available evidence clearly indicates that two hours of reperfusion following 
a 60 min coronalY artery occlusion allows accurate histochemical determination of infarct size 
with para-nitrobluetetrazolium staining in pigs. 
Clill;cal Refevallce 
Until recently, myocardial preconditioning was studied using brief total coronary artery 
occlusions followed by complete reperfusion. These abmpt total occlusion and reperfusion 
sequences are useful for the study of basic mechanisms of myocardial preconditioning hut do not 
reflect the clinical situation where patients with myocardial infarction often have significant 
coronary artery lesions associated with (transient) reductions in coronary blood flow. In this 
respect it is also of interest that Schulz e/ al142! have shown that a complete coronary occlusion 
without intervening reperfusion preconditioned myocardium against infarction produced by a 
partial occlusion. The present study shows that a partial flow reduction can be a preconditioning 
stimulus that is as effective as the classical brief total occlusion and reperfusion sequence, 
provided that the degree of flow reduction is sufficiently severe. Our data also suggest that mild 
flow reductions, even when sustained for 90 min, will not produce sufficient stimulation to 
precondition the myocardium. Our findings may have implications for interpretation of clinical 
shldies in which the effects of reperfusion therapy on infarct size are evaluated, as the myocardial 
perfusion status immediately preceding the coronary artery occlusion may be an important source 
of infarct size variability. 
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Rapid Ventricular Pacing Produces Myocardial Preconditioning 
by Non-ischemic Activation ofK\TP Channels 
Monique M.O. Koning, MD, PhD; Ben C.O. Gha, MD; Erik van Klaarwater, MSc; 
Rene L.J. Opstal, Bsc; Dirk J. Duncker, MD, PhD; Pieter D. Verdouw, PhD. 
Backgrollnd Rapid ventricular pacing reduces ventricular arrhythmias during a subsequent 
sllstained period ofischemia and reperfusion. \Ve investigated whether rapid ventricular pacing 
also limits myocardial infarction and determined the role of myocardial ischemia and activation 
of K+ ATP channels in the protection afforded by ventricular pacing. 
Methods and Results Myocardial infarction was produced by a 60 min coronary artery 
occlusion in open-chest pigs. Infarct size of pigs subjected to 10 min of ventricular pacing at 200 
beats pennin followed by 15 min of normal sinus rhythm prior to the occlusion (83±2% ofthe 
area at risk, mean±SEM) was not difierent from control infarct size (85±2%). 111irty min pacing 
followed by 15 min sinus rhythm resulted in marginal albeit significant reductions in infarct size 
(72±2%, P<0.05 versus control). In contrast, 30 min pacing immediately preceding the occlusion 
without intervening sinus rhythm resulted in considerable limitation of infarct size (62±4%, 
P<0.05). The K'AlPchmmcl blockcr glibenciamide abolishcd the protection by pacing (7S±5%, 
P=NS). K\TP channel activation did not appear to involve ischemia: (i) myocardial endo/epi 
blood flow ratio was I.07±0.OS, (ii) phosphocreatine and A TP levels and arterial-coronary 
venous differences in pH and PC02 were unchanged, (iii) endMsystolic segment length did not 
increase and post-systolic shortening was not observed during pacing, and (iv) systolic shortening 
recovered immediately to baseline levels and coronary reactive hyperemia was absent following 
cessation of pacing. 
COllclusiolls Ventricular pacing preconditioned myocardium via nonMischemic activation of 
K+ ATPchannels. 
Keywords infarct size, myocardial blood flow, swine, tachycardia, transmural distribution of 
myocardial infarction. 
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Myocardial preconditioning can be induced by a variety of ischemic stimuli. Thus, one or 
more brief totalll1 or partialP, 31 coronary artery occlusions can limit infarct size produced by a 
sustained ischemic period. Moreover, infarct size can be limited by transient ischemia in adjacent 
myocardiuml4l or even different organs.I5.6) In all these studies a temporary intemlption of oxygen 
supply either within or outside the myocardial region of interest was required to produce 
preconditioning. Recent studies suggest that non-ischemic stimuli may also precondition the 
myocardium. Thus, Ovize et aP) reported that an increase in left ventricular wall stretch 
produced by acute volume overload protected the myocardium against infarction during a 
subsequent 60 min coronary artery occlusion. Also two consecutive 2 min periods of rapid 
ventricular pacing in open-chest dogs reduced the incidence of ventricular arrhythmias during 
and inunediately following a subsequent 25 min coronary artery occlusionsl . In contrast, Marber 
et a~9J failed to show a protective effect of a single five min period of rapid atrial pacing against 
myocardial infarction in the rabbit heart. To date no study has addressed the effect of rapid 
ventricular pacing on infarct size development produced by a sustained coronary artery 
occlusion. 
In the present study we therefore investigated whether rapid ventricular pacing preceding a 
60 min total coronary artery occlusion (60min TCO) altered infarct size development in open-
chest pigs. In two groups of animals we studied the effects of either 10 min or 30 min of rapid 
ventricular pacing followed by 15 min of noruml sinus rhythm on infarct size produced by 60min 
TCO, analogous to the classical preconditioning model of a brief ischemic stimulus followed by 
rcperfusion. In view of our earlier findings that ischemia produced by a partial coronary artery 
occlusion can precondition the myocardium without the need for intermittent reperfusion3, we 
also studied a third group of animals in which the 30 min rapid ventricular pacing period 
preceded the 60min TCO without normal sinus rhytlun. If rapid ventricular pacing produces 
protection by inducing ischemia,l8.to] protection is likcly to be distributed heterogeneously across 
the left ventricular wall because ischemia would occur prcdominantly in the inner layers. 
Consequently, infarct size was also determined for the outer and inner halves of the left ventricle. 
To explore the mechanism of preconditioning produced by rapid ventricular pacing, we 
investigated if ischemia occurred in animals subjected to 30 min of rapid ventricular pacing 
followed by 180 min of nonnal sinus rhytlun without 60min TCO. Also, in view of evidence that 
ventricular pacing can activate ventricular K+ chatmels,III.12) and that activation ofK+ ATPcharmels 
is cardioprotective in pigs,IIJ.J.t) we also studied the role ofK+ATPchatmels in preconditioning 
induced by rapid ventricular pacing. 
Methods 
All experiments were performed in accordance with the nGuiding principles in the care and 
use of animals II as approved by the Council of the American Physiological Society and under the 
regulations of the Animal Care Committee of the Erasmus University Rotterdam. 
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Experimental Groups 
Studies were perfonllcd in a total of 46 pigs assigned to six experimental groups (Figure I). 
In five groups, animals underwent a 60 min total coronary artery occlusion (60min TCO) 
foHowed by 120 min of reperfusion. Eleven animals served as control and underwent only a 
single 60min TCO. Two groups of animals underwent a 60min TCO preceded by either 10 min 
(IF4) or 30 min (n~6) of rapid left ventricular pacing (RVP) at 200 bpm and 15 min of normal 
sinus rhythm. In 18 animals the GOmin TCO was preceded by 30min RVP at 200 bpm without 
an intermittent period of normal sinus rhythm; 7 of these animals were pretreated with 
glibenclamide (I mglkg, iv) 10 min before the start of RVP. This dose of glib en clam ide was 
chosen as it was previously shown to block preconditioning by a single 10 min coronary 
occlusion in pigs. IS In the latter two groups ventricular pacing was terminated immediately 
«10 s) following the start of the GO min left anterior descending coronary artery (LADCA) 
ligation. To evaluate wether RVP produced myocardial ischemia, wall function in the distribution 
area of the LADCA, high energy phosphates, oxygen consumption and regional myocardial blood 
flow were obtained in seven animals throughout a 30 min period of left ventricular pacing at 
200 bpm followed by 180 min of normal sinus rhytlull. 
EXPERIMENTAL GROUPS 
Group 
1 (n~ 12) Control 
Stimuli 
2 (n~6) tOmlnRVP+15minNSR 
3 (n~7) 30minRVP+15mlnNSR 
60 min TCO 120 min Rep 
_
_ ----.J __ ~----?/ L..-/ -----" 
7 / 
___ JIX~,[I=' JlIIIIIIIIIl __ 7/ //~_~ 
~ 7 r 
_JIE0S/3/~/z.[I·~IIIIIIIIII~_-7/L/ __ ~ 
- 7 / 
4 (n=7) 30mlnRVP+Glib+15minNSR _JI=V<;<:X3';XZ,~K.=.J.IIIIIIIIII~_-77//"/'-_~ 
5 (n~ 12) 30mlnRVP 
Glib 
6 (n~8) Glib+30minRVP -,JL...IV"'7"2SV~'], 1I1I1I1I1I~--7/ L/'-_--' 
- 7 / 
7 (n=7) 30minRVP+180mlnNSR 
LI--LI--~I-----LI--7J/// I 
Glib = glibenclamide (1 mg/kg, Iv) -60 -30 0 60 180 
[SJ:::: RVP :::: Rapid Ventricular Pacing time (min) 
o = NSR :::: Normal Sinus Rhythm 
• :::: TCO :::: Total Coronary Artery Occlusion 
Figure I. Experimental groups in which the effect of rapid ventricular pacing on infarct size after a 60 min total 
coronary arter), occlusion was determined. Filled bar = 60 min total coronary artery occlusion (60min TeO), hatched 
bar = rapid ventricular pacing (RVP). NSR = nomlal sinus rh)1hm, Rep = reperfusion, Glib = glibenc1amide (I 
mgik, iv). 
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Surgical procedure 
Domestic Yorkshire-Landrace pigs (25-35 kg, HVC, Hedel, The Netherlands) were sedated 
with ketamine (20 mg/kg, im), anesthetized with pentobarbital (25 mg/kg, iv) and instmmented 
for measurement of arterial and left ventricular pressure and control of arterial blood gases. 16 
Following administration ofpancuroniulll bromide (4 mg Lv., Organon Teknika B.V., Boxtel, 
The Netherlands) and a midline thoracotomy, an electromagnetic flow probe (Skalar, Delft, The 
Netherlands) was placed around the ascending aorta to measure cardiac output (Figure 2). The 
left anterior descending coronary artery (LADCA) was dissected free from the surrounding tissue 
to allow placement of a microvascular clamp (groups 1-5) and a Doppler flow probe (Crystal 
Biotechlnc., Hopkinton, MD, U.S.A.) (groups 2-6). In the animals that underwent RVP an 
electrode was attached to the anteriolateralleft ventricular wall close in the vicinity of the apex 
for stimulation of the myocardium by electrical monophasic stimuli with an amplitude of2 mA 
and a frequency of 3.33 Hz. A small cannula was inserted into the vein accompanying the 
LADCA for the withdrawal of local venous blood for the determination of blood gases. 
aortic pressure 
.' 
EM flow probe 
.' 
.' 
II 
/I 
atraumatic 
-+,1'---+1-1 
clamp 
LV Pressure 
coronary doppler 
flow probe 
atrial catheter 
coronary venous 
catheter 
SL crystals 
(LCXCA) 
SL crystals 
(LADCA) 
pacing electrode 
Figure 2. Schematic presentation of the experimental model. The pacing electrode was inserted into the superficial 
layers of the anteriolateral wall of the left ventricle. Pairs of ultrasonic crystals were inserted into the mesocardial 
layers of the left anterior descending coronary artery (LA DCA) area and the left circumflex coronary artery 
(LCXCA) area. The LA DCA was occluded althe site of the clamp causing the shaded area to become ischemic. 
The site of the clamp was varied in the control animals to create a range of areas at risk. LV = left ventricle, EM 
= electromagnetic, SL = segmenllength. 
54 Chapter 4 
Regional Myocardial Function 
In all six groups, pairs of ultrasonic crystals (Sonotek Corporation, Del Mar, CA, USA) were 
positioned into the midmyocardial layers of the left ventricle in the distribution areas of the 
LADCA and the left circumflex coronary artery (LCXCA) for the measurement of regional 
segment shortening by sonomicrometrYI4,16] (Triton Technology Inc., San Diego, CA, 
USA)(Figure 2). From the segment length tracings systolic segment length at the end of diastole 
(EDL, onset of positive ascending aortic flow) and the length at the end of systole (ESL, end of 
positive aortic flow) were determined and regional systolic segment shortening (8S) was 
computed as: 
SS(%) ~ 100· (EDL - ESL)/EDL, 
and post-systolic segment shortening (PSS) was calculated as: 
PSS(%) ~ 100 • (ESL - minimum segment length)/EDL. 
Regional Myocardial Blood Flows 
In the animals of group 6 (Figure I) we also investigated the effects of rapid ventricular 
pacing on the distribution of transmural myocardial blood flow. For this purpose, the left atrial 
appendage was cannulated for injection of 1-2 .106microspheres, lS±l (SD) ~tm in diameter 
(NEN Company, Dreieich, Germany), labelled with either 95NB, I03Ru, 1 JJSn, 46SC or J41Ce. 
Processing of myocardial tissue samples and computation of blood flow data have been described 
earlier.llS) 
High Enel'gy Phosphate Metabolism 
High energy phosphates were measured in transmural myocardial biopsies, taken with a Tm-
Cut needle ('[ravenol Laboratories Inc., Deerfield, IL, USA) from the area perfused by the left 
circumflex coronaty artery (LCXCA) at baseline and immediately before the 60min TCO. This 
procedure allowed assessment of the effects of ventricular pacing on high energy phosphate 
metabolism without interfering with the infarct size determination in the area perfused by the 
LADCA. Biopsies were innnediately dipped into 0.9% NaCI at O°C to remove adherant blood, 
frozen in liquid nitrogen (within 10 s) and stored until analysis at -SO°C. Adenine nucleotides 
(ATP, ADP, AMP), creatine (Cr) and creatine phosphate (CrP) were measured by isocratic ion-
pairing high perfomance liquid chromatography as previously described.lIS] From these 
measurements CrP/Cr and CrP/ATP ratios were calculated to estimate changes in oxidative 
phophorylation potential. Energy charge was calculated as (A TP + 0.5 ADP)/[ ATP + ADP + 
AMPj,lI7] 
Experimental protocols 
After completion of the instnullcntation, 5,000 LU. of heparin were administered 
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intravenously and a stabilization period of at least 30 min was allowed before baseline data were 
obtained of systemic hemodynamic variables, coronary blood flow and regional segment length 
changes. The animals were then subjected to one of the six shldy groups (Figure 1). In case of 
ventricular fibrillation defibrillation using DC countershocks (15-30 Watt) was started within 10 
s. If defibrillation could not be accomplished within 2 min, animals we,re excluded from further 
study. Throughout the experimental protocol body core temperature was rigorously controlled 
with a heating pad to maintain temperature within a narrow range (37~38°C) to minimize 
temperature-induced infarct size variability.(l8.19] 
In the animals of groups 3 and 6 arterial and coronary venous blood samples for the 
detcnnination of oxygen content and pH were withdrawn at baseline, at lO min and 30min RVP 
and at 2, 5 and 15 min of nonnal sinus rhytlun. In the animals of group 6 measurements were also 
made at 60, 120 and 180 min ofnonnal sinus rhythm. Myocardial biopsies for the measurement 
of high energy phosphate levels in the LCXCA perfused area were obtained at baseline and at 
30min RVP. The effects ofRVP on the distribution of myocardial blood flow were determined 
in group 6 by injection of radioactive microspheres at baseline and at 30min RVP. 
Area at risk and infarct size 
Validation of the methods to determine the area at risk and infarct size has been described 
extensively.ll.f.201 Briefly, following reocclusion of the LADCA the area at risk was identified by 
an intra-artrial injection of30 ml ofa 5 % (w/w) solution of fluorescein sodium (Sigma Chemical 
Co, St. Louis, USA). Ventricular fibrillation was then induced with a 9V battery and the heart 
was excised. Both atria, the right ventricular free wall and the left ventricular epicardial fat were 
removed. The left ventricle was filled with alginate impression material (BayerDental, 
Leverkusen, Germany), cooled in crushed ice and sliced parallel to the atrioventricular groove 
into 5 segments. The cut surface(s) of each segment and the demarcated areas at risk (AR) were 
then traced on an acetate sheet under UV light. The viable myocardium was then stained deeply 
blue by incubating the segments for 20 min in 0.125 g para~nitrobluetetrazolium (Sigma 
Chemicals Co., St. Louis. USA) per liter of phosphate buffer (pH 7.1) at 37'C. The non-stained 
pale infarcted tissue was traced onto the acetate sheet. The surface of each ring was subdivided 
into an endocardial (inner) half and an epicardial (outer) hatfby drawing a line which divided the 
myocardial wall into only two layers of equal thickness. Division into two layers was done as it 
provides information on the transmural distribution of intarct size, yet preserving sufficient 
accuracy ofintarct size determination in the two halves. Surf.'lce areas of the subendocardial and 
subepicardial halves, and of the subendocardial and subepicardial areas at risk and infarct areas 
CIA) were determined and averaged for the apical and basal side of each individual ring. The 
fraction of the ring that was infarcted and at risk were then multiplied by the weight of the ring 
to yield the weight of the area at risk and infarct area for that ring. Subsequently, the weights of 
the subendocardial and subepicardial halves and the total weight of each ring were summed to 
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yield the L Vendo' L Vepi and total LV mass. The weights of the endocardial, epicardial and total 
areas at risk of each ring were summed to yield A~ndo' ARepi and total AR mass; the weights of 
the endocardial, epicardial and total infarct areas of each ring were added to yield I~ndo' IJ\pi and 
total IA mass. Endocardial, epicardial and total AR and IA data were expressed as a percentage 
of LVendo' LVepi and total LV mass, respectively. 
Data analysis 
Infarct size data have been presented by plotting the IA against AR for the endocardial and 
epicardial half and for the whole left ventricular wall. Linear regression analysis was performed 
to detenniue the relation between endocardial and epicardial IA and AR in the control group. For 
all experimental groups individual infarct size data points are presented. Intergroup differences 
between IA"dO' IA,pj or total IA were analyzed by analysis of covariance (ANCOV A), with 
AR.:ndo. A~pi or total AR as covariate. \Vhen a significant effect was observed comparisons 
between individual groups were made with ANCOV A followed by modified Bonferroni 
procedure to correct for multiple comparisons. Intragroup differences between IA.:ndo and IAepi 
were analyzed using ANCOV A for repeated measurements, with AR-endo and A~pi as covariates. 
The effect of rapid ventricular pacing on the incidence of ventricular fibrillation during 60min 
TCO was analyzed by Fisher's exact test. 
Hemodynamic and regional myocardial function data were analyzed by two-way ANOVA 
followed by either paired t-test (intragroup) or unpaired t-test (intergroup) with modified 
Bonferroni procedure to correct for multiple comparisons. A P value less than 0.05 was 
considered statistically significant (two-tailed). Data are presented as Mean ± SEM. 
Results 
Ventricular Fibrillation and Mortality 
In the control group one animal was excluded because of unsuccessful defibrillation during 
the 60min TCO. All other animals that fibrillated were defibrillated successfully. Table I shows 
that ventricular fibrillation occurred in 7 of the 11 control animals during the 60min TCO. The 
incidence of ventricular fibrillation in all groups that were subjected to rapid ventricular pacing 
before the 60min TCO (groups 2-5) was not significantly different from the control group 
indicating that in this model RVP did not protect against ventricular fibrillation during the 
subsequent coronary artery occlusion. Ventricular fibrillation was rare when reperfusion was 
reinstated which is in agreement with previous observations that in pigs ventricular fibrillation 
during reperfusion occurs predominantly following 10-30 min coronary artery occlusions.l2 lJ 
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Table 1. Ventricular fibrillation ill all pigs 
Experimental groups 
Control 
10 min RVP + IS NSR + 60 min TCO 
30 min RVP + 15 NSR + 60 min TCO 
30 minRVP 
Glib + 30 min RVP 
+ 60 min TCO 
+60min TCO 
60minTCO 
7(11 )' 
1(4) 
4(6) 
6(11) 
2(7) 
Reperfusion 
1(10)' 
0(4) 
0(6) 
0(11) 
0(7) 
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In parentheses is indicated the total number of animals per group at the onset of each intervention. TeO - Total 
coronary artery occlusion; RVP = rapid ventricular pacing at 200 beats per minute; NSR = nOnllal sinus rhythm; 
Glib = Glibenclamide 1 mglkg Lv. as a bolus 10 min prior to the onset of RVP; 0 one pig fibrillated during both 60 
min TCO and Reperfusion. 
Infarel Area - Area at Risk Relation 
Mean areas at risk (expressed as percentage of left ventricular mass) for the five experimental 
groups of animals which undenvent the 60min TeO were not different from each other (34±2%, 
34±2%, 37±2%, 31±2% and 31±3% for groups 1,2,3,4 and 5, respectively; F~I.O, P~O.4I). 
In the 10 control animals transmural infarct area was linearly related with the area at risk 
(FO.92, P<O.OO I; Figure 3). Separation of the left ventricular wall into two layers of equal 
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Figure 3. Effects of rapid ventricular pacing on the transmural, endocardial and epicardial relations between infarct 
area (lA) and area at risk (AR). Shown are the relations in the control group (60 min of total coronary artery 
occlusion, 60min TCO) and animals subjected to either 10 or 30 min of rapid ventricular pacing (RVP) separated 
from the 60min TeO by 15 min of normal sinus rhythm (l5min NSR). Note that while IOmin RVP had no effect 
on transmural infarct size (F=0.6, P=NS), 30min RVP produced a small, but statistically significant decreases in 
transmural infarct size (F=13.3, P<0.005). This was due to a selective reduction in epicardial infarct size (F=lIA, 
P<O.01), as endocardial infarct size was not significantly altered (F=3.4, P=NS). NS=not signiticant. 
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Figure 3 Effects of rapid ventricular pacing on the transmural, endocfirdial and epicardial relations between infarct 
area (IA) and area at risk (AR). Shown are the relations in the control group (60 min of total coronary artery 
occlusion, 60min TeO) and animals subjected to either 10 or 30 min of rapid ventricular pacing (RVP) separated 
from the 60min Teo by 15 min ofnonnal sinus rhythm (15min NSR). Note that while IOmin RVP had no effect 
on transmural infarct size (F=O.6, P=NS), 30mm RVP produced a small, but statistically significant decreases in 
transmural infarct size (F=I3J, P<O.005). 1l1is was due to a selective reduction in epicardial infarct size (F=ll A. 
p<o.o I), as endocardial infarct size was not significantly altered (F=3A, P=NS). NS=not significant. 
thickness revealed a highly linear relation in both endocardial half (f'=0.91, P<O.OO I) and 
epicardial half(f'=0.88, P<O.OOI) of the left ventricle. Ten min ofRVP, separated from the 60min 
TeO by a 15 min period of nonnal sinus rhythm, failed to reduce transmural, epicardial and 
endocardial infarct size compared to the control group (Figure 3). When the period of rapid 
venticular pacing was extended to 30 min, infarct size in the endocardial half was again not 
significantly different from that in the control group (F~3.4, P~0.09), but now small albeit 
statistically significant reductions in epicardial (F~ IIA, P<O.O I) and transmural (F~ 13.3, 
P<0.005) infarct size were observed (Figure 4). In this group of animals the transmural IAiAR 
ratio was also significantly lower than that in the control group (72±2% versus 85±2%, P<O.O I). 
The transmural IA in eight of the eleven animals that underwent 30min RVP immediately 
followed by 60min TCO was located well below the regression line describing the relation 
between IA and AR in the control group (Figure 5). The IAJ AR of this group of animals was 
62±4% (P<O.O I versus control group). ANCOV A showed that 30min RVP inlllediately followed 
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Figure 4. Effects of rapid ventricular pacing on the transmural, endocardial and epicardial rclations between infarct 
area (IA) and area at risk (AR). In the top panels are shown the control animals (60 min of tot a! coronary artery 
occlusion, 60lllin TeO) and the animals subjected to 30 min of rapid ventricular pacing (RVP) immediatley 
preceding the 60min TCO. 30min RVP produced significant reductions in transmural (F=19.l, P<O.OOI), epicardial 
(F=IS.7, P<O.OOS) and endocardial (F=I3.8, P<O.005) infarct size. 111e lower panels illustrate that pretreatment with 
glibenclamide (Glib, I mgfkg, intravenous) prcvented the protective effects of rapid ventricular pacing. NS=not 
significant. 
by 60min TCO significantly reduced infarcted area for a given area at risk compared to the 
control group (F~ 19.1, P<0.0005). Further analysis indicated that the infarct size reduction was 
not different between subepicardium and subendocardium (Figure 5). Pretreatment with 
glibenclamide abolished the protective effect of 30min RVP in both the endocardial and 
epicardial halves (Figure 5). This is tilfther illustrated by the IA/AR ratio which was 78±5% 
(P~NS versus control group and P<0.05 versus 30min RVP + 60min TCO). 
Hemodynamic Responses to Rapid Ventricular Pacing and Total Coronary Artery 
Occlusion (Groups 1-5). 
In the tive groups that underwent 60min TeO (groups 1-5), there were no significant 
differences between heart rate (l08±3 bpm, n=38), mean aortic pressure (85±1 mmHg), cardiac 
output (2.8±O.1 Limin), LVdP/dt",,, (191 O± I 00 nunHg/s) or LV end-diastolic pressure 
Table 2. Systemic hemodynamics at baseline, during 30 minutes of rapid ventricular pacing and during subsequent 15 min of normal sinus 
rhythm. 
Rapid Ventricular Pacing (min) Normal Sinus Rhythm (min) 
Baseline 
10 30 0.5 2 5 IS 
HR 108 ±4 200 ± 0* 200 ± 0* 137 ± 4* 133 ± 3* 132 ± 3* 126 ± 3* 119±3'" 
CO 2.& ± 0.2 1.8±0.1* 1.9±0.1* 3.1 ± 0.2 3.2 ± 0.3 3.1 ± 0.1 2.9±0.1 2.6 ± 0.1 
SV 26±2 9± 1* 9± 1* 23 ± 1 24± 2 23 ± 1 23 ± 1* 22± 1* 
MAP 83 ±. 2 55 ±3* 61 ±2* 94 ±4* 97 ±4* 97± 3* 93 ±2* 84±2 
SVR 31 ± 1 31 ±2 33 ± 2 32± 3 32 ±4 31 ± 1 33 ± 1 33 ± 1 
LVdP/dt", •• 17&0± 130 1980 ± 220 2010 ± 160 1770± 150 1820 ± 130 1840 ± 100 1910 ± 160 1600 ± 140 
LVEDP 9±1 7±1 8±1 8± I 8±1 8± I 8 ± I 8±1 
MW 231±12 102±9* 1l6±9* 294±25* 312±30* 302±14* 271±12* 218±10 
HR"" heart rate (bpm): CO 0;;; cardiac output (Llmin): SV :::: stroke volume (ml); MAP"" mean arterial pressure (mmHg); SVR:= systemic vascular resistance (mmHglLlmin); 
LVdP/dtma.~:::: maximum risc in left ventricular pressure (mmHgls): LVEDP "" left ventricular end diastolic blood pressure (mmHg); MW = myocardial work, MAP·CO 
(mmHg·Llmin). Data are mean±SEM. n=13; * P<0.05 vs baseline. 
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(9±1 mmHg) at baseline. Rapid ventricular pacing in groups 2, 3 and 4 was associated with 
immediate decreases in mean arterial blood pressure (38±3 %), cardiac output (41±2%) and 
stroke volume (69±2%), while systemic vascular resistance, left ventricular end diastolic pressure 
and LVdP/d~a'( remained unchanged. This hemodynamic profile was maintained during the 
remainder of the ventricular pacing period and was not different between the Huee groups. In the 
animals of groups 2 and 3, in which pacing was tenninated without an immediate occlusion of 
the LADCA, all variables returned to baseline within 1 min of normal sinus rhythm except for 
heart rate which remained slightly (-15 bpm) elevated during the 15 min following cessation of 
ventricular pacing. In groups 1-4 (n=31), total coronary artery occlusion resulted in decreases in 
cardiac output (15±3%) and increments in heart rate (15±4%) and LV end-diastolic pressure 
(37±8%) compared to baseline values (all P<0.05), with no significant decrease in mean aortic 
pressure (4±3%); these responses were not different between the four ~roups. None of the 
hemodynamic variables recovered significantly toward baseline levels during 120 min of 
reperfusion. 
Glibenclamide produced modest increments in left ventricular end-diastolic pressure from 
9±1 to 11±3 (P<O.05) and mean aortic pressure from 84±3 mmHg to 95±4 mmHg (P~O.055). 
The the latter was due to systemic vasoconstriction as cardiac output was not altered by the K\TP 
channel blocker. Glibenclamide had no effect on LADCA blood flow, LADCA vascular 
resistance or systolic segment shortening in the LADCA perfused segment. Pretreatment with 
glibenclamide enhanced the pacing-induced decreases in mean a0l1ic pressure (56±4%), cardiac 
output (62±3%), and coronary blood flow (40±6%) but had no effect on hemodynamic changes 
produced by 60min TCO. 
Effect of Rapid Ventricular Pacing 011 Myocardial Pcrforllance (Groups 3 and 6). 
Rapid ventricular pacing in groups 3 and 6 was associated with inunediate decreases in mean 
arterial blood pressure and cardiac output and hence myocardial work, while LvdP/dt"m~" systemic 
vascular resistance, and left ventricular end diastolic pressure were maintained (Table 2). Thirty 
min of rapid ventricular pacing decreased coronary blood flow by 20±5% (n= 13) accompanied 
by a small increase inm),ocardial ox),gen extraction from 72±2 % to 76±2 ~ (P<O.05, Table 3). 
Oxygen consumption per gram of myocardium tended to decrease during RVP tIus failed to reach 
levels of statistical significances. Microsphere data revealed that the subendocardial to 
subepicardial blood flow ratio at 30min RVP was maintained well above unity (l.07±O.08, n~6) 
although absolute levels were slightly lower than at baseline (1.23±O.07) (P<O.05). Coronary 
vascular resistance (calculated as mean arterial pressure divided by coronary blood flow per g of 
myocardium) was also maintained during pacing. Fractional systolic shortening decreased 
markedly in both the LADCA and the LCXCA perfused segments. However, this was due to a 
marked decrease in end-diastolic length of both the LADCA (l7±1 %) and the LCXCA (15±2%) 
perfilsed segments as end-systolic length of both LADCA (4±1 %) and LCXCA (5± 1 %) segments 
Table 3. Regional myocardial performance at baseline, during and following 30 minutes of rapid ventricular pacing and during subsequent 
15 min of normal sious rhythm. 
Rapid Ventricular Pacing (min) Normal Sinus Rhythm (min) 
Baseline 
10 30 0.5 2 5 15 
LADCA 
CSF 1.73±0.18 1.47 ± 0.16 1.38 ± 0.18* 1.93 ± 0.21 1.91 ± 0.21 1.77 ± 0.20 1.70 ± 0.20 1.58 ± 0.21 
CYR 0.55 ± 0.06 0.47 ± 0.08 0.52 ± 0.06 0.54 ± 0.05 0.56 ± 0.06 0.61 ± 0.06 0.62 ± 0.06 0.62 ± 0.06 
cvPOz 23.8±0.8 222±O.9 23.1±1.5 26.7±1.6'" 24.8±1.1 23.5±0.8 
Oz extraction 72±2 76±2* 76±2* 68±4 71±2 73±1 
MYO, 6.84 ± 0.78 6.16±0.73 6.01 ± 0.87 6.47 ± 0.90 6.93 ± 0.87 6.62 ± 1.02 
EDL 9.50±0.23 7.88±0·.18* 7.89±0.21 * 9.86±0.26 9.87±0.24 9.71±0.21 9.59±0.20 9.34±0.22 
ESL 7.96±0.20 7.72±0_17* 7.70±0.19"' 8.33±0.24 8.22±0.21 8.19±0.17* 8.07±0.16 7.96±0.17 
SS (%) 16.2 ± 0.9 2.8 ± 1.2* 2.5 ± 1.4* 14.8 ± 0.8 15.8 ± 0.9 15.6 ± 0.7 15.8 ± 0.5 14.8 ± 0.8 
PSS (%) 1.3 ± 0.6 0.6 ± 0.4 0.8 ± 0.5 3.3 ± 0.9 2.4 ± 0.6 2.1 ± 0.5 2.3 ± 0.7* 1.4 ± 0.5 
LCXCA 
EDL 10.87±0.35 9.1 9±0.41 * 9.16±0.39'" 10.86±0.44 10.85±0.49 10.79±0.38 10.73±0.36 10.58±0.36' 
ESL 9.31±0.32 8.70±0.38* 8.71±0.31'" 9.43±0.46 9.61±0.48 9.54±0.33"' 9.43±032* 9.37±0.31 
SS (%) 14.8 ± 1.5 9.7 ± 2.4* 9.8 ± 2.3"' 12.7 ± 1.6 12.9 ± 1.5 10.8± 1.3* 12.1 ± 1.3* 11.6 ± 1.2'" 
PSS (%) 0.7± 0.4 0.2 ± 0.2 0.1±0.1 0.4 ± 0.2 0.6 ± 0.3 0.6 ± 0.2 0.4 ± 0.2 0.4±0.2 
LADCA - left anterior descending coronary artery: LCXCA - left circumflex coronary artery; CBF - coronary blood flow (ml"min-1_g-1): CVR "" coronary vascular resistance 
(mmHg-mt1.min-g): cvPOz "" coronary venous partial O2 pressure (mmHg); O2 extraction"'" Oz extraction of the LADCA area (% of arterial O2 content); MVQ "" Q -consumption 
of the LADCA area ()lI"min-1-g- I); EDL"" end diastolic segment length (nun): ESL"" end systolic segment length (nun); SS "" segment shortening; PSS "" post~systolic segment 
shortening.Data are mean±SEM, n=13~ * P<0.05 vs baseline. 
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decreased slightly (Table 3). Furthennore the decrease in systolic shortening during RVP was not 
accompanied by the appearance of post-systolic shortening. Throughout the pacing protocol the 
arterial-coronary venous differences in pH (O.04±O.OI and O.04±O.OI at baseline and 30min RVP, 
respectively) and in pCO, (II.4±O.5 mmHg and IO.2±O.9 mmHg at baseline and 30min RVP, 
respectively) were maintained. In further support of aerobic metabolism we also did not observe 
decreases in ATP levels (36.3± 1.4 ~lmol/g protein at baseline vs 36.5± 1.4 ~mol/g protein at 
30min RVP), CrP/Cr ratio (1.24±O.12 vs I.36±O.12), CrPI A TP ratio (1.52±O.26 vs 1.65±O.29) 
or energy charge (O.922±O.003 vs O.924±O.003), at 30min RVP versus baseline, respectively. 
Immediately after RVP was stopped systemic hemodynamic variables recovered to baseline 
values except for heart rate which remained slightly elevated following restoration to normal 
sinus rhythm. Mean aortic pressure increased to levels slightly higher than baseline during the 
tIrst min but had recovered to baseline levels at 15 min after cessation of rapid ventricular pacing. 
During the first minute of post-pacing systolic shortening in both the LADCA and LCXCA 
perfused segments recovered to baseline values, although this was followed by a slight decrease 
in systolic thickening in the LCXCA area during the remainder of the protocol. Because reactive 
hyperemia was also absent these findings indicate that 30min RVP was not associated with 
myocardial ischemia. 
Discussion 
The present study has yielded several important findings: 1) infarct size after 60 min coronary 
artery occlusion is limited when the occlusion is immediately preceded by a period of rapid 
ventricular pacing. 2) In contrast, when the period of rapid ventricular pacing was separated from 
the 60 min total coronary artery occlusion period by 15 min of nomlai sinus rhythm the protective 
effect of rapid ventricular pacing was nearly completely lost. 3) Pretreatment with glibenclamide 
abolished the protective effect of rapid ventricular pacing suggesting the involvement of 
activation ofK+ATPchmmeis in the preconditioning and 4) the pacing-induced activation K+ATP 
chatmels was not due to myocardial ischemia. 
The protection afforded by rapid ventricular pacing against irreversible myocardial damage 
produced by a sustained period of ischemia was reversed by glibenclamide indicating that K\TP 
channels mediate, at least in part, the protective mechanism of rapid ventricular pacing. Since 
we and others have shown that K\TP chatmel blockade inhibits ischemic preconditioning in 
several species including rabbits,[22] dogs!23] and swine,[15,H] it could be hypothesized that 
ventricular pacing produced preconditioning via induction of myocardial ischemia. In support 
of this hypothesis Vegh et a~8] and Szilvassy et aP IO ] reported that ventricular pacing produced 
myocardial ischemia as judged from myocardial ST-segment elevation. In contrast, in the open-
chest pig model used in the present study we failed to observe evidence of myocardial ischemia 
during rapid ventricular pacing at 200 bpm: (i) transmural myocardial blood flow during rapid 
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ventricular pacing remained equally distributed across the hmer and outer layers of the left 
ventricular wall, (ii) the decrease in systolic shortening was entirely due to a decrease in end-
diastolic length, not aan increase in end-systolic length, (iii) development of post systolic 
shortening was not observed,{2S] and (iv) no changes were observed in myocardial ATP and 
phosphocreatine levels, energy charge and arterial or coronary venous pH levclsp6] Furthermore, 
following restoration to normal sinus rhythm evidence for myocardial ischemia during the 
preceding period of rapid ventricular pacing was also absent because (v) reactive hyperemia did 
not occur, (vi) coronary venous oxygen tension was minimally affected following restoration to 
normal sinus rhythm (vii) systolic segment shortening recovered instantaneously to baseline 
levels at which it was maintained throughout the subsequent 180 min nonnal sinus rhythm period 
and (viii) there was no sustained post-systolic shortcning during Ilormal sinus rhythm suggesting 
that post-ischemic myocardial sturuling did Ilot occur. These findings fail to support the 
occurrence of significant myocardial ischemia in the present study. Although we cannot entirely 
exclude the occurrence of subtle subendocardial ischemia, this certainly would have been 
insufficient to induce ischemic preconditioning as Ovize et aPl have shown that a 25 min 50% 
flow reduction immediately preceding a 60 min total coronary artery occlusion (resulting in total 
loss of contractile function in the area perfused by the partially occluded coronary artery) failed 
to limit infarct size. In addition, we recently observed that 30 min or 90 min periods of 30% 
coronary blood flow reduction, associated with a 25% decrease in systolic segment shortening 
(due to an increase in end-systolic length), did not protect the myocardium against infarction 
produced by 60 min of total coronary artery occlusion immediately following the 30% flow 
reduction (chaptcr 3). Therefore if some endocardial might have gone undetected it is highly 
unlikely that this was responsible for the protective effect produced by rapid ventricular pacing. 
Although the exact mechanism ofK+ATPchannel activation by ventricular pacing catinot be 
determined from the present study, there is ample evidence that ventricular pacing is capable of 
activating transient outward K+ currents. Thus, Geller and Rosenl12J observed that an increase in 
electric activation rate of canine ventricular slabs from 90 pulses per min to 130 pulses per min 
shortened the action potential. The action potential shortening persisted for several min after the 
activation rate was lowered to 90 pulses per min, indicative of myocardial "memoryl1 for the 
activation stimulus. The persistent shortening of the action potential could be antagonized by 
blockade ofthe transient outward K+ current. Although the specific role of K+ATP channels was 
not investigated in that study, our findings that after 15 min after cessation of30 min of rapid 
ventricular pacing a small but statistically significant reduction in infarct size occurred, suggest 
that K+ATr challl1el activation by ventricular pacing may also display memory. Interestingly, 
GeHer and Rosen[l2] reported that cardiac memory in isolated slabs of canine ventricular 
myocardium was only produced when the activation sequence was abnormal (stimulation from 
the lateral side of the preparation. i.e. perpendicular to the fiber axis, mimicking ventricular 
pacing[Il]) but not when the activation sequence was normal (stimulation from the basal end of 
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the preparation in the direction of the fibers, mimicking atrial pacing). This could explain why 
Marber el aft') failed to observe a protective effect of 5 min of alrial pacing followed by 10 of 
normal sinus rhythm on myocardial infarct size in rabbit hearts. 
Ventricular pacing afforded myocardial protection which was slightly greater in the epicardial 
half than in the endocardial half,vhen pacing was followed immediately by the 60 min coronary 
artery occlusion. In' addition, protection was marginal in the subepicardiulll but absent in the 
subendocardium when a 15 min period ofnonnal sinus rhythm was allowed between the pacing 
period and the sustained occlusion. There is evidence that the K+ chmmels are heterogeneously 
distributed across the left ventricular wall. Geller and Rosen{12] reported that transient outward 
repolarizing K+ currents in the epicardium increased more than in the endocardium during altered 
myocardial activation sequence. Also, Litovsky et ap71 reported that acetylcholine sensitive K+ 
channels are present in the epicardium but not in the endocardium. The distribution ofK+ATP 
channels is presently unknown, but our findings that 30 min of rapid ventricular pacing followed 
immediately by a sustained period of ischemia limited infarct size in both endo- and epicardium 
indicate that ventricular pacing can stimulate both endocardial and epicardial K\TP channels. 
Following cessation of pacing the protective effect appeared to be lost more rapidly in the 
endocardium than in the epicardium. There is evidence that exposure of the myocardium to 
repeated periods of ventricular pacing progressively prolongs cardiac memory.!'l] It is thus 
possible that repeated bouts of rapid ventricular pacing in pigs could have resulted in greater 
infhrct size limitation compared to a single episode when pacing was separated by 15 min from 
the sustained coronary artery occlusion. 
Conclusions 
Thirty min of rapid ventricular pacing decreased myocardial infarct size produced by a 60 
min total coronaty artery occlusion in open-chest pigs. The magnitude of protection was greatest 
when the period of ventricular pacing immediately preceded the sustained period of ischemia, 
as the protection was nearly completely lost when 15 min of normal sinus rhythm separated the 
rapid ventricular pacing period from the sustained occlusion. The protective effect of pacing was 
abolished by K\TP chatlllel blockade indicating that K+ ATr channel activation is involved in the 
mechanism of protection. Since we failed to observe significant myocardial ischemia during 
rapid ventricular pacing, it appears that K+ ATP channel activation was produced via a non-
ischemic mechanism, possibly an alteration in ventricular activation sequence. 
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Myocardial protection by brief ischemia in 
noncardiac tissue. 
Ben C.G. Gho, MD; Regien G. Schoemaker, PhD; Mirella A. van den Doel, BSc; 
Dirk J. Duncker, MD, PhD; Pieter D. Verdouw, PhD. 
Backgroulld Brief coronary artery occlusions (CAO) protect both the artery's own perfusion 
territory ("myocardial preconditioning") and adjacent "virgin" myocardium. \Vhether ischemia 
in remote organs protects myocardiml1 is unknown. We examined whether brief occlusion of the 
anterior mesenteric artery (MAO) or left renal artery (RAO) protects against myocardial 
infarction. 
Methods alld Results Area at risk (AR) and infarcted area (IA) were determined in 
anesthetized rats after 180 minutes ofreperfusion following a 60-minute CAO. At nonnothennia 
(36.S-37.SoC body temperature), IAIAR was 68±2% (mean ± SEM, IFII) in control rats and 
S0±3% (n~9, P<.OOI) in rats preconditioned by IS-minute CAO, 10 minutes prior to 60-minute 
CAO. A IS-minute MAO was equally protective (IAlAR~SO±3%, n~IO, P<.OOI), while IS-
minute RAO failcd to limit IAIAR (72±S%, n~8). Hypothemlia (30-31 °C body temperature) did 
not effect IAIAR (67±3%, IFII) in control animals, but enhanced protection by IS-minute CAO 
(JAlAR~22±3%, n~8), while protection by IS-minute MAO (IAlAR~ 44±S%, n~II, P<.OOI) 
was minimally enhanced. Hypothermia unmasked protection by IS-minute RAO 
(IAlAR~46±6%, n~9, P<.OI). Hexamethonium (20 mg/kg IV) did not alter protection by IS-
minute CAO, but abolished protection by IS-minute MAO. When MAO was sustained 
throughout the study, cardioprotection was absent. 
COllclusion Brief ischemia in "remote" organs protects myocardium against infarction as 
effectively as myocardial preconditioning. The mechanism of protection by MAO differs from 
that of CAO as ganglion blockade abolished protection by MAO but not by CAO. The 
neurogenic pathway is activated during reperfusion after I5-minute MAO as sustained MAO 
failed to produce cardioprotection. 
Remote myocardial protection 71 
Ischemic preconditioning has been described not only for the myocardium,ll] but also for the 
kidney,J2l skeletal muscle,P] brainl4] and liVCr.15J Furthermore, Przyklenk et af6] reported that a 
brief coronary artery occlusion (CAO) preconditioned not only the myocardium within but also 
outside its perfusion tcrritOlY ("remote" but intracardiac ischemic preconditioning). It is 
unknown, however, whether remote organ ischemia can protect the myocardium against 
infarction. 
Therefore, we first examined whether brief remote organ ischemia prior to a 60-minute CAO 
limited myocardial infarct size. For this purpose, we produced transient ischemia in the small 
intestine or left kidney by occluding the anterior mesenteric artery (MAO) or the left renal artery 
(RAO) in rats and examined its effect on myocardial infarct size. Since body temperature may 
influence infarct sizeP,8J and cardioprotection by the adenosine deaminase inhibitor pentostatin 
was only observed in the presence of mild hypothermia[9] studies were performed at two 
temperatures. Because results indicated that brief MAO provided cardioprotection at both 
temperatures, MAO was selected to examine the mechanism of protection by remote organ 
ischemia. To investigate whether a neurogenic pathway was involved we repeated the studies 
after ganglion blockade with hexamethonium. To determine whether activation of the neurogenic 
pathway occurred during remote organ ischemia or the subsequent 10 minutes of Reperfusion, 
we also determined infarct size after 60-minute CAO in the presence of permanent MAO. 
Methods 
Experimental Design 
Experiments in ad libitum fed male \Vistar rats (± 300 g) were perfomled in accordance with 
the Guiding principles in the care and use of animals as approved by the Council of the 
American Physiological Society and under the regulations ofthe Animal Care Committee of the 
Erasmus University Rotterdam. 
Effect of 15-/1/;lIl1le MAD or 15-II/;lIl1le RAD Oil Illfarct She Prodllced by 60-1I/;/I/lle CAD 
(Prolocol I). 
Nine groups were studied in this protocol (Figure 1). Eight groups underwent a 60-minute 
occlusion of the left anterior descending coronary artery followed by 180 minutes ofReperfusion 
at 110nnothermia (36.5-37.5"C body core temperature) (groups 1-4) or hypothermia (30-31"C 
body core temperature) (groups 6-9). Control groups I and G underwent a 25-minute sham period 
prior to the GO-minute CAD. Groups 2 and 7 underwent either a 15-minute CAD, groups 3 and 
8 a 15-minute MAO and groups 4 and 9 a 15-minute RAO each followed by Reperfusion starting 
10 minutes prior to 60-l11inute CAO. One group ofnormothenllic rats (group 5) underwent only 
a IS-minute CAO to determine whether the classical ischemic preconditioning stimulus produced 
irreversible myocardial damage. 
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EXPERIMENTAL GROUPS (Protocol I) 
(n= 11) 
(n=9) 
(n= 10) 
(n=8) 
(n=4) 
(n= 11) 
(n=8) 
(n= 11) 
(n=9) 
Stimulus 
------.. GOmin CAD 180mln Rep 
~--~==~~ Sham 
15min CAO + 10min Rep 
15min MAO + 10min Rep 
15min RAD + 10mln Rep 
15mln CAO + 250min Rep 
Sham 
15min CAD + 10m!n Rep 
15m!n MAO + 10min Rep 
15m!n RAO + 10min Rep 
.. 
[7] 
o 
.. 
.. 
IZl 
o 
-25-100 60 240 
time (min) 
Figure I. Schematic presentation ofthe 9 groups in which the protection by IS-minute renal artery and mesenteric 
artery occlusions against infarct size produced by 6O-minute CAD was studied (Protocol I). CAO=ieft anterior 
descending coronary artery occlusion; MAO=anterior mesenteric artery occlusion; RAO=iefi renal artery occlusion; 
Rep=reperfusion. 
lill'olpemellt of Nellrogellic Pathway ill Cardioprotectioll by IS-millllte MAO (Protocol II). 
Six groups of rats were studied after pretreatment with the ganglion blocker hexamethonium 
(20 mg/kg IV) 15 minutes before the ischemic stimulus was applied (Figure 2). Groups 10-12 
were studied during normothermia and groups 13-15 during hypothennia. In groups 10 and 13 
the effcct of ganglion blockade on infarct size produced by 60-minute CAO was studied. The 
effect of ganglion blockade on cardioprotcction by 15-minute CAO was studied in groups II and 
14, and that by 15-minute MAO in groups 12 and 15. 
III/portallce of Reper/llsiollfor Cart/ioprotectioJl by MAO (Protocol III). 
To investigate whether activation orthe neurogenic pathway occurred during occlusion or 
reperfusion of the anterior mesenteric artery we determined infarct size produced by 60-minute 
CAO in the presence of a permanent MAO (Figure 3). 
Surgical and Experimental Procedures 
Rats were anesthetized 'with pentobarbital (60 mglkg IP) and intubated for positive pressure 
ventilation (Harvard) with room air. A PE- 10 catheter was positioned in the thoracic aorta for 
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Figure 2. Schematic presentation of the 6 groups in which the effect of ganglion blockade by hexamethonium, 
(HEX, 20 mglkg IV) on the protection by IS-minute MAO against myocardial infarct size produced by a 6O-minute 
CAO was studied (Protocol II), For further details see Figure I, 
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Figure 3. Schematic presentation of the 2 groups in which infarct size produced by 6O-minute coronary artel)" 
occlusion (CAO) was studied in the presence of sustained anterior mesenteric artery occlusion (MAO) (Protocol 
III). 
measurement of arterial blood pressure and heart rate (Baxter Diagnostic Inc.). A PE-50 catheter 
was positioned in the inferior caval vein for infusion ofhaemaccel. After intercostal thoracotomy 
the pericardium was opened and a silk (6-0) suture was looped under the coronary aliery for later 
production of CAO)IO· 11] Following laparotomy, a catheter was positioned in the abdominal 
cavity to allow intraperitoneal infusions of pentobarbital for maintenance of anesthesia. Then, 
the anterior mesenteric artery or the left renal artery was dissected free and a suture was placed 
around thc artery to facilitate later MAO and RAO with an atraumatic clamp. After applying the 
ischemic stimulus, the abdomen was closed. The control and the classical ischcmic 
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preconditioning groups underwent the same procedure, but without dissection of the renal or 
mesenteric artery. 
Body core temperatures were continuously measured rectally using an electronic thermometer 
(Electromedics Inc.) and were maintained in the designated range using either heating pads or 
ice-filled packages. Except during application of the coronal), artery occlusions and reperfusions 
the thoracotomy site was covered with aluminium foil to prevent heat loss from the thoracic 
cavity. The adequacy of this procedure was verified in five rats in which simultaneous 
measurements of rectal and intrathoracic temperature showed no differences at baseline 
(37.2±0.2"C and 36.9±0.02"C, respectively) or at the end of60-minute CAO (36.9±0.2"C and 
36.8±0.2 "C, respectively). Rats that fibrillated during ischemia or reperfusion were allowed to 
complete the protocol when conversion to normal sinus rhythm occurred spontaneously within 
I minute or when resuscitation, by gentle thumping on the thorax, was successful within 2 
minutes after onset of fibrillation. Occlusion as well as reperfusion were visually verified by 
appearance and disappearance of myocardial, small intestinal or renal cyanosis. 
Measurement of Area at Risk and Infarcted Area 
At the end of the experiment the heart was quickly excised and cooled in ice~cold saline, 
before it was mounted on a modified Langendorff apparatus and perfused retrogradely via the 
aorta with 10 ml ice~cold saline to wash out blood. [1O, I IJ After the coronary ligature was retied the 
heart was perfused with 3 ml Trypan Blue (0.4%, Sigma Chemical Co.) to stain the nonllally 
perfused myocardium dark blue and delineate the non-stained area at risk (AR). The heart was 
then frozen at -80°C for 10 minutes and cut into slices of I mm from apex to base. From each 
slice, the right ventricle was removed and the left ventricle (LV) was divided into the AR and the 
remaining left ventricle. The AR was then incubated for to minutes in 37°C Nitro-Blue-
Tetrazolium (Sigma Chemical Co.; I mg per I ml Sorensen buffer, pH~7.4), which stains vital 
tissue purple but leaves infarcted tissue unstained. After the infarcted area (lA) was isolated from 
the non-infarcted area the different area's of the left ventricle were dried and weighed separately. 
Data Analysis and Presentation 
Infarct area (% total L V m~') was analysed using ANCOV A with IA as dependent variable, 
experimental groups as independent factor and AR (% total LV mass), the heart rate- systolic 
arterial blood pressure product and temperature as covariates. Infarct size (lAiAR in %) was 
analysed using one way ANOV A followed by unpaired t-test and modified Bonferroni 
correctiotl.l12] Hemodynamic variables were compared using two way ANOV A for repeated 
measures followed by the paired or unpaired t~test and modified Bonferroni correction. Data are 
presented as mean ± SEM. 
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Results 
Mortality 
Eight out ofthe 89 rats that entered protocol I (one rat in each of the groups 1,2,3,8 and 9 
and three rats in group 4) and seven out of the 49 mts that entered protocol II (I rat in each of the 
groups 12 and 15,2 rats in group 13. and 3 rats in group 14) were excluded because of sustained 
ventricular fibrillation. In group 16 (protocol III) I oCthe 9 rats had to be excluded. 
Areas at Risk in the Three Study Protocols 
There were no significant differences between AR of the experimental groups (Table I). 
Effect of IS-minute MAO or IS-minute RAO on Infarct Size Produced by 6O-minute CAO 
(protocol I). 
Normothermia (Figure 4, Table 1). There was a strong linear relationship between IA and 
AR of control mts which underwent the 60-minute CAO (lA~O.76(±O.04)AR-1.93(±1.20); 
r2~O.98, P<.OOI). A single IS-minute CAO limited IAiAR produced by 60-minute CAO to 
50±3% against 68±2% in the control groups (P<.OOI). The IS-minute CAO itself resulted in 
negligible necrosis (lAlAR~3±1%, IF4). A IS-minute MAO was equally protective 
(IA1AR~50±3%, P<.OOI) as IS-minute CAO, while IS-minute RAO failed to protect the 
myocardium (IAlAR~72±5%). 
Hypothermia (Figure 4, Table I). IAiAR of the hypothermic control groups (67±3%) was 
similar to IAiAR of the normothermic control group (lA~O.74 AR-1.80, r'~O.90, P<.OOI) . In 
contrast, protection by IS-minute CAO was greater during hypothermia (lAlAR~22±3%, P<.OOI) 
than during normothermia (P<.O I). The limitation ofIAi AR to 44±5% (P<.005) by IS-minute 
MAO was not different from that produced by IS-minute MAO during normothermia. The 15-
minute RAO, ineffective during normothermia, limited IAiAR to 46±6% during hypothermia 
(P<.O I versus hypothermic control). 
Involvement of Neul'Ogenic Pathway ill Cardioprotection by IS-minute MAO (protocol II). 
Figure 5 and Table I illustrate that during normothermia as well as hypothermia ganglion 
blockade had no effect 011 infarct size produced by 60-minute CAO (IN AR~68±3% alld 
IAlAR~67±3%, respectively) and illfarct size limitation by IS-minute CAO (IA1AR~54±3%, 
P<.OOI and IAlAR~18±4%, P<.OOI respectively). III contrast, cardioprotection by IS-minute 
MAO was completely abolished by ganglion blockade during both normothermia 
(IA1AR~74±2%) and hypothermia (IA1AR~69±3%). 
Importallce ofMcsenteric Artel)' Rcperfusion for Cardiopl'Otectioll by MAO (protocol III). 
Figure 6 and Table 1 show that when MAO was sustained throughout the experimental 
protocol, myocardial infarct size was not ditferent from that of the control animals 
(lAlAR~70±3% and 63±3% at normothermia and hypothermia, respectively). 
Table 1. Effect of Remotc Organ Ischemia on Infarct Size produced by 60-minute Coronary Artery Occlusion in Rats 
Protocol I 
(Ganglion inlact) 
Sham + 60min CAO 
15min CAO+JOmin Rep+60min CAO 
15min MAO+10min Rep+60min CAO 
15min RAO+]Omin Rep+60min CAO 
Protocol II 
(After ganglion blockade) 
Sham+60min CAO 
15min CAQ+l0min Rep+60min CAO 
15min MAO+]Omin Rep+60min CAO 
Protocol III 
Pennanent MAO+60min CAO 
36.S w 37.5"C 
31±4(n=11) 
47±4 (n~9) 
42±4 (n=IO) 
35±8 (n=8) 
37±5 (n=7) 
45±3 (n=7) 
40±3 (n~7) 
36±4 (n=6) 
AR(%LVmaJ 
30-31°C 
36±4 (n~ll) 
40±5 (n~8) 
41±3 (n=11) 
37±2 (n=9) 
35±3 (n=7) 
35±2 (n=7) 
37±3 (n=o7) 
34±2 (n=8) 
IAlAR(%) 
36.5-37.5°C 
68±2 
50±3'" 
50±3* 
72±5 
68±3 
54±3* 
74±2 
70±3 
30-31 "c 
67±3 
22±3",t 
44±5'" 
46±6",t 
67±3 
18±4",t 
69±3 
63±3 
Sham=control group undergoing 60 min CAO without ischemic stimulus. CAO=coronary artery occlusion: MAO=mesenteric artery occlusion.., RAO=renal artery occlusion; 
Rep-=;;rcperfusion; Hcx=hexamethonium (20 mg/kg IV). Permanent MAO started 25 min before the onset of 60 min CAO and was maintained until the end of the three hour 
repcrfusion period. Date are mean ± SEM. * P<.05 vs Control; tP<.05 vs corresponding 36.5-37.5°C group. 
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Figure 4. Scatlerplots show effects of 15-minute CAO, IS-minute MAO, or 15-minute RAO on the relation 
between IA and AR produced by 6O-minute CAO during nonnotilernlia and hypothennia. The regression Jines are 
for the 60-minule CAO control groups. * P<O.05. For further details see Figure 1. 
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that hexamethoniulll per se had no eftect on myocardial infarct size. The regression lines are for the control (60-
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Figure 6, Scatterpiots show the lack of effect of sustained MAO on the relation between IA and AR produced by 
6O-minute CAO. *P<O.05. For further details see Figure 1. 
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Table 2. Systemic Hemodynamics ill Rats of Protocol I 
BL Organ Ischemia Organ Rep CAD Rep 
(15 min) (10 min) (60 min) 180min 
Normothermia 
Sham (,,~JO) 
IIR 340±8 350±12 344±9 355±9 332±6 
M/\P 77±5 87±6' 86±5' 70±5 66±5' 
15111ill CAD + 10lllin Rep (n=9) 
HR 366±11 357±16 360±11 359±7 351±8 
MAP 89±5 78±6' 77±4 75±3' 69±3' 
/5min MAO + IOmin Rep (n=IO) 
HR 358±7 368±6 356±6 356±8 351±7 
MAP 98±6 110±4' 84±6' 73±4' 68±4' 
15min RAG + JOmill Rep (11=4) 
HR 350±17 348±19 354±15 330±12 333±10 
MAP 92±7 95±7 99±4 69±6 70±6 
Hypothermia 
Sham (1/=7) 
HR 284±12' 266±15" 266±14" 288±8f 249±7" 
MAP 86±4 84±6 86±5 95±4 74±3 
15min CAD + 10m;" Rep (1/=8) 
IIR 320±12' 303±8' 288±12' 276±14" 245±14" 
MAP 94±4 80±4' 83±4' 75±S' 61±3' 
15111;11 MAO + IOmi" Rep (1/=5) 
HR 267±14' 260±12' 254±13' 252±13' 217±8' 
MAP 90±4 99±6 83±3 85±7 71±4 
15111;11 RAD + IOmill Rep (11=7) 
HR 252±llt 252±16' 263±16' 251±27' 222±1 r' 
MAP 67±5 76±6 79±5 72±6 59±5 
BL-baseline; Rep-reperfusion; CAO-coronary artery occlusion; Sham-control group undergoing 60 min CAO 
without organ ischemia stimulus; i-IR=heart rate (beats/min); MAP=mean arterial blood pressure (mmHg); 
MAO=mesentric artel)l occlusion; RAO=rcnai artery occlusion; Rep=reperfusion. ·P<.05 vs Baseline. tp<.05 vs 
corresponding nonnothennia group. There were no significant dift'erences between the preconditioning groups and 
the corresponding sham group for both heart rate and mean aortic pressure. All data are mean ± SEM. 
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Hemodynamics 
Heart Rate alld Meau Arterial Blool! Pressure 
Protocol! Under normothermic baseline conditions heart rate (351±5 bpm), mean arterial 
blood pressure (86±3 IllIllHg), or the product of heart rate and systolic arterial blood pressure 
(34500± 1300 bplll'lllmHg) were not different in groups 1-4 (Table 2). Hypothermia did not 
affect mean arterial blood pressure (84±3 nunHg) but decreased heart rate (285±8 bpm, P<.OO I) 
and the rate pressure product (2841 O± 1400bpm'lmnHg, P<.OOI). There were also no differences 
in baseline values of heart rate and arterial blood pressure between groups 6-9. 
None of the ischemic stimuli had an effect on heart rate during either normothermia or 
hypothermia. A IS-minute CAO resulted in a 12±3 mmHg (P<.05) decrease in mean arterial 
blood pressure, which did not recover during the 10 minutes of Reperfusion. In contrast, 15-
minute MAO and IS-minute RAO produced increases in mean arterial blood pressure of 11±3 
mmHg (P<.05) and 6±3 IllmHg (P<.05), respectively. In the MAO-groups arterial blood pressure 
decreased to below baseline values during the 10 minutes of Reperfusion but was maintained at 
1l±3 mmHg (P<.05) above baseline in the RAO-groups. 
Protocol II Administration of hexamethonium caused decreases in mean arterial blood 
pressure of 24±3 mmHg (P<.05) and 20±6 IllmHg (P<.05) during normothermia and 
hypothermia, respectively, and decreases in heart rate of 34±5 bpm (P<.05) and 58±6 bpm 
(P<.05 vs normothennia), respectively. IS-minute CAO decreased mean arterial blood pressure 
slightly further (7±3 mmHg, P<.05), whereas MAO caused an increase in mean arterial blood 
pressure (18±2 mmHg, P<.05). These responses were not different from those observed in the 
absence of hexamethonium in protocol I (Table 3). 
Protocol III Heart rate did not change in either group during the experimental protocol. After 
onset of pennanent MAO mean arterial blood pressurc increased by 14±3 mmHg (P<.05) during 
nOlll1othennia and by 16±S nunHg (P<.05) during hypothermia, but returned to baseline levels 
during thc 6O-minute CAO (Table 4). 
Lack of Effect of Systemic HemodYllamics 011 Illfarct Size 
Multivariate regression analysis of the groups in protocol I demonstrated that in the two 
shalll- and two MAO-groups AR explained 99% (r'~O.99) and 93% (r'~O.93), respectively, of 
the variability in IA with no contributions of temperature or rate-pressure product measured at 
the onset of 60-minute CAO. In both CAO- and RAO-groups AR explained 88% and 90% ofIA 
variability, respectively, whereas AR together with temperature explained 94% and 94% of the 
variability ofIA with no contribution of the rate-pressure product. Similarly, ANCOVA (with 
temperature as independent factor and AR and the rate-pressure product as co-variants) 
demonstrated that temperature but not diflerent hemodynamic conditions explained the enhanced 
protection in the hypothermic RAO- and CAO-groups. There was no correlation between the 
mean arterial blood pressure response to the preconditioning stimuli and INAR in the CAO-, 
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Table 3, Systemic Hemodynamics in Rats of Protocol II 
BL Hex Organ Ischemia Organ Rep CAO Rep 
(15 (15 min) (10 min) (60 min) (180min) 
min) 
Normothermia 
Hex COl/fro/ (11=7) 
HR 354±9 323±5' 325±6 320±5 333±5 329±7 
MAP 89±9 64±4' 64±5 64±5 66±4 66±3 
Hex15mill CAO+}O min Rep (n=7) 
HR 341±10 308±4' 313±7 309±5 314±9 315±8 
MAP 92±6 65±2' 62±5 61±4 62±3 66±3 
Hex 15min MAO+/O mill Rep (n=7) 
fiR 358±7 320±8' 334±6 319±11 337±14 341±6 
MAP 85±6 64±4' 82±St 61±4 66±7 67±4 
Hypothermia 
Hex control (11=7) 
HR 25l±IOt I 97±S't 213±9tt 206±8 225±8H 223±6tt 
MAP 91±3 71±3' 81±3 76±4 74±4 74±2 
Hex /5mill CAO+/Omin Rep (11=7) 
HR 260±12' 19S±7't 202±91 204±8' 211±81 203±IO, 
MAP 87±6 69±4' 58±2f 66±4 69±7 62±5 
Hex J 5min MAO+ 10 min Rep (n=7) 
HR 268±JSI 213±8'1 221±91 215±JOt 231±14' 219±9! 
MAP 82±6 62±2' 79±4 t 62±3 67±3 59±5 
BL baseline (pre hexamethonium); Hex hexamethonium (15 min post-administration); Rep reperfusion; 
CAO=-coronaf), artery occlusion; Sham=controi group undergoing 60 min CAD without organ ischemia stimulus; 
HR=heart rate (beats/min); MAP=mean arterial blood pressure (mmHg); MAO=mesentric artery occlusion; 
RAO=renal artery occlusion; ·P<O.05 HEX vs Baseline; tp<.05 vs Hex; ;P<.05 vs corresponding nomlOthemlia 
group. All data are mean ± SEM. 
MAO, and RAO-groups, indicating that the pressure responses to 15-minute CAO, MAO or 
RAO were not responsible for the decrease in IAI AR. This is supported by the observation that 
despite a pressor response to the permanent MAO, this stimulus failed to limit infarct size. 
In both the hexamethoniulIl treated sham- and MAO-groups, AR explained 99% of the 
variability in IA with no contribution of either temperature or rate~pressure product measured at 
the onset of 60,minute CAO, In the CAO-groups, AR explained 82% of the IA variability, 
whereas AR together with temperature explained 97% of IA variability, again with no 
contribution of the rate~pressure product. Taken together with the observation that 
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Table 4. Systemic Hemodynamics in Rats of Protocol III 
BL Organ Ischemia Organ Ischemia CAD Rep 
(15 min) (25 min) (60 min) ISO min 
Normothermia 
Permanent MAO (n=6) 
HR 353±8 360±14 355±15 362±6 340±23 
MAP 95±7 I09±7' I04±8 90±8 54±3' 
Hypothermia 
Permanent MAO (n=8) 
HR 247±6t 243±St 232±St 234±6t 24S±9t 
MAP 97±6 1I3±4' 101±3 93±3 77±4' 
BL-baseline; Rcp=reperfuston; CAO-coronary artery occlusion; HR-heart rate (beats/min); MAP-mean arterial 
blood pressure (mmHg); MAO=mcsentric artery occlusion; Rep=reperfusion. ·P<.05- vs Baseline. tp<.OS vs 
corresponding nomlOthemlia group. All data are mean ± SEM. 
hexamethonium had no efiect on the relation between IA and AR or lAiAR despite the decreases 
in herut rate and arterial blood pressure, the data clearly indicate that AR, temperature and brief 
remote organ ischemia, but not hemodynamic conditions were determinants of lA. 
Discussion 
Until now the protective efiects of ischemic preconditioning have only been investigated in 
models in which the preconditioning stimulus was applied to the organ that was also sUbjected 
to the prolonged period of ischemia. [1-5] The present study investigated whether ischemia in an 
organ other than the heart could limit infarct size produced by a sustained coronary artery 
occlusion and examined the mechanism(s) leading to cardioprotection. For this purpose we first 
investigated if protection by remote organ ischemia could be organ specific, and evaluated the 
effects of ischemia in two different organs, the kidney and small intestine. Secondly, we 
performed our studies at two different body temperatures (36.5-37.5'C and 30-31 'C). This 
approach was chosen because earlier studies have shown that infarct size development depends 
on temperature{7,8J but also because the ability of the adenosine deaminase inhibitor pentostatin 
to limit myocardial infarct size was only observed at lower body temperature.[9] The major results 
of the tirst part of the present study were that (i) ischemia in remote organs can limit myocardial 
infarct size as effectively as ischemic myocardial preconditioning with 15-minute CAO since 15-
minute MAO limited infarct size to the same extent as ischemic myocardial preconditioning 
during normothermia, (ii) the degree of protection depends on body temperature as I5-minute 
RAO failed to protect the myocardium during normothermia but was protective during 
hypothermia, and (iii) the protection by ischemic myocardial preconditioning was more 
pronounced during hypothennia than during normothermia though infarct size produced by 60-
minute CAO per se was not different during normothermia and hypothermia. Because of the 
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results of the first part of the study we selected the IS-minute MAO stimulus to examine its 
mechanism of protection. To investigate the involvement of a neurogenic pathway, we examined 
the effect of ganglion blockade on the protection by 15-minute MAO as well as 15-minute CAO. 
Ganglion blockade abolished the protection by IS-minute MAO during both normo- and 
hypothermia, but had no effect on in~1rct size produced by 60-minute CAO and protection by 
ischemic myocardial preconditioning at either temperature. These results demonstrate the 
involvement of a neurogenic pathway in the protection by I5-minute MAO, indicating that 
protection by remote organ ischemia may be different from that by ischemic myocardial 
preconditioning. However, our data do not exclude a common intramyocardial endpoint for the 
mechanism of protection by remote organ ischemia and ischemic myocardial preconditioning, 
e.g. activation of protein kinase C,l13·15] 
The final question we addressed was whether activation ofthe neurogenic pathway occurred 
during MAO or in the ensuing 10 minutes ofReperfusion. The observation that pennanent MAO 
failed to limit myocardial infhrct size produced by 60-minute CAO indicates that reperfusion of 
the small intestine was mandatory to activate the neurogenic pathway. These data could be 
interpreted to suggest that upon reperfusion substances released in the mesenteric bed (e.g. 
oxygen derived free radicals[161, cytokines[I1]) stimulate afferent neurofibers. From the present 
study it cannot be determined whether these neurofibers are activated within or outside the 
mesenteric bed. Future studies should therefore be directed at examining the factors involved in 
activating the neurogenic pathway upon release of the MAO and how this activation results in 
limitation of myocardial infarct size. 
The finding that I5-minute MAO protected the myocardium during both normothermia and 
hypothermia, whereas the I5-minute RAO was only protective during hypothermia might suggest 
that I5-minute RAO resulted in a subthreshold stimulus during normothermia. The renal and 
mesenteric artery are of similar size in terms of amount of total blood flow, but whereas the 
anterior mesenteric flow is considered almost completely nutrient flow, less than 10% of renal 
blood flow is nutrient flow.ll 8J Consequently, the amount of tissue that becanlc ischemic during 
renal at1ery occlusion was less than during mesenteric artery occlusion so that the stimulus by 
RAO may have been below threshold. We can therefore not exclude that multiple or a single 
longer renal occlusion or bilateral renal artery occlusion could have protected the myocardium. 
In this respect it should be kept in mind that in ischemic myocardial preconditioning the severity 
of ischemia appears to be more important than its duration in order to elicit cardioprotection. [19} 
Neveliheless, briefintermption of renal aliery blood flow protected the heart during hypothermia. 
There have been preliminary reports that a renal artery occlusion may reduce infarct size 
produced by a coronary artery occlusionpo, 21} In our earlier stud)A211 we did not control 
temperature as rigorously as in the present study. In subsequent experiments we observed that 
without appropriate measures, temperature can decrease easily by as much as 3-4 °C during the 
course of surgical instrumentation. \Ve can therefore not exclude that in our earlier study the 
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effects by the 15-minute RAO occlusions were due to the presence ofhypothennia. 
An intriguing finding in the present study was that hypothermia per se had no effect on 
infarct size in the control rats, but unmasked a protective effect by I5-minute RAO. In contrast, 
the protection by IS-minute MAO tended to be enhanced but this was not statistically significant. 
The lack of effect of hypothermia on infarct size in the control rats seems at variance with 
previous observations in rabbitsPl However, in that study a different temperature range (35-
42°C) was employed while the sustained coronary artery occlusion lasted only 30 minutes. At 
30 minutes of occlusion infarction progresses rapidly in the rabbit so that a small delay of 
infarction by a decrease in body temperature may have a greater effect on infarct size. It is 
possible that in rats infarcts produced by 60-minute CAO are less susceptible to the delay in 
infarction produced by a decrease in body temperature. This hypothesis is supported by two 
recent studies in swinc. Whereas Duncker ef a/18] observed that a decrease in body temperature 
from 39°C to 35°C reduced infarct size produced by 45-minute CAO by more than 80%, 
fvIcClanahan ef aP9) reported that a decrease in temperature from 37°C to 35°C had no effect on 
infarct size following 60-minute CAO. These findings indicate that the effect of temperature on 
infarct size may depend critically on the experimental model, including the duration of the 
sustained CAO. 
In contrast to the lack of effect of temperature on infarct size in the control rats, hypothennia 
markedly modified the efficacy of the preconditioning stimuli. \Vith the exception of the 
mesenteric preconditioning stimulus, which was only slightly but not significantly enhanced by 
the presence of hypothermia, protection by intramyocardial ischemic preconditioning was 
enhanced and a cardioprotective effect of brief renal ischemia now emerged. The mechanism of 
this synergistic (intramyocardial ischemia) or urllllasking (renal ischemia) action of hypothermia 
is not readily explained. The present study excludes a contribution of activation of a neural 
pathway, as hexamethonium did not affect the enhanced protection of ischemic myocardial 
preconditioning by hypothermia. l\kClanahan el aPl reported that either mild hypothennia or 
adenosine deaminase inhibition alonc had no effect on infarct size. In contrast, when these 
stimuli were combined a significant reduction in myocardial infarct size was observed. Their 
findings are in agreement with the present study and suggest that body temperature even when 
it does not alter infarct size by itself can signific~mtly modify the cardioprotective effects of other 
physiological or pharmacological interventions. The protection by I5-minute MAO was not 
signiticantly increased when experiments were performed at hypothermia, which might suggest 
that the stimulus was already maximally effective at normothermia. 
~lethodological Considerations 
In the present study body core temperature was measured rectally. That this temperature 
retlects intrathoracic temperature was demonstrated in five rats in which simultaneous 
measurements of rectal and thoracic cavity temperatures were not difterent (see Method section). 
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The question could be raised whether these rectal measurements reflect intramyocardial 
temperature. In a previous study in swine,IS] rectal temperature exceeded Illoycardial temperature 
on average by only 0.3°C at baseline, while at the end of 4S-millutc CAO, intramyocardial 
temperature was 0.3 °C lower than rectal temperature. Those findings suggests that although 
subtle differences in temperature of myocardium and rectum may have been present in tlus study, 
these were small compared to the 6°C rectal temperature difference in the normothermic and 
hypothennic groups. 
An increase in myocardial stretch produced by rapid volume loading can limit infarct size 
produced by a 60-minute CAO in dogsP2J \Ve did not measure left ventricular diastolic volume 
or pressure, and can therefore not exclude that MAOR or RAORillduced pressor responses 
produced stretch mediated cardioprotectioll. However, such a mechanical pathway of protection 
appears unlikely as ganglion blockade abolished the MAO-induced protection, even though the 
pressor response persisted. 
Clinical Implications 
The present study may have important clinical implications as it suggests that ischemia in 
remote organs could result in cardioprotection when preceding a coronary thrombotic event. 
Thus, patients suffering from abdominal angina or perhaps even intermittent claudication might 
conceivably have a longer time-window for thrombolytic therapy to salvage ischemic 
myocardium. The present study also supports earlier reports that myocardium can be protected 
by stimuli which do not produce myocardial ischemia such as myocardial stretcrJ22J or ventricular 
pacing. (23J The ability of such diverse stimuli, e.g. nonRischemic myocardial stimuli and nonR 
myocardial ischemic stimuli, to protect the myocardium may hamper the unequivocal 
demonstration of ischemic myocardial preconditioning in many~·26J 
Conclusion 
The present study is the first to demonstrate that not only brief ischemia in an adjacent 
myocardial region, but also a brief period of ischemia followed by reperfusion in a remote organ, 
such as small intestine or kidney, can protect the myocardium against itTeversible damage 
produced by a prolonged coronary artery occlusion. Mesenteric atiery occlusion and reperfusion 
resulted in protection both during hypo- and normothermia, whereas the protection by renal 
ischemia was only apparent under hypothennic conditions. The mechanism of protection by brief 
mesenteric artery occlusion involved a neurogenic pathway that required mesenteric artery 
reperfusion for its activation. 
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The myocardial infarct size limiting effect of low body 
temperature in rats depends on the duration of 
the coronary artery occlusion. 
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The myocardial infarct size limiting effect of low body temperature in rats 
depends on the duration of the coronary artery occlusion 
Backgroulld A reduction in body temperature has been reported to result in smaller 
myocardial infarct size produced by a 30~ and 45-minute coronary artery occlusion (CAO) in 
rabbits and swine respectively. However, in rats we previously found that infarct size produced 
by a 60-minute CAO at nonnothermia (36.5°C-37.5°C) or at hypothermia (30°C-31°C) did not 
differ. Consequently, in the present study we examined whether the protective effect of low body 
temperature depends on the duration of the CAO. 
Methods al/d Results Area at risk (AR) and infarcted area (IA) were determined in 
anesthetized rats after 180 minutes of reperfusion following CAD's varying between 15 and 120 
minutes. During normothermia, INAR was 3±1 % (mean ± SEM, IF4), 48±9% (n~6), 62±6% 
(n~ll), 68±2% (n~ll) and 75±3% (n~4) after 15-, 30-, 45-, 60- and 120-minute CAO, 
respectively. During hypothermia, INAR was 14±3% (n~5 , P<O,OI), 54±2% (n~7, P~NS), 
69±2% (IFIO, P~NS) and 72±I% (n~2, P~NS) after 30-,45-,60- and 120-minute CAO, 
respectively (P vs corresponding normothermia groups). Although, hypothermia was 
accompanied by a lower heart rate (275±8 bPlll, n=24, vs 355±5 bpm during normothermia, 
n~28), elimination of hypothermia-induced bradycardia by atrial pacing at 360 bpm did not 
increase the INAR produced by 30-minute CAO (l2±2%, n~5, P~NS vs 30-minute CAO during 
spontaneous sinus rhythm). 
COllclusioll The myocardial infarct size limiting effect of low body temperature depended 
critically 011 the duration ofthe coronary artery occlusion, but was independent of its effects on 
heart rate and systolic arterial blood pressure. 
Key Words: infarct size, temperature 
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Introduction 
Recently, we showed that myocardial infarct size produced by a 60-minute coronary artery 
occlusion (CAO) in rats was not different when the experiments were perfonlled at noml0thenllia 
(36.5°C-37.5°C) or hypothermia (30°C-31°C) [11. This finding is at variance with previous 
studies in rabbits [2J and swine [3J in which infarct size produced by 30- [2J and 45-minute {3J CAO 
was smaller at lower body temperatures. Reasons for the apparent discrepancy could be 
differences in species or the duration of the CAD. Consequently, the present study investigated 
the importance of the duration ofCAO on the infarct size limiting effect of hypothermia. Since 
hypothenl1ia was associated with bradycardia, which could possibly limit infarct size per se [4], 
we studied an additional group ofhypothenllic rats in which heart rates were increased to heart 
rates at baseline of the normothermic animals. 
Methods 
Experimcntal Design 
Experiments in ad libitum fed male \Vistar rats (± 300 g) were perfonned in accordance with 
the Guiding principles in the care and use of animals as approved by the Council of the 
American Physiological Society and under the regulations of the Animal Care Committee of the 
Erasmus University Rotterdam. 
Expcrimental Groups. 
Ten groups of rats were studied (Figure 1). Five groups (groups 1-5) were subjected to left 
anterior descending coronary artery occlusions of different durations followed by 180 minutes 
ofreperfusion during nOl1nothenllia (36.5°C-37.5°C body core temperature), while five groups 
(groups 6-10) were studied during hypothermia (30°C_31°C body core temperature). Groups 1, 
2,3,4 and 5 underwent CAD's of 15,30,45,60 or 120 minutes, respectively, while groups 6, 
7, 8 and 9 were subjected to CAD's of30, 45, 60 or 120 minutes, respectively. Group 10 was 
subjected to 30-minute CAD followed by 180 minutes of reperfusion, while heart rate was raised 
to 360 bpm to detennine the contribution of bradycardia to the temperature-induced infarct size 
limitation. Infarct size data of rats of groups 1,4 and 8 have been reported earlier [ll. 
Surgical and Experimental Pl'ocerlul'Cs 
Rats were anesthetized with pentobarbital (60 mg/kg IP) and intubated for positive pressure 
ventilation (Harvard) with room air. A PE-l 0 catheter was positioned in the thoracic aOl1a for 
measurement of arterial blood gases, arterial blood pressure and heart rate (Baxter Diagnostic 
Inc.). A PE-50 catheter was positioned in the inferior caval vein for infusion of polygeline 
(35mglml). After intercostal thoracotomy the pericardium was opened and a silk (6-0) suture was 
looped under the coronaty artery for later production of CAD (1, 5, 6). In rats of group 10, a 
pacing electrode (negative pole) was implanted in the wall of the left atrial auricle while the zero 
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EXPERIMENTAL GROUPS 
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Figure I. Schematic presentation of the 10 groups in which the effect of temperature on the relation between infarct 
size and duration of the coronary artery occlusion was studied. CAO=ieft anterior descending coronary artery 
occlusion; Rep=reperfilsion. 
electrode was positioned in the major pectoral muscle. Following laparotomy, a catheter was 
positioned in the abdominal cavity to allow intraperitoneal infusions of pentobarbital for 
maintenance of anesthesia. 
Body core temperatures were continuously measured rectally using an electronic thermometer 
(Electromedics Inc.) and were maintained in the designated range using either heating pads or 
ice-filled packages. Except during application of the coronary artery occlusions and reperfusions 
the thoracotomy site was covered with aluminium foil to prevent heat loss from the thoracic 
cavity. The adequacy of this procedure has been verified earlier (chapter 5) III. Rats that fibrillated 
during occlusion or reperfusion were allowed to complete the protocol when conversion to 
normal sinus rhythm occurred spontaneously within 1 minute or when resuscitation, by gentle 
thumping on the thorax, was successful within 2 minutes after onset of fibrillation. Occlusion as 
well as reperfusion were visually verified by appearance and disappearance of myocardial 
cyanosis. 
Measuremcnt of Area at Risk and Infarcted Area 
At the end of the experiment the heart was quickly excised and cooled in ice-cold saline 
before it was mounted on a modified Langendorff apparatus and perfused retrogradely via the 
aorta with 10 ml ice-cold saline to wash out blood 15,6). After the coronary ligature was retied the 
heart was perfused with 3 ml Trypan Blue (0.4%, Sigma Chemical Co.) to stain the normally 
Temperature and myocardial infarct size 91 
perfused myocardium dark blue and delineate the non-stained area at risk (AR). The heart was 
then frozen at _80°C for lO minutes and cut into slices of I mm from apex to base. From each 
slice, the right ventricle was removed and the left ventricle (LV) was divided into the AR and the 
remaining left ventricle. The AR was then incubated for 10 minutes in a 37°C Nitro-Blue-
Tetrazolium solution (Sigma Chemical Co.; 1 mg per I ml Sorensen buffer, pH=7.4), which 
stains vital tissue purple but leaves infarcted tissue unstained. After the infarcted area (IA) was 
isolated from the non-infarcted area, the different area's of the left ventricle were dried and 
weighted separately. In addition, the isolation technique show an increased variability in 
measuring infarct size at smaller area at risks, we therefore excluded animals in which the area 
at risk was below 20% of left ventricular dry weight. 
Data Analysis and Presentation 
The effects of temperature on infarct size (lAiAR * 100%) were analysed using Two way 
ANOVA with IAiAR as dependent variable, and temperature and duration of CAO as 
independent factors. \Vhen a significant effect was observed, post-hoc testing was performed 
using the unpaired t-test with a modified Bonferroni correction [1[. Heart rate, mean arterial blood 
pressure and the rate-pressure product (heart rate * systolic arterial bloodpressure) were analyzed 
using three way (CAO duration, temperahlre and time) ANOVA for repeated measures followed 
by the paired or unpaired t-test and modified Bonferroni correction. Data are presented as mean 
±SEM. 
Results 
Mortality. 
One of the rats (group 4) that entered the study was excluded because of irreversible 
ventricular fibrillation, while one animal had to be excluded because of technical failure. 
Areas at Risk (Table 1). 
There were no significant differences between AR of the 10 experimental groups. 
Time course of infarct size development (Figure 2, Table 1). 
NOl'mothel'mia. IAiAR of groups I, 2, 3, 4 and 5 was 3± I %, 48±9%, 62±6%, 68±2% and 
75±3% afier 15-, 30-, 45-, 60- and 120-minute CAO, respectively, demonstrating that the 
suspectibility of the myocardium to the development of irreversible damage increased sharply 
between 15 and 30 minutes (3% of the AR per min). 
Hypothermia IAiAR of gonps 6, 7 and 8 was 14±3% (n=5, P<O.Ol vs corresponding 
nonnothennia group), 54±2% (n~7, P~NS), 69±2% (IF I 0, P~NS) and 72±1 % (IF2, P~NS) after 
30-, 45-, 60-, 120-minute CAO, respectively. These data show thatduring hypothennia the most 
sensitive period for the development of irreversible damage was delayed, but that the sensitivity 
Table I. Effect of Temperature on Infarct Size produced by Coronary Artery Occlusion of Different Durations in Rats 
AR(%LYmw) IAIAR(%) 
36.5°C~37S'C 300C~31 °C 36.5°C-37.S0C 30°C-31°C 
Control 
IS-minute CAO 44±4 (n"4) 3±1 
30-minute CAO 39±4 (n"6) 40±3 (n"5) 4S±9 14±3* 
45-minutc CAO 44±3 (n"6) 38±3 (n=7) 62±6 54±2 
60-minute CAO 38±3 (0=8) 39±3 (0=10) 71±2 69±2 
120-min CAO 43±3 (n"4) 34±2 (0=2) 75±3 72±1 
Pacing +30-minute CAO 42±3 (n"7) 12±2"l" 
CAO'""coronary artery occlusion; Pacing=atrial pacing at 360 bpm started 25 minutes before the onset CAO and was maintained until the end of the three hour reperfusion period. 
Date arc mean ± SEM. * P<.05 vs nonnothermic group (36.5°C-37.S°C); tP<.05 vs corresponding group with the same temperature and occlusion duration. Table 1 
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Figure 2. Effect of temperature on the infarct size after CAO's of difterent duration. Experiments were performed 
at nomlOthennia (36.5°C-37,5°C, 8) and hypothemlia (30°C-31°C, 0). * P<.05 vs nomlOthemlic group, IA and 
AR are infarcted area and area at risk respectively. Data are mean±SEM. 
per se was unaltered (2.7% of AR per min), \Vhen the occlusions were maintained for longer than 
45 minutes, IAI AR was not different for the normothermic and hypothermic rats. 
\Vhen the 30-minute CAO experiments were performed during atrial pacing at 360 bpm 
INAR was I2±2% (group 10, P<O.OS vs group 2), which was not different from the INAR of 
14±3% in group 6. 
Hemodynamics 
Heart Rate, Mean Arterial Blood Pressure amI Rate-Pressure Product (Figure 3). 
Under nonnothenllic baseline conditions heart rate (355±5 bpm, n=28), mean arterial blood 
pressure (89±4 mmHg, n~28), or the rate-pressure product (36600± ISOO bpm.mmHg, n~28) 
were not different in groups 1-5. Hypothermia did not affect mean arterial blood pressure (92±3 
1l11l1Hg, IF24) but decreased heart rate (27S±8 bp1l1, P<.OOI) and the rate-pressure product 
(28700±1SOO bpm·nullHg, P<.OOI, IF24). There were no differences in baseline values of heart 
rate, mean arterial blood pressure and the rate-pressure product between groups 6-9. In group 10 
heart rate, mean arterial blood pressure and the rate-pressure product during atrial pacing were 
not significantly different from the respective baseline levels in the nonllothermia group 2. 
Table 2. Heart Rate and Mean Arterial Blood Pressure in Rats undergoing Coronary Artery Occlusion under Normo- and Hypothermia. 
BL Pre CAO CAO CAO CAO CAO Rep 
(15 min) (30 min) (45 min) (60 min) (180 min) 
Normothermia (36.5°C-37.s°C) 
I5-minute CAO (n~.f) 
HR 32S±5 328±5 323±15 330±I3 
MAP 66±3 66±3 63±5 56±4 
30-minute CAO (n~6) 
HR 363±8 355±8 357±8 348±9 357±5 
MAP 87±4 97±3 78±5 84±6 79±9 
.f5-minute CAO (n~6) 
HR 36S±5 347±13 355±7 343±10 360±9 360±17 
MAP I07±6 90±9 79±6 83±5 93±5 66±7 
60-minule CAO (n=7) 
HR 351±9 351±9 356±7 360±8 364±10 361±11 336±7 
MAP 78±7 82±8 75±IO 75±9 74±7 67±6 62±6 
Hypothermia (30°Cw31 0c) 
30-minule CAO (n=;;5) 
HR 25S±15 240±16 260±16 252±20 254±13 
MAP 93±5 83±8 86±7 92±8 83±2 
.f5-minute CAO (n~7) 
HR 266±12 257±5 277±13 282±15 287±14 272±14 
MAP 92±2 90±4 84±6 99±5 lOl±4 77±3 
60-minute CAO (n==7) 
HR 286±14 269±17 285±15 290±14 286±12 289±9 251±8 
MAP 84±6 84±6 83±8 94±7 97±8 9S±5 75±4 
Pacing + 30-minute CAO (n-=:=7) 
HR 284±5 360±1 348±12 360±1 360±1 
MAP 79±8 7S±5 7S±6 86±7 72±4 
BL-baseline: CAO-·coronaI)' artery occJusion~ Rep Reperfusion~ HR heart rate (bpm)~ MAP~ean arterial blood pressure (mmHg); Pacing atrial pacing at 360 bpm. ·P<.05 
vs Base!ine. ~P<.05 vs corresponding normothermia group. [ P<.05 vs corresponding time point. There were no significant differences between the groups for both heart rate 
and mean aortic pressure. AU data are mean ± SEM. 
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Figure 3. Relation between the rate-pressure product (HR *SAP) and infarct size (IA/AR) for rats that underwent 
a 30-minute CAO .• normolhennia, 0 hypothemlia, 6. hypothennia and atrial pacing at 360 bpm, fA and AR are 
infarcted area and area at risk respectively. Data are mean±SE!'vt. 
Figure 3 shows that the bradycardia-induced decrease in the rate-pressure-product did not 
contribute to the limitation in in£'uct size in the hypothermia group. 
Discussion 
Some ten years ago Voorhees el ailS] reported that in dogs at temperatures below the normal 
range (~26°C) infarct size produced by a 5-hour coronary artery occlusion was less than in 
normothermic animals (~39°C). The results of that study must be interpreted with caution 
because infarct size was determined inU11ediately at the end afthe 5 hour occlusion period using 
nitroblue tetrazoliul11 staining. To minimize £1lse positive staining myocardial reperfusion must 
be allowed to facilitate washout of nicotinamide-adeninedinucleotide from necrotic 
myocardium!')!. Voorhees et al [S] did not allow reperfusion of the ischemic myocardium and 
intarct size may therefore have been underestimated. Furthel111ore, the authors reported collateral 
blood flow data which were much higher than usually measured during coronary artery occlusion 
in dogs [IS!. Finally. infarct size was expressed as a percent of the left ventricle without taking into 
acollnt the size of the area at risk. 
Recently. Chien et al (2) reported a steep relation between body core temperature in the 
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"nonnothenllic" range (35°_42°C) and myocardial infarct size ill rabbits subjected to a 3D-minute 
CAO and 3 hours ofreperfusion, so that an increase of 1°C resulted in 12% infarction of the area 
at risk with 110 infarction Deeuring at a body core temperature of 34.5°C. Duncker el at [3J showed 
an even steeper relation between body core temperature and infarct size produced by a 45 minute 
coronary artery occlusion and four hours of reperfusion in swine as as 20% of the area at risk 
became infarcted with a IOC increase in temperature in the range of 35°C to 39°C. 
In contrast to these studies in an earlier Shicly in rats we could not show a protective effect 
ofhypothennia on infarct size determined 3 hours after a 60-minute CAO [II, \Ve hypothesized 
that the discrepancy with the earlier studies could be caused by either a difference in the duration 
of the CAD or a difference in species. The present study demonstrates that the infarct size 
limiting effect of hypothermia depends on the duration of the coronary artery occlusion. Thus, 
when in rats the coronary artery was occluded for 30 minutes, hypothcmlia was protective (5.2% 
of the area at risk per l°C) , but when the duration of the CAD was extended to 60 minutes the 
protective effect ofhypothcrmia could not be detected (Figure 4). 
Rabbits and swine like rats display a steep relation between occlusion duration and infarct 
size. It is likely that in species like the dog and baboon in which infarction progresses more 
slowly [10.11 1, the effect of temperature will be less than in species sllch as swine, rabbits cmd rats. 
100 
75 120 min I 0.5% per 1°C fP= NSl B 60 min 0.3% per 1°C P= NS 
-ct 45 min. 1.2% per 1°C (P= NS) 
......... Q" ... a:: 50 
~ 5.2% per 1°C (P<0.01) ~\<:-
25 
,?><::J 
Or-------~--------~------~ 
Hypothermia Normothermia 
Figure 4. Sensitivity (% infarction of AR per 1°C) for devclopment ofirrcversible damage during a 30-minute CAO 
in rats. Experiments were performed at nomlOthemlia (0) and hypothemlia (0). * P<.05 vs normothermic group, 
t P<.05 vs nonnothermic group.IA and AR are infarcted area and area at risk respeetivcly. Data are mean±SEM. 
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Mechanisms by which hypothermia could exert protection 
The role of myocardial oxygen demand at the onset of the coronary atiery occlusion as a 
detemlinant of infarct size is controversial. A positive correlation [12, J3] as well as no relation [13-
17] between the rate-pressure product and infarct size have been reported, Nienaber et al [4] 
produced bradycardia in dogs with a synthetic opiate to lower the metabolic demand at the onset 
of a 24 hour coronary artery occlusion thereby producing a smaller infarction compared to a 
group of animals with a high metabolic demand at the onset of coronary artery occlusion, It 
cannot be excluded that the obtained protection by bradycardia was actually a direct result of~­
opoid receptor stimulation [18J, In collateral deficient species such as rabbit and swine infarct size 
does not appear to be correlated with the rate-pressure product {14, 171, In the study by Duncker et 
al [3J univariate or stepwise multivariate regression analysis did not reveal a significant correlation 
between temperature and systemic hemodynamic variables at baseline or myocardial blood flow 
under baseline conditions, suggesting that temperature did not exert its effect by altering 
myocardial oxygen demand at the onset of occlusion. Similarly, in rabbit hearts [2J and rat hearts 
(present study) the infarct size limiting effect of hypothermia was unmitigated when 
hypothennia-induced bradycardia was prevented. It is likely that during coronary artery occlusion 
when contraction ceases, energy utilization is no longer reflected by the rate-pressure product 
Cellular determinants of myocyte viability distal to a coronary artery occlusion are 
incompletely understood, but may include depletion of high energy phosphate pools below a 
critical level (A TP<l 0% of normal), or damage to mitochondrial membranes and sarcolemma 
with altered ion homeostasis. Since many enzyme systems in manunalian membranes (including 
ATPases) are temperature sensitive, a decrease in temperature might decrease infarct size through 
reduction of energy utilization with consequent slowing of high energy phosphate depletion, In 
agreement with this hypothesis, Jones el a1 120} reported that a 3°e decrease in temperature 
markedly slowed the rate of ATP depletion and lactate production in the globally ischemic 
isolated dog heart. There is evidence that a decrease in temperature can result in decreased 
fluidity and, consequently, decreased ion permeability ofmembranes[21,221, The latter mechanism 
has been implicated in the protective effect of hypothermia against calcium overload associated 
with the calcium paradox [21J and during reoxygenation following hypoxia in isolated perfused 
rodent hearts [23J. Thus, potential mechanisms through which a lower temperature decreases 
infarct size likely include a decrease in energy utilization and/or maintained ion homeostasis 
during ischemia and reperfusion, 
Methodological Considerations 
iVfeasurement of temperature_ In the present study body core temperature was measured 
rectally. That this temperature reflects intrathoracic temperature was demonstrated in five rats 
in which simultaneous measurements of rectal and thoracic cavity temperatures were not 
different [11. The question could be raised whether these rectal measurements reflect 
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intramyocardial temperature. In a previous study in swine [3], rectal temperature exceeded 
moycardial temperature on average by only 0.3°C at baseline, while at the end of 45-minute 
CAO, intramyocardial temperature was 0.3°C lower than rectal temperature. Those findings 
suggest that although subtle differences in temperature of myocardium and rectum may have 
been present in the present study, these were likely to be small compared to the 6°C rectal 
temperature difference in the normothermic and hypothermic groups. 
Area at risk. Early canine studies of the effects of coronary artery occlusion on myocardial 
infarction used occlusions at an anatomically identical site, expressing in~1rct size as a percent 
of the left ventricle [191, However, variability in the pattern of distribution of terminal arterial 
branches can result in substantial variability of the myocardial mass perfused by the occluded 
arterial segment [151, To take into account this anatomic variability in coronary vascular 
distribution, infarct size is generally expressed as a percent of the area at risk, Recently, it was 
shown that even in collateral deficient species like rabbit [24J and swine [!4J the relation between 
the area at risk and the infarcted area has a positive intercept through the area at risk axis, As a 
result the ratio ofinfarcted area divided by the area at risk depends on the size of the area at risk, 
However, in rats the intercept through the area at risk axis is not different from zero, implying 
that infart size expressed as a percentage ofthe area at risk is independent of the area at risk Ill, 
which justifies the use of infarct size expressed as a percent of the area at risk in the present 
study. 
Collateral bloodj/oll' to the Area at Risk. In species with substantial and variable degrees 
of native collateral circulation such as the dog, collateral blood flow to the ischemic region exerts 
a protective effect on infarct size [10, 13,25, 261, The rat does not possess an extensive collateral 
circulation and collateral blood can therefore be excluded as a confounding factor. 
Conclusions. 
The myocardial infarct size limiting effect of low body temperaturc depended critically on 
the duration of the coronary artery occlusion, but was independent of its effects on heart rate and 
systolic arterial blood pressure. 
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Does Protein Kinase C Playa Pivotal Role in the Mechanisms of Ischemic Preconditioning? 
Ben C.G. Gho, MD; YVOIme E.G. Eskildsen-Helmond, MSc; Sandra de Zeeuw, MSc; 
Jos MJ. Lamers, PhD; Pieter D. Verdollw, PhD. 
Summary. TItis communication reviews the evidence for the pivotal role of protein kinase 
C in ischemic myocardial preconditioning. It is believed that several intracellular signalling 
pathways via receptor-coupled phospholipase C and its "cross-talk" with phospholipase D 
converge to activation of protein kinase C isozymes which is followed by phosphorylation of 
until now (a number of) unknown target proteins which produce ischemic preconditioning. 
After briefly introducing the general biochemical properties of protein kinase C, its isozymes 
and the limitations of the methodology used to investigate the role of protein kinase C, studies 
are discussed in which phanuacological inhibition and activation and (inuuunore)activity and/or 
isozymes measurements of protein kinase C isozymes were applied to access the role of 
activation of protein kinase C in ischemic myocardial preconditioning. 
Conclusion. It is concluded that definitive proof for the involvement of protein kinase C in 
preconditioning requires future studies which must focus on the isozyme(s) of protein kinase C 
that are activated, the duration of action, cellular translocation sites and the identity and stability 
of (covalently bound phosphate) of phosphorylated substrate proteins. 
Key JVords. myocardial ischemia; infarct size; myocardial protection; ischemic preconditioning; 
protein kinase C; phospholipase C; phospholipase D 
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Introduction 
Ischemic preconditioning is not an organ specifIc phenomenon, as it does not only occur in 
the heart [1,21, but also in kidney 131, liver {4] and skeletal muscle [51, while the brain is protected 
against the consequence of a new ischemic event at 24 hours after the preconditioning stimulus 
was applied [6J. Furthermore, brief ischemic in organs other than the heart may also limit 
irreversible damage produced be a subsequent coronary artery occlusion. Thus, in rats a 15-
minute occlusion of the mesenteric arteI)' 10 minutes prior to a 60-minute coronary artery 
occlusion limited myocardial infarct size by 40% [7). Since ganglion blockade abolished 
myocardial protection by mesenteric arteI)' occlusion-reperfusion but not by brief coronary artery 
occlusion-reperfusion, the mechanism of protection by brief ischemia-reperfusion in other organs 
appears to differ from that by brief myocardial ischemia-reperfusion [71. 
Initially, ischemic preconditioning studies focussed on time characteristics and the search 
for extracellular endogenous and exogenous factors that either mimicked or inhibited the 
phenomenon. It proved that protection occurred during two distinct episodes: a first window of 
protection (F\VOP) that lasted 2 to 3 hours after the preconditioning stimulus was applied {1,21, 
and a second window of protection (S\VOP) between 24 and 72 hours [S-1OI, The mechanisms of 
protection for these two windows are most likely not the same. Endogenous rapidly factors 
produced agonists may activate intracellular pathways during F\VOP, while the slower process 
of induction of heat-shock proteins may be involved during the S\VOP. Initially, attention 
focussed on activation of adenosine AI-receptors [11,121 or K+ATP chatmel opening (lJ, 141, as the 
mechanisms for protection during F\VOP. More recently activation of protein kinase C has 
received wide attention {15}, Prior to reviewing the role of protein kinase C, we first review the 
current state of knowledge of the molecular mechanism(s) of ischemic preconditioning and 
introduce the generally ktlO\\,ll biochemical properties of protein kinase C and before discussing 
the limitations ofthe techniques used to investigate the potential role of protein kinase C. Finally, 
the evidence that activation of protein kinase C and the intracellular signalling pathways leading 
to its activation playa pivotal role in the mechanism of ischemic preconditioning is summarized. 
However, not all studies support a role for protein kinase C in preconditioning and this issue 
rcmains therefore controversial at the present time, 
.Most studies on ischemic preconditioning used in£'1fct size as endpoint, but other endpoints 
such as recoveI)' of contractile function, and protection against rcperfusion-induced ventricular 
arrhytlunias have also been used. Because these other endpoints require different experimental 
conditions (Le, shorter duration of the sllstained occlusions) we have limited ourselves to studies 
which used infarct size as endpoint. For this same reason we have excluded studies on ischemic 
preconditioning in other organs. 
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Figure 1. Isozymes of prole in kinase C, the functional domains in their primal)' structure, and receptor-coupled 
phospholipase C-mediated signal transduction leading to protein kinase C activation. The various protein kinase 
C isozymcs share some sequence homology and have all a common ATP-binding site(C3) and catalytic site (C4). 
Only protein kinase Ca, -Pl' -Pl and -y have a Ca2' binding site (e2) and 1 ,2-diacylglyceroJ (I ,2-DAG) - binding 
site (C I). In the inactivated state the isozymes of protein kinase C are folded so that an endogenous "pseudo 
substrate" region on the N-temlinal part of the protein occupies the catalytic site (C·tenninal part). When agonisls 
(see text) bind to their specific receptors linked to phospholipase C in the cardiac sarcolemma, receptor activation 
is followed by phospholipase C catalyzed hydrolysis of Pldlns(4,5)P2 to foml inositol-I,4,5-trisphosphate 
(Ins(I,4,5)PJ). Ins(I,4,5)P) releases Cal + from the Ins(1 ,4,5)P) receptor-sensitive Cal < storage sites in the cardiac 
sarcoplasmic reticulum. Ptdlns(4,5)P2 hydrolysis also fOrulS 1,2-diacylglycerol (1,2-DAG), which increases the 
affinity ofsomc isozymes for Ca2t-. When the intracellular free Ca2' concentration increases, some isozymes become 
more lightly associated with membranes containing the negatively charged head groups ofPldSer, allowing 1,2-
DAG to reach its binding site (CI) on the protein kinase C. The 1,2-DAG·protein kinase C complex npproaches 
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the membrane by placing.the kinase in a pocket ofnegativcly-charged head groups ofPtdSer in which Ci+ remains 
attracted. When this occurs, the conformation of protein kinase C changes, exposing the unoccupied catalytic site, 
thereby allowing the kinase to phosphOl)'Jate cellular proteins. 11Iere is also evidence that specific binding proteins 
(e.g. MARCKS and RACK) determine the cellular translocation process of protein kinase C isozymes. The 
membrane-bound protein kinase C-DAO-(Ca2+)-mcmbrane complex only slowly dissociates and this property is the 
basis for the commonly used "translocation assay" for assessment ofPKC activation. Figure adapted from Zeisel 
e/ al lH1 , with pernlission of the FASEB Journal. 
Current state of knowledge ofthc molecular mechanism(s) of ischemic preconditioning 
Activation of receptors by exogenously administered stimuli such as adenosine {II. 12], 
bradykinin {16, 171, noradrenaline [18, 19J, acetylcholine (20,21 1, endothelin-l In) or opiates {23J mimic 
myocardial protection by ischemic preconditioning. Intracellular signalling by these stimuli, via 
GTP-binding-protein-linked receptors and phospholipase C and possibly phospholipase D (see 
later) [24,25], leads to activation of one or more isozymes of the protein kinase C family which then 
phosphorylate putative target proteins [15, 261. Possible target proteins are those that regulate 
opening ofK\TP channels [13, 14, 27J, activate ecto-5'-nucleotidase {28J (during F\VOP) or modulate 
transcriptional regulation of the expression of heat shock proteins 129,301 (during S\VOP). For 
instance, K\TP chaImcls are opened when all ischemic preconditioning stimulus is applied, while 
blockade ofK+ATP chaImels prevents ischemic preconditioning [13.141. It is likely that modulation 
ofK+ATP channels in the mitochondria, sarcoplasmic reticulum or the nucleus are involved in the 
mechanism of protection as blockade of the action potential shortening by dofetilide does not 
abolish protection by ischemic preconditioning pl}. Since protein kinase C can be activated via 
various receptors linked to phospholipase C- and possibly phospholipase D-mediated signalling 
pathways, these receptors may act synergistically (IS]. Opening of K\TP channels by 
pharmacological substances lowers the threshold for ischemic preconditioning P21, which is 
consistent with the hypothesis that K\TP channels arc target proteins for protein kinase C. 
Kitakaze et at 128) reported that ischemic preconditioning increased ecto-51-nucleotidase activity 
and that activation of protein kinase C increases ecto-5 1-nucleotidase activity in isolated rat 
cardiomyocytes, supporting the candidacy of ecto-5'-nucleotidase as another target protein of 
protein kinase C. 
General biochemical properties of protein kinase C 
In general, the confonnation of protein kinases consists of two regions which are connected 
by a region functioning as a hinge. The protein substrate fits into the groove between the two 
regions and interacts with a catalytic domain and cofactors interacting with the regulatory domain 
{33], The specificity of protein kinases such as cyclic AivfP dependent protein kinase, Ca2+_ 
calmodulin dependent protein kinase (CaM-PK) and protein kinase C for their substrate proteins 
is detennined by both the primary sequence of these proteins around their phosphorylation site 
and the capacity of these sites to interact with the catalytic domain of the protein kinase. 
Generally, protein kin8ses are inactivated by the interaction between a pseudo substrate region 
106 Chapter 7 
in the protein kinase's primary sequence and the active site [331, This restraint is removed during 
activation by changes in protein kinase conformation due to interaction of second messengers 
(e.g. cyclic AMP, 1,2-diacylglycerol (l,2-DAG) and Co") with the protein kinase's regulatory 
sites and by competition between the protein substrates and the pseudo substrate site, all present 
at the N-terminal region of the primary structure of the protein kinases (Figure 1). Indeed, 
activation of most protein SerinefThreonine (Scrrrhr) kinases is preceded by receptor activation 
followed by synthesis or release of low-molecular-weight protein kinase effectors or second 
messengers. 
Protein kinases can be divided in several types. Protein kinase A is a cyclic ANIP dependent 
proteiIvSerrrhr kinase, while protein kinase C is a group of protein-Serrrhr kinases which are 
phosphatidylserine (ptdSer-), 1,2-DAG- and/or Ca"-dependent. Recently, protein kinase D was 
discovered in COS cells to be dependent onl,2-DAG and phorbol esters, but infonnation on this 
enzyme in myocardium is not yet available pSI. In myocardial cells protein kinase C regulates 
various processes, including myocardial contraction, ion transport, energy metabolism, gene 
expression and hypertrophic growth [25, 36, 371. The role of protein kinase C in growth and 
proliferation has been implied by its identification as a high-affinity intracellular receptor for 
tumor-promoting phorbol esters which directly activate most protein kinase C isozymes in a 
relatively unspecific maruler. Phosphorylation of target proteins by protein kinase C isozymes 
depends on their intracellular location at the time of action, This compartmentalization may be 
caused by the architecture and intracellular localization of anchor proteins e.g. the so-called 
receptors for activated C kinase (RACK) [38. 391. Therefore, after protein kinase C is activated it 
translocates to other cellular compartments such as the sarcolemma where it exerts its principal 
action (Figure 1). However, several other compartments such as mitochondria, myofibrils, 
sarcoplasmic reticulum and the perinuclear zone also possess specific receptor sites for protein 
kinase C isozymes {40J. 
Protein kinase C isozymes. 
The protein kinase C family can be divided into three distinct subfamilies on basis of their 
structure and catalytic and regulatory properties (Figure I). Classical protein kinase C isozymes 
(cPKC's) such as protein kinase C-a, -PI' -p, and -yare activated by Ca'· ,PtdSerand 1,2-DAG 
or phorbol esters such as phorbol-12-myristate-13-acetate (PMA). Novel protein kinase C 
isozymes (nPKC's) such as protein kinase C-o, -E, -t), -8 and -11 are Ca2t independent and only 
need PtdSer and 1,2-DAG (or PMA) to become activated. Atypical protein kinase C isozymes 
(aPKC's) are protein kinase C-(, -\ and -A which are also Ca'·independent and only require 
PtdSer, to become activated (Figure 1), At present, the still growing number of isozymes can be 
discriminated by immunoblot or immunohistofluorescence analysis, Most investigators use 
histone III-S as substrate and y-32P-Iabelled ATP as phosphate donor to measure protein kinase 
C activity, which reflects the activity of some of the isozymes present in the cellular fraction, 
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Histone IlI-S, is a poor substrate for some nPKC's (0, E and 11) compared to the other isozymes 
(a, PI' Il" y) [411. Moreover, techniques such as hydroxylapatite high-pressure-Iiquid-
chromatography can be used to determine the activity of protein kinase C isozymes after 
separation [421. Measurement of the mRNA concentration using specific cDNA probes on 
Northern blotting can also be used for the detection of protein kinase C isozymes (431, but mRNA 
levels offer only limited infonllation because these do not always reflect the functional activities 
of the isozymes. 
In a preliminary study it was found that a, 13, E and ( are the most prominent isozymes in the 
rat heart (HI. Similar observations have been made in cultured neonatal rat cardiomyocytes [45J and 
adult rat cardiomyocytes [~6J. However, in a more recent study in adult rat ventricular myocytes, 
protein kinase C-E was abundantly present and protein kinase C-a could not be detected [47.48J, 
while in another study protein kinase C- a, -0, -E, -11, -8, -(, -).. and -l were detected in adult rat 
heart [~9J. In the canine heart the presence of protein kinase C-a, -PI' -P2' -y, -0, -E, -t, -8 and-( 
has been described [50]. Thus, the species and the type of assays determine the pattern of protein 
kinase C isozymes. Furthermore, the affinity and the specificity of the antibodies used to detect 
the protein kinase C isozymes determine the abundancy of detection but not the absolute 
concentration of the isozyme in vivo. In the pig, using rabbit polyclonal antibodies, we have 
demonstrated the presence of protein kinase C-a and -E, while the isozymes -0 and -( were 
undetectable. Other isozymes were not studied [5IJ. The studies carried out on myocardial 
hOlllogenates do not only include myocytes but also fibroblasts, smooth muscle cells and 
endothelial cells. Consequently, the protein kinase C isozymes of these cells in these 
homogenates all togcther are measured. So far, in only one study immunohistochemistry was 
used to detect the isozymes in situ [~81. In that study it was concluded that protein kinase C-o is 
probably the most important isoform involved in preconditioning in the rat heart {48J. 
PI"otein kinase C in coupling phospholipase e- to phospholipase D-activation 
Endogenous ligands such as adenosine Al -, a[-adrenergic- and muscarinic agonists) 
bradykinin, angiotensin II. endothelin-l or opiates stimulate, via the receptor-G-protein coupled 
to phospholipase. the intracellular signalling pathway. [15, ~8< 52.56J. Phospholipase C catalyzes 
hydrolysis of phosphatidylinositol-4,5-biphosphate (Ptdlns (4,5)P,) which leads to formation of 
the second messengers inositol-I,4,5-trisphosphate (Ins(l,4,5)PJ ) and 1,2-DAG (Figure I) [251, 
These messengers. directly or indirectly, activate Ccr+ -independent and/or Ca2+ -dependent protein 
kinase C isozymes and calmodulin-dependent protein kinase (Carvl-PK). The activated protein 
kinase C isozymes and/or CaM-PK phosphorylate specific target proteins which may be 
responsible for FWOP. Phospholipase D, another 1,2-DAG forming enzyme, can be strongly 
stimulated by phorbol esters [.1b.45.5U7,58], It lIses phosphatidylcholine (PtdCho) as substrate and 
its activation leads initially to formation of phosphatidic acid (PtdOH) and choline [59[, PtdOH 
is rapidly hydrolysed to I ,2-DAG and inorganic phosphate (P,) by PtdOH hydrolase. The 1,2-
Table 1. Protein kinase C inhibitors and nrotection bv ischemic nreconditioning. 
----------- -------------------
Model Species CP-Stimulus Prolonged· Protein kinase C inhibitor Evalu.ation Result Reference 
»(l+R) (min) Stimulus (ISUFR) 
!(R) (min) 
Isolated heart "", 3x(SI+SR) 301(120R) Polymyxin B. before PC-stirn ISL Abohshes [66] 
3x(SI+SR) 301(120R) Chclerythrine. before PC-stirn ISL Abolishes 
lx(2I+10R) 201(40R) Staurosporinc. beforc PC-stirn FR Abolishes [481 
Phenylcphrine+l0R 20I(40R) Staurosporine. before PC-stirn FR Abolishes 
Ix(2I+I0R) 201(40R) Chelerythrine. before PC-stirn FR Abolishes 
Phenylephrine+ 1 OR 20I(40R) Chelerythrine, before PC-stirn FR Abolishes 
Rabbit 1»(SI+l0R) 30I(l20R) Staurosponne, before and after PC-stirn ISL Failed to abolish [17} 
lx(SI+l0R) 30I(120R) Staurosporine, after PC-stirn ISL Abolishes 
Brndykinln 30I(120R) Staurosporine, after PC-stirn ISL Abolishes 
Brndykinin 301(l20R) Polymyxin B, 50 min starting S min before PC-stirn ISL Abolishes 
l»(SI+10R) 301(lSOR) Polymyxin B. S min after PC-stirn ISL Abolishes [521 
Phenylephrine 301(120R) Polymyxin B, before and after PC-stirn ISL Abolishes [5SJ 
Angiotensin 1I 30I(120R) Polymyxin B, 50 min starting Smin before PC-stirn ISL Abolishes [S6J 
In Vivo "", Ix(5J+l0R) 451(150R) Chelerythrine, after PC-stirn ISL Abolishes [S3] 
3»(31+SR) 90I(240R) Calphostin C, before and after PC-stirn ISL Abolishes [68] 
Rnbbit lx{SI+IOR) 30I(lS0R) Staurosporine,5 min after PC-stirn ISL Abolishes [S2J 
Ix(SI+IOR) 301(ISOR) Polymy;<in B. 5 min :liter PC-stirn ISL Abolishes 
lx(51+10R) 301(lSOR) Chelerythrine, 8 min after PC·stim ISL Abolishes [67J 
lx(SI+l0R) 30I{JSOR) Staurosporine, before PC-stirn ISL Partw.lly ubolishes [63] 
lx(Sl+IOR) 301(ISOR) Colchicine. 30 min before PC-stirn ISL Abolishes 
Do, 4x(5I+1OR) 60I(240R) H-7 (IV). before, during and after PC-stirn ISL Failed to ubolish [64J 
4x(51+10R) 601(240R) H-7 (1C). before. during and after PC-stirn ISL Failed to abolish 
4x(5I+l0R) 60I(240R) Polymyxin B, before. during and after PC-stirn ISL Failed to abolish 
4x(51+5R) 901(360R} Polymy;<in B. S min before and during PC-stirn ISL Abolishes [28] 
4x(SI+SR) 901(360R} GFI 09203X. 5 min betbre and during PC-stirn ISL Abolishes 
Methoxamine 9OJ(360R) Polymyxin B. S min before and during PC-stirn ISL Abolishes 
Methoxamine 9OI(360R) GFJ09203X. S min before and during PC-stirn ISL Abolishes 
Pig 2x(10I+30R) 60I(120R) Stallrosponne ISL Failed to abolish [69] 
BIS 601(120R) Bisin.dolylmaleimide ISL Mimics 
I""ischemia; R reperfusion; CP cardioprotective; BIS bisindoiyimaieimide; H-7 1-(5-isoquinoiinesuifonyl)-2-methylpiperazine; ISL infarct size limitation; FR~functional 
recovery. 
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DAG formed by phospholipase D potentially contributes to activation of protein kinase C 
isozymes [51 1, Stimuli such as noradrenaline, angiotensin II and endothelinwl stimulate both 
phospholipase C and phospholipase D 145,58, 601, In fact, protein kinase C has been proposed to 
function as a switch which reduces the rate of Ptdlns(4,5)P, hydrolysis catalyzed by 
phospholipase C and stimulates the rate ofPtdCho hydrolysis catalyzed by phospholipase D 151. 
58, 591, Through this "cross talk"- mechanism between phospholipase C and D, the cardiomyocytes 
may be continuously supplied with 1,2wDAG after receptor stimulation, because the ceBular 
concentration ofPtdCho is about 100 times higher than that ofPtdlns(4,5)P2,The continuous 
production of 1,2wDAG could be of importance for maintenance of activation of the protein 
kinase C isozymes involved in ischemic preconditioning, 
Evidence for a role of protein ldnasc C in ischemic preconditioning 
Inhibition a/protein kinase C Cfable I) 
Selective inhibition of protein kinase C activation by administration of inhibitors prior to or 
after applying the cardioprotective stimulus is one approach to investigate the role of protein 
kinase C in ischemic preconditioning, Depending on the inhibitor, protein kinase C function can 
be blocked at its catal)1ic or regulatory sites (Figure 1), It is also possible to downregulate protein 
kinase C activity by prolonged (1-2 days) stimulation with phorbol ester I'\{. This last approach 
has not been used in ischemic preconditioning, but is ofinterest in view of the development of 
tolerance to ischemic preconditioning when a very large number of brief occlusion-reperfusion 
sequences are applied[62l, 
The most prominent drugs used to inhibit protein kinase activation or translocation are 
staurosporine [11,48,51,631, 1 w(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7) 127,6--11, chelel)'thrine 
153,65--611, calphostin-C [68], polymyxin B [11,52,55,56,6-.1,661• bisindolylmaleimide [28,69] and colchicine 
[631, Staurosporine, H-7, and polymyxin B are non-specific inhibitors of protein kinase C 
compared to cyclic AMP-dependent protein kinase, CaM-PK or protein-Tyr killases 1701. All non-
selective inhibitors act on the catalytic domain of protein kinase C, which contains a high degree 
of sequence homology with other protein kinases, The more specific inhibitor calphostin-C [711 
acts on the regulatory domain (Figure I), Chelerythrine, another specific inhibitor [611 interacts 
with the catalytic domain but also competes with the classically used protein substrates of protein 
kinase C {S7J, Furthennore, polymyxin B directly blocks 1('" AlP channels, one of the possible target 
proteins of protein kinase C and is therefore not well suitable to investigate the role of protein 
kinase C in ischemic preconditioning [72, 7J], Moreover, it is unknown whether protein kinase C 
inhibitors are equipotent for all enzyme isozymes, It is quite feasible that the degree of inhibition 
depends on both the isozyme 160, 1-.1-76] and species, Table I shows that polymyxin B ]661, 
staurosporine [48J and chelerythrine [48J abolished the protective effect in isolated rat hearts and 
calphostin-C [68J and chelerythrine [53] in the in vivo rat model. Polymyxin B 111, 52, 55, 56J and 
Table 2. Protein kinase C activators and mlCocardial infarct size. 
Model Species CP-Stimulus Prolonged- Evaluation Result Reference 
x(I+R) (min) Stimulu.~ (ISLlFR) 
I(R) (min) 
]$olatcd he:trt R" SAG 20I(40R) FR Mimics [48J 
Rabbit PMA 301(180R) ISL Mimics [52J 
OAG 30I(180R) ISL Mimics 
PMA 301(120R) ISL Mimics [63J 
In Vivo R" DOG 451(150R) ISL Mimics [53J 
Rabbit PMA 30I(180R) ISL Mimics [63J 
Pig PMA None ISL Failed to mimic [69J 
I""ischemia; Ro;;reperfusion; CP=cardioprotective; SAG=lwstearoyl-2~arachidonoyl glycerol; PMA=phorbol-12-myristate~13-acetate: OAG=oleyl acetyl-glycerol; DOG=1,2-
dioctanoyl sn-glycerol: ISL=infarct size limitation: FR=functional recovery. 
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staurosporine (171 abolished protection in ill vitro and polymyxin B [52], staurosporine [52,63], 
chelerythrine [67] and colchicine 163J in in vivo rabbit modeL In dogs, the data are different as 
Przyklenk el at [64] observed that polymyxin Band H-7 did not abolish cardioprotection by 
ischemic preconditioning, In a preliminary study in pigs, staurosporine and bisindolylmaleimide 
limited infarct size [69), These studies suggest a different role for protein kinase C in rats and 
rabbits than for dogs and pigs. The different results in rat, rabbit and pig could be related to 
species~dependent differences in myocardial expression, in the task performed and the site of 
translocation of the various isozymes [38,39,48, 6-t, 771, Moreover, the various isozymes might be 
activated differently by Ca2+, 1,2~DAG and free fatty aeids [24. 25,36,37], 
Reviewing the studies using phannacological blockade one is tempted to conclude that the 
protein kinase C family is involved in the mechanism of ischemic preconditioning in rat and 
rabbit. However, none of the studies investigated whether blockade of protein kinase C actually 
occurred in the in vivo modeL In vitro assays of enzyme activity will not provide conclusive 
answers either because these have to be performed in subcellular fractions in the absence of the 
inhibitor due to the isolation procedure and in the presence of optimal amounts of 1 ,2~DAG 
and/or Ca2+, The ideal experimental design would be to study the enzyme activity in vivo by 
measuring phosphorylation degrees of one or more of the unknown specific target proteins, 
Aclivalioll o/proleill killase C (Table 2) 
Activation of protein kinase C by administration of phorbol esters, such as 12-0~ 
tetradecanoyl phorbol-13-acetate (TPA) and PMA [21.66] or 1,2-0AO analogues such as 1-
stearoyl-2-arachidonoyl glycerol (SAO) ]48], 1,2-dioctanoyl "II-glycerol (000) lOll and oleyl 
acetyl-glycerol (OAG) [64J prior to a sustained coronary artery occlusion has been a second 
approach to investigate the role of protein kinase C in ischemic preconditioning, The advantage 
of using phorbol esters over 1 )-DAG as activating substances is that they are not metabolized 
and produce prolonged protein kinase C activation, Protein kinase C translocation takes place 
after phorbol ester (or the I ,2-0AO analog) is bound to the enzyme's regulatOly domain whereby 
it obtains not only an increased aft111ity for acidic membrane phospholipids (PtdScr) but also an 
increased activity (Figure I). 
PMA and severall,2-DAG analogs mimic preconditioning in the rat [53] and rabbit {52.63], but 
PMA failed to limit infarct size in pigs [69J, Przyklenk el al [6-t] measured protein kinase C 
translocation after administration of PMA in dogs, Although these studies lack information 
regarding activation (translocation) of the isozyme(s) in relation to the protective effect, the 
results with activators suggest a role for protein kinase C in ischemic preconditioning in rat and 
rabbit. Furthennore, the route of administration and the dose used may be different for the large 
animal studies and the in vitro and vivo studies of small animals. For instance, Vogt et a/{69] used 
intramyocardial administration of PMA (1 ~{.r..1) to activate protein kinase C but failed to mimic 
the protective effect of ischemic preconditioning, However, the dose could have been too high 
Table 3. Protein kinase C translocatioDiactivation and erotection h;y ischemic Ereconditioning. 
Model Species CP·Stimulus Prolonged. PKC :tSsay Result Reference 
x(l+R) (min) Stimulus 
l(R)(min) 
Isolated heart Rot Ix(21) none immunohisto fluorescencc PKC-o to s:ll'co1emma. € to nucleus, no (, 0:, i3J [48] 
Phcnylephrine none lmmunohisto fluorescence PKC·o to s:lI'co1emma.' to nucleus, no E, 0:, i3J, T] 
In Vivo Do, 4x(SI+iOR) None Fluorescent to binding by confocal microscopy No PKC translocation [64] 
4x(SI+I0R) None Activity by protein phosphorylation No PKC activation 
None lOi Activity by protcin phosphorylation PKC activation vs Coni 
4x(SI+IOR) lOi Activity by protein phosphorylation PKC activation vs Coni 
PMA None Activity by protein phosphorylation PKC activation 
Dog 4x(51+SR) None Activity by protein phosphorylatIon PKC activation [28] 
Pig Jx(JOl+7.5R) Nonc Immunoreactivity on Western blot PKC-€ translocation [58] 
Ix(lOI+7.5R) None Activity by protein phosphorylation PKC-€ translocation 
Pig 2.-.(10+30) None Activity by protein phosphorylation PKC activation [69] 
PMA None Activity by protein phosphorylation PKC activation 
I"'ischemia; R""reperfusion; CP=cardioprotective; PMA""phorbo!-12-myristate-13-acetate; PKC= protein kinase C. 
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because Cohen el al l781 found that 0.2 nM PMA was protective while 2 nM PMA was damaging 
in the isolated rabbit heart. It is feasible that in that study the low dose of PMA activated an 
isozyme that is protective, while at the higher dose an isozyme was activated that was damaging 
[78J, 
Measuremellls o/proleill killase C-lralls/oealioll (aelivalioll) (Table 3) 
Translocation of protein kinase C from the cytosol to the membrane has been investigated 
employing; (1) immunoblot analysis using protein kinase C isozyme-specific antibodies of SDS-
electrophoretically separated subcellular fractions isolated from myocardial homogenates [44,51, 
691; (2) immunohistofluorescence detection (with confocal microscopy) of protein kinase C 
isozymes in sections of myocardial tissue 148, 6-41; (3) assay of total protein kinase C activity in 
subcellular fractions isolated from myocardial homogenates by measurement ofC~+ - and/or 1,2-
DAG-dependent 32p incorporation from y-32P-labelled ATP into histone III-S or a protein kinase 
C isoenzyme-specific substrate protein such as peptide-€ [51,54,6-4, 79J or other peptides [28,6-41, A!l 
three methods have their limitations, For instance, in protein phosphorylation or inununo-
reactivity assays, cardiac biopsies are usually rapidly frozen in liquid N,. followed by preparation 
of particulate fractions from the hOl11ogenates. It can not be excluded, however, that 
relocalization or (in)activation occurs during isolation of the subcellular fractions. In the 
subfractions both the basal rate and the maximum rate of histone III-S (or other substrate protein) 
phosphorylation are measured in the presence of Ca'·, PtdSer and I ,2-DAG. The results of these 
measurements only reflect the total protein kinase C activities in the subcellular fractions. 
Moreover, histone III-S is, a relatively poor substrate for some nPKC's (0, € and 11) compared 
to the cPKC's [411. Therefore, measurements of the rate of 32p incorporation into the synthetic 
protein kinase C-E-specific substrate peptide-€ may provide the required information about the 
E isozyme 1511. It should also be noted that mixed micelles ofCa'·-1,2-DAG-PtdSer elllbedded 
in Triton-X-IOO micelles, used to activate proteih kinase C in the 32p incorporation assays, only 
mimic the cellular membrane envirorunent of protein kinase C in the intact cell. It is unknown 
whether myocardium is preconditioned homogenously or heterogeneously, In the latter case, the 
sampling site of the biopsy may pose a restriction. Because, protein kinase C assayed in 
subcellular fractions isolated from homogenates of whole myocardial tissue represents a mixture 
of activities of myocytes, fibroblasts, smooth muscle cells and endothelial cells, 
Inununohistofluorescence measurements must therefore be perfonned to provide information on 
the cell type involved in protein kinase C translocation/activation, Measurements of protein 
kinase C isozyme activity by immunohistofluorescence must, however, be interpreted with 
caution, because the specific antibodies are not always capable to distinguish active from inactive 
protein kinase C isozymes. 
\Veinbrenner et ai, using \Vestem blotting, showed in rats a rapid translocation of the Ca2+_ 
dependent protein kinase C isozyme a and the Ca2t -independent isozymes (0, E and () to the 
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sarcolemma after brief ischemia and increased expression of the Ca2+-independent of protein 
kinases C-o and -E in the cytosol after prolonged ischemia [241, Mitchell et all using 
immullohistofluoresccnce, showed in rat hearts that protein kinase C-O translocated from the 
cytosol to the sarcolemma after both brief ischemia and ai-adrenergic stimulation [48], Brief 
ischemia also caused translocation of protein kinase C-E from the cytosol to the nuclear region. 
Measurements of other protein kinase C-isozymes (0:, Pl' ( and 11) did not provide evidence for 
occurrence of translocation after brief ischemia or ai-adrenergic stimulation [481, These results 
provide the first evidence that (at least in the rat) specific protein kinase C isozymes arc involved 
in ischemic preconditioning. 
Przyklcnk el al used a probe consisting of the protein kinase C inhibitor bisindolylmaleimide 
conjugated to fluorescein that selectively binds to active protein kinase C and observed no 
difference in the total amount and the cellular distribution of protein kinase C fluorescence with 
preconditioning in dogs [M). The advantage of this method over immunofluorescence is that it 
distinguishes between active and inactive protein kinase C. In their study Przyklenk et al also 
obtained quantitative information on the changes in the amount and subcellular distribution of 
protein kinase C by measuring the rate ofJlp incorporation into the threonine group of a protein 
kinase C-spccific peptide, which was not further specified [M). A small rise in protein kinase C 
activity was found in the membrane fraction isolated from biopsies obtained after 10 min of 
ischemia compared to those isolated after four sequences of 5 min occlusion-reperfusion or no 
intervention 1M ). However, no difference in protein kinase C activity between matched groups of 
controls and 'ischemic preconditioned' dogs could be measured at time points comparable to the 
onset of the long occlusion or at 10 min into sustained ischemia IMI. Using the same protein 
kinase C analysis, Vogt el al found a modest (10 to 20%) redistribution of protein kinase C from 
the cytosol to the membrane fraction in pig hearts subjected to 10 min of ischemia [691. In contrast 
to the studies by Przyklenk e/ al [641, Kitakaze e/ al PSI observed in the same canine model a 
marked translocation of Ca~+ - and lipid-dependent protein kinase C activity in cytosol and 
membrane fractions isolated from preconditioned epi- as well as endomyocardium. These authors 
ascribed their positive findings to the time of measurements (5 min after the preconditioning 
stimulus against 10 min by Przyklenk el al [MJ). 
\Vc studied translocation of protein kinase C enzyme activity by 31p incorporation into histone 
III-S and E-peptide and immunoreactivity of a number of protein kinase C isofonns (a, E, 0 and 
() of cytosolic and membrane fractions isolated from biopsies of porcine myocardium 
preconditioned by a lO-minute coronary artery occlusion and 7.5-minutes ofreperfusion [5I, SOI. 
Cal" and I ,2-DAG-stimulated protein kinase C activity with histone III-S as substrate was higher 
in the cytosolic and particulate fractions isolated from the preconditioned myocardium than from 
the control region. Significant Ca2> -independent, 1,2-DAG-stimulated phosphorylation of E-
peptide was found in the cytosolic fractions, but not in the particulate fractions. However, no 
signiticant increase of 1,2-DAG-stimulated phosphorylation of E-peptide in the cytosolic fraction 
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from the preconditioned myocardium was observed. These were rather unexpected findings in 
view of our protein kinase C~E inullunoreactivity measurements (see below). The cytosolic and 
particulate fractions were also examined by immunoblot analysis using rabbit polyclonal 
antibodies specific for protein kinase C~a, ~o, ~E and ~C isozymes [511. This analysis revealed 
signHicant levels of expression of the Ca2t ~independent isozyme protein kinase C~E, the abundant 
presence of protein kinase C~a, while protein kinase C~O and -C were virtually undetectable. The 
immunoreactivity data also indicate that neither the (Ca'· and I ,2-DAG)-stimulated histone lII-S 
and peptide-E kinase activities of the cytosolic nor those of the particulate fractions reflect the 
relative immunoreactivities in the corresponding fractions. In contrast to the 32P~incorporation 
data, the immunofluorescence data suggested that the total amount and subcellular distribution 
of protein kinase C~a and -E was not altered in the preconditioned region compared to the non~ 
ischemic region of the left circumflex coronary artel)'. Therefore, by using immunofluorescence 
we were unable to detect the occurrence of ischemia-induced expression of protein kinase C or 
ischemia-induced translocation of protein kinase C from the cytosolic to the particulate fraction 
of the protein kinase C isozyme ~a, ~o, ~E or C. On the other hand, binding proteins, such as 
myristoylatcd-alanine-rich-C-kinase-substrate (MARCKS) and RACK may determine whether 
activated protein kinase C isozymes translocate and are providing another mechanism for 
functional specificity to specific intracellular locations. Thus, in the in vitro phosphorylation 
assays of the subcellular tractions, different amounts of ~vlARCKS- or RACK~bound protein 
kinase C isozymes can alter the protein kinase C activity measured [8!}. This could cause the 
discrepancy between the activity assays and "'estern blotting. Nevertheless, our results on 32p 
incorporation demonstrate an increase ill cytosolic and membralle~bound protein kinase C 
activities due to brief ischemia and supports a role for protein kinase C in ischemic 
preconditioning in pigs [511. 
Concluding remarks 
At present MARCKS is the only endogenous target protein for protein kinase C, that has 
been shown to be phosphorylated in preconditioned rabbit myocardium. However, the fanner is 
believed to be an intracellular location site rather than a protein lactor intimately involved in the 
protective response [l\21. Irrespective of the target protein(s) we are deating with, its (their) 
covalently bound phosphates must be relatively stable during the 2 to 3 hours in which the 
cardioprotection is present (F\VOP). Furthermore, the precise time point that protein kinase C 
is maximally translocated (activated) during ischemia or rcperfusion (preconditioning stimulus) 
is unknown and consequently also the time point at which the enzyme reaches the target proteins 
for catalyzing their phosphorylation. It is quite feasible that protein kinase C is removed from its 
translocation site or proteolytically degraded after it has performed its action and thereafter it is 
not longer detectable by immunoreactivity or activity measurements. It is therefore mandatory 
to determine the time course of translocation/activation and subsequent 
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relocalizationlinactivation or proteolytic degradation of the protein kinase C isozyme and the 
time course(s) of phosphorylation and dephosphorylation or proteolytic degradation of the target 
protein(s). Because the time course of weaning of the protective effect of the FWOP is roughly 
known, the time course of dephosphorylation/inactivation of the target protein could be 
correlated to the time course of weaning of protection. Candidate target proteins of protein kinase 
C involved in the F\VOP are c.g. the K+ATPchannel [13, 14j and/or the ecto~51-nucleotidase 128], but 
experimental evidence for phosphate incorporation into these proteins or regulating proteins is 
lacking. If the K\1J' chaIll1cl or the ecto-S-nucleotides are target proteins the most likely 
translocation site for the protein kinase C isozyme(s) involved in the F\VOP is the sarcolemma. 
Protein kinase C is involved in the agonist-receptor interaction induced changes in gene 
expression of many cells {25, 36, 37, 74, 75, 41, 831. Taking into account the time required for inducing 
heat shock/stress proteins [29, 30J the former may only play a role in S\VOP. Therefore, a 
transcription factor involved in the regulation of expression of heat shock/stress proteins could 
be another potential target protein of protein kinase C. If true, the nucleus may be the 
translocation site for the protein kinase C isozyme(s). 
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Chapter 8 
Myocardial protein kinase C isozymes-cx, -6, -E and -C in classic 
ischemic preconditioning and cardioprotection by remote organ 
ischemia 
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Myocardial pl'Otein kinase C isozymes-cx, -0, -E and -( in classic 
ischemic preconditioning and cardioprotection by remote organ 
ischemia 
Backgrolilld. \Ve have shown in rats that not only brief coronary artery occlusion (CAO) 
(ischemic preconditioning) but also brief anterior mesenteric miery occlusion (MAO) limits 
myocardial infarct size produced by a sustained coronary artery occlusion. It has been postulated 
that intracellular translocation of protein kinase C following activation of receptors is involved 
in ischemic preconditioning. In the present study we investigated the cellular distribution of 
myocardial protein kinase C isozymes ~a, -0, -E and -( in rats after brief MAO and CAD in order 
to investigate the possible involvement of activation of protein kinase C in the cardioprotection 
by brief MAO and CAO. 
Methods alld Results. In 3 groups of anesthetized rats left ventricular free wall was isolated 
after a 25Rminute sham period or after 15 minutes CAO and 10 minutes reperfusion or after 15 
minutes MAO and 10 minutes reperfusion. Tissue samples were processed to isolate cytosolic 
and membrane fractions wherein the immunoreactivities of protein kinase CRa, RO, RE and R( were 
measured by \Vestern blotting. Total protein kinase C activity was also measured in the 
subcellular fractions using (y"P-)ATP and histoll III-S as a substrate. Protein kinase C-a, -O,-E 
and R( immunoreactivities expressed as percentage of the chemiluminescence counts per pg of 
the total protein content of the cytosolic and membrane fraction of the matched control 
experiment tended to decrease in the cytosolic fractions of the CAO. Only the decrease in 
cytosolic protein kinase CRo was significrult (P=O.Ol). No changes of the protein kinase CRa, RO, 
RE and R( immunoreactivities in the mem.brane fractions were observed. In the MAO group no 
changes of the protein kinase CRa, RO, -E and R( immunoreactivities in the cytosolic as well as 
in the membrane fractions were observed. By histon IIIRS phosphorylation no cluUlges of protein 
kinase C isozymes in the cytosolic fractions of the CAO and MAO were found. Moreover, Ca2+ 
and (1,2)diacylglycerol dependent activity was virtually absent in membranes. 
Conclusion. On basis of the immunoreactivity measurements we conclude that protein 
kinase CRo may trrulsiocate after CAO but not .MAO but disappearance of its immunoreactivity 
from the cytosol is not accompanied by an increase of immunoreactivity in the membrane. The 
observed change in cytosolic protein kinase C-O immunoreactivity in CAD did also not lead to 
changes in protein kinase C activity measured by histon III-S phosphorylation. 
Key JVol'ds. myocardial infarct size, signal transduction, protein kinase C, ischemic 
preconditioning, intestinal ischemia, remote cardioprotection 
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Introduction 
Exposure to brief periods of acute myocardial ischemia protects the heart against infarction 
during a subsequent longer episode of ischemia [I, 21. Tills phenomenon (ischemic 
preconditioning) is neither a tissue specific phenomenon as it has been described not only for the 
myocardium, but also for the kidney [31, brain [41, liver [51, skeletal muscle [61, lung PI and intestine 
181 nor a species specific phenomenon as it has been demonstrated in i.e. the rat [91, rabbit 1101, dog 
[II and pig [Ill, Furthermore there are indications that ischemic preconditioning also can be elicited 
in the human heart during angina pectoris preceding an acute myocardial infarction and 
percutaneous transluminal coronary angioplasty 112, 131, In our previous study we have shown that 
a brief period of mesenteric artery occlusion and reperfusion (MAO) also protects the 
myocardium [141, Thus, ischemic preconditioning may be an intrinsic protective property 
occurring within each cell type but the mechanism leading to this phenomenon does not 
necessarily have to be the same in each cell type, For instance, we observed that MAO-induced 
cardioprotection can be but the CAO-induced cardioprotection cannot be blocked at a neurogelllc 
levell14I• However, MAO- and CAO-induced cardioprotection may still have a common endpoint, 
e,g. activation of protein kinase C isozyme(s), Despite the numerous efforts to elucidate the 
molecular mechanism(s) by which transient ischemia protect(s) the myocardium the mechatllsm 
of ischemic preconditioning remains incompletely understood, Advanced hypotheses point 
toward a role for activation of adenosine [JS, J6J or activation ofK+ATP receptor chaJlllels {!7, J81, 
More recent studies suggest that endogenous ligands such as adenosine-A J, a)-adrenergic and 
muscarinic agOlllsts, bradykinin, angiotensin II, endothelin-l 1)9,201 and opioids [211 initiate an 
intracellular signalling pathway by acting via G-protein-coupled receptors, which leads to 
activation of phospholipase C-p {!9,22-271, Currently there is some evidence suggesting the 
involvement of phospholipase D in addition to phospholipase C in the production of 
(I,2)diacylglycerol ((I,2)DAG) [281, Activation of phospholipase C-p (and D) increases the levels 
of the second messenger inositol-l,4,5-triphosphate (Ins(1 ,4,5)P) which mobilizes intracellular 
Ca" and 1,2-diacylglycerol ((I,2)DAG) which activates protein kinase C isozymes [191, These 
messengers can act synergistically by activation of the Ca2+-dependent, (1,2)DAG stimulated 
protein kinase C isozymes and Ca2+-calmodulin dependent protein kinase (CaM-PK), Activated 
protein kinase C isozymes and/or CaM-PK then phosphorylate specific proteins that ultimately 
lead to cardioprotection. In line with this hypothesis, the rate of dephosphorylation by 
phosphoprotein phosphatases of the specific phosphoproteins involved in preconditioning, should 
determine the period in which the protective state is maintained, The protective state of the 
myocardium appears to occur in two stages, The first window of protection (F\VOP) occurs 
immediately after the preconditioning stimulus has been applied and lasts about 2 hours [1, 291. A 
second window of protection (SWOP) appears approximately 24 hours aftcr applying the 
stimulus [30,31] and has weaned off after 3 days [321, It is most likely that F\VOP is based upon 
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changes in protein kinase C induced phosphorylation of specific proteins. The protective state 
expresses itself by a delay in the development of infarctionf\I, Thus early reperfusion after a 
prolonged coronaty artery occlusion remains a necessity to effectively limit infarct size after 
ischemic preconditioning. Consistent with the protein kinase C hypothesis is the assumption that 
all known stimuli which mimic the protective state of preconditioning converge into the 
activation of specific isozymes of the protein kinase C family via receptor-mediated activation 
of phospholipase C-p or -D [33, 34J, K+ATP -channels [17,18J and ecto-S'·nucleotidase (35] has already 
been proposed as target proteins of protein kinase C. Long-term protein kinase C stimulation is 
known to down regulate the enzyme providing a possible mechanism of tolerance development 
to continuous stimulation [361, 
Unfortunately, the pattem oftranslocation or activation of protein kinase C and the protein 
kinase C isozymes has only been investigated by immunohistochemistry in the rat after ((,-
adrenergic stimulation [251, In this study we measured the (immunore)activities of protein kinase 
C isozymes of subcellular fractions in the cardioprotection in rats obtained by brief anterior 
mesenteric artery occlusion and classic ischemic preconditioning in order to elucidate the 
underlying (different) mechanisms, or speaking in terms of Brooks and Hearse [37J in order to 
resolve the question whether protein kinase C is a player or spectator in ischemic 
preconditioning? 
Materials and Methods 
All experiments were perfonned in accordance with the Guldillg principles in the care and 
lise of animals as approved by the Council ofthe American Physiological Society and under the 
regulations ofthe Animal Care Committee ofthe Erasmus University Rotterdam, Ad libitum fed 
male \Vistar rats (± 300 g, TNO Zeist, The Netherlands) were used in all experiments, 
Surgical procedures 
The in situ rat heart model for ischemia and reperfusion and remote cardioprotection has 
been extensively described in our previolls study [141, Briefly, rats were anesthetized with 
pentobarbital (60 mg/kg intra peritoneal) and intubated for positive pressure ventilation (Harvard) 
with room air. A PE-IO catheter was positioned in the thoracic aorta via the right carotid artery 
for measurement of arterial blood pressure and heart rate (Baxter Diagnostic Inc.), APE-50 
catheter was positioned in the inferior caval vein via the left femoral vein for infusion of 
Haemacccll (Behring Pharma). After intercostal thoracotomy the pericardium was opened and 
a silk (6-0) suture was looped under the left anterior descending coronary artery (LADCA) for 
sham or later production ofa coronary artery occlusion [38,39J, Following laparotomy, a catheter 
was positioned in the abdominal cavity to allow intra peritoneal infusions of pentobarbital for 
maintenance of anaesthesia. Subsequently the anterior mesenteric artery was dissected free and 
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a suture was placed around the artery for sham operation or to facilitate later a mesenteric artery 
occlusion with an atraumatic clamp. After the ischemic stimulus was applied, the abdomen was 
closed. The sham operated rats (Sham), as well the .MAO rats as the CAO rats which underwent 
the classical ischemic preconditioning protocol were subjected to the same procedures. Body core 
temperature was continuously measured rectally using an electric thermometer (Electromedics 
Inc.) Temperatures were maintained at 36.5-37.5°C using a coverage of the rat with aluminum 
foil and heating pads. \Vhen rats encountered ventricular fibrillation during ischemia or 
reperfusion, they were allowed to complete the experimental protocol when conversion of 
ventricular fibrillation occurred spontaneously within 1 minute or when resuscitation by gentle 
tiulInping on the thorax, was successful within 2 minutes after the onset of fibrillation. Occlusion 
as well as reperfusion were visually verified by appearance and disappearance of myocardial or 
small intestinal cyanosis. 
Experimental groups 
Left ventricular free wall of anesthetized rats was isolated after a 25-minute sham period 
in the Sham group (n= 1 0) or after 15 minutes CAO and 10 minutes reperfusion in the CAO 
group (n~ 1 0) or after 15 minutes MAO and 10 minutes reperfusion in the MAO group (n~ 1 0) 
(Figure I). 
137.5'C t 1 36.5'C 2 
3 
Experimental Groups 
(n ~ 1 0) Con (Sham) 
Stimulus. r PKC 
measurement 
(n~10) 15min CAO + 10mln Rep 
(n ~ 1 0) 15min MAO + 10min Rep 
IIIIIIL 
~ 
-25-100 
time (min) 
Figure I. Schematic presentation of the 3 experimental groups in which the left ventricular free wall was isolated 
for protein kinase C analysis (immunoreactivity and enzyme activity). PKC=protein kinase C; Sham=control; 
CAO=left anterior descending coronary artery occlusion (closed bars); MAO=anterior mesenteric artery occlusion 
(hatched bars); Rep=reperfusion. 
Protein kinase C-Cf., -0, -E and -( imlJlllflO analysis 
Frozen left ventricular tissue samples (5-10 mg wet weight) of 8 animals of each 
experimental group were pulverized (Braun Mikro Dismembrator) under liquid N2 temperature 
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in 200 ~I homogenization buffer containing 25 mM Tris/HCI (PH 7.4), 5 mM EGTA, 2 mM 
EDT A and 5 mM dithiothreitol (DTT), thawed and subsequently centrifuged for 20 minutes at 
19,000 rpm in a JA 20 rotor (Beckman Model J2-21 Centrifuge) at 4°C and the obtained 
supernatants (cytosolic fractions) were stored frozen (M80°C) for the ultimate protein kinase C 
(inmumore)activity measurements. The sediments werc resuspended in 200 ~l homogenizing 
bufier containing 1% (v/v) TritOIlMX-lOO. Next, the suspensions were incubated for 60 minutes 
on ice and centrifuged again as above. The supernatants containing the solubilized membranes 
(membrane fractions) were used for protein kinase C analysis and the sediment discarded. Protein 
levels in 15 ~tl of the cytosolic and solubilized membrane fractions were determined using the 
standard Bradford procedure. Protein kinase C-rt, -n, -E and -( of the cytosolic and solubilized 
membrane fractions were separated on sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-P AAGE) and detected by imlllunoblotting following the procedure for protean II mini gel 
set up of Biorad with a 10% gel (Western-blot) and detection of the innnunoreactivity by the 
ECL"I kit (SupersignaITh' CL-HRP Substrate System GS-363 from Biorad (USA)) on the CL-
screen in the Molecular Imager (GS-363) [281. In each gel that was run, samples of the cytosolic 
as well as membrane fraction of one experiment of the Sham (control), CAO and MAO group 
were applied so that relative chemiluminescence data were normalized to the total protein content 
of the cytosolic and membrane fractions and these could all be expressed as percentage of the 
counts of the cytosolic and membrane samples of the Sham group. 
Protein kinase C activity measurements by histonill-S phosphOlylafioJ1 
In 7 animals of each experimental group protein kinase C was assayed in both the cytosolic 
and membrane fractions. The reaction medium for the basal activity of protein kinase C 
contained 10 ~tl of the reaction medium without Ca'+ (100 mM Tris/HCI (pH 7.5) and 25 mM 
MgCI,),5 pI of 100 mM p-mercaptoethanol, 1 ~I of 0.05% (w/v) histon Ill-S, 2.5 pI of 4 ~M 
phosphoprotein phosphatase inhibitor okadaic acid, 21.5 ~II water, 5 ~tl of I 00 ~IM y32P_A TP (50-
100 cpm/pmol) and 5 ~II tissue sample. The reaction medium for the Ca'" phosphatidylserine 
(PtdSer) and (I,2)DAG dependent activity of protein kinase C contained 10 pI of the reaction 
medium with Ca" (100 mM Tris/HCI (PH 7.5), 25 mM MgCI" and 2.5 mM CaCI,), 5 pi of 100 
mM p-mercaptoethanol, 5 ~tl of an uItrasonified mixture of 0.016% (w/v) phosphatidylserine 
(ptdSer) and 0.004% (w/v)(I,2)DAG, I ~II of 0.05% (w/v) histon III-S, 2.5 ~I of 4 ~M okadaic 
acid, 16.5 ~I water, 5 ~I of 100 ~M y32P_ATP (50-100 cpm/pmol) and 5 ~I tissue sample. The 
assay mixtures were preincubated at 30°C for 2 minutes and the reactions were stat1ed by adding 
5 pI of the tissue samples and stopped after 5 minutes by spotting 25 III reaction mixture directly 
on \Vhatman P8I paper. Protein kinase C activity was measured as 32p incorporation using the 
Molecular Phosphor Imager (OS-363) {281. The activity was then expressed as pmol 32p per min 
per J-lg protein. 
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It should be noted that protein kinase C isozyme (immunore)activity distribution was only 
determined in cytosolic and solubilized membrane fractions. After solubilization of the 
membranes a particulate fraction which likely contains cell organelles such as mitochondria, 
myofibrils and nuclei. \Ve were not able to measure (immunore)activity of protein kinase C 
isozymes accurately in tIus particulated fractions. The reason was the low activities and the 
inhomogeneity of the particulated sllspensions. 
Data analysis 
Comparisons between groups were analyzed using ANOV A and a post hoc Student - t - test. 
Results were described as mean±SEM and a P-value <0.05 was considered significant. 
Results 
HemodYllamic measuremellts 
Heart rate and mean arterial blood pressure 
Under normothermic (36.5-37.5°C) baseline conditions heart rate and mean arterial blood 
pressure were not significantly different between the Sham (control), CAO and MAO groups 
(Table I), Heart rate and mean arterial bloodpressure did not change during the 15-minute CAO 
and MAO and the subsequent 10 minutes of reperfusion, 
Table 1. Systemic hemodynamics in rats dOl'ing the intervention of Sham, CAO and MAO 
BL Organ Ischemia Organ Rep 
(15 min) (10 min) 
Sham (1l~7) 
HR 373±7 370±9 364±6 
MAP 98±6 95±7 88±6 
15 min CAD + 10 min Rep (n~7) 
HR 369±11 377±8 373±12 
MAP 93±7 88±8 83±8 
15 min MAO + 10 min Rep (1l~8) 
HR 369±8 363±8 356±8 
MAP 98±7 109±5 '95±6 
BL baseline; Rep=reperfusioll; CAD coronary artery occlusion; Sham control group without ischemia stimulus; 
HR=heart rate (beats/min); MAP=mean arterial blood pressure (mmHg); tv1AO=mesenteric artery occlusion. There 
were no significant differences between the preconditioning groups (CAD and MAO) and the corresponding sham 
group for both heart rate and mean aortic pressure, All data arc mean ± SEM. 
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Proleill klllase C isozyme measurements by lmmlllloreaclivlty 
Protein kinase C isozymes ~a, -0, -E and -( were measured by immunoreactivity. In the CAO 
group immunoreactivity of the cytosolic and the membrane fractions of protein kinase C 
isozymes -ct, -0, and -E tcnded to decrease, and -( tcnded to increase. However, only the decrease 
of protein kinase C isozyme-o immunoreactivity in the cytosolic fraction is significantly different 
(P~O.oI and P~O.OOI respectively) (table 2). In addition, cytosolic protein kinase C-O decreased 
in the:MAO group but this was not significant (P=O.ll and P=O.067, respectively), Protein kinase 
C-a, -0, -€ and -( immunoreactivity in the membrane fractions remained unchanged. The ratio 
membrane over cytosolic protein kinase C isozymcs-a, -0, -E and -( also did not show significant 
differences between the 3 groups. On the basis of these measurements it may be concluded that 
protein kinase CMo translocates/disappears from the cytosol but the disappearance of 
immunoreactivity is not accompanied by an increase in the membrane fraction after a CAO 
period. 
Proteill kinase C activity measurements by histon III-S phosphorylatioll 
No evidence of translocation of protein kinase C activity by histon IHMS phosphorylation 
from the cytosol to the membrane was found (table 3). Moreover, Ca2t _ cmd (1,2)DAG dependent 
activity was vittually absent in the membrane fractions, which was rather unexpected based upon 
the immunoreactivity measurements. Furthermore, the observed changes in immunoreactivity 
of the cytosolic protein kinase C-O in CAO did not lead to changes in protein kinase C activity 
by histon III-S phosphorylation in the cytosolic fractions. 
Discussion 
Protein kinase C, first identified in the brain [40-431, is present in all organs and some of its 
functions in the myocardium have now been recognized {l9,~1. In myocardial cells, protein kinase 
C regulates processes such as contractility, ion channel function, energy metabolism, specific 
gene expression and hype11rophic cell growth [451. The specificity of action or the protein kinase 
isozymes most likely depends on their intracellular location. The translocation is guided by the 
architecture and intracellular localization of anchor proteins, the so-called receptors for activated 
C kinase (RACKs) [46. 471. After activation, protein kinase C isozymes translocate to other cellular 
compartments such as the sarcolemma where they may have their actions. Mitochondria, 
myofibrils, the sarcoplasmatic reticulum or the perinuclear zone arc other possible action sites. 
The translocation process may occur via the cytoskeleton or by active transport directed .by 
microtubuli [481. 
The protein kinase C isozymes can be divided into 3 subgroups. The classical protein kinase 
C-u is activated by phosphatidylscrine (PtdSer), Ca:!t and (l,2)DAG. The novel protein kinase 
isozymes C-O and -E require PtdSer and (l,2)DAG for their activation but are Ca2' independent 
Table 2. Protein kinase C isozymes (a, 0, E and 0 in cytosolic and membrane fractions and the ratio measured by immunoreactivity. 
PKC-C( PKC-o PKC-E PKC-( 
Grou~ Cytosol Membrane Ratio Cytosol Membrane Ratio Cytosol Membrane Ratio Cytosol Membrane Ratio 
Sham (n=8) 88±6 12±3 12.0±3.4 51±6 49±6 1.2±O.3 76±8 24±8 6.0±2.9 86±6 14±6 3.5±O.7 
CAO (n=8) 77±24 IO±2 lO.9±2.5 21±4* 33±13 l.O±O.3 49±29 26±14 2.8±1.4 59±29 77±42 4.8±4.5 
MAO (n=8) 95±23 12±3 10.8±2.9 34±6 42±9 l.O±O.2 72±14 41±12 2.1±O.4 68±31 11±4 3.2±1.6 
PKC=protein kinase C. Values are mean chemiluminescence counts (immunoreactivity) as percent of Sham (Control) ± SEM, * P<O.05 vs Sham. 
Table 3. Protein kinase C activity (basal and Ca2++(l,2) diacylglycerol (DAG) activated) in cytosolic and membrane fractions measured as histon IIJ-s phosphorylation. 
Cytosol 
Groups Basal Ca'>+(1.2) DAG 
Sham en=7) 35±5 30±8 
CAO (n=7) 35±7 49±12 
MAO (n=8) 37±7 35±7 
Values are mean pmol 32P/minlJ,1g protein ± SEM (histon III-S phosphorylation). 
Basal 
42±7 
35±4 
37±5 
Membrane 
Ca'>+(I.2) DAG 
-9±5 
-2±2 
-1±8 
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and the atypical protein kinase C-( only need PtdSer, but no Ca" and (l,2)DAG. Weinbrenner 
et al (49J showed that protein kinase eRa, -0, -€ and -( are the most prominent isoforms in the rat 
heart which were also found in cultured neonatal (53] and adult rat cardiomyoC)1es [HI, 
'Veinbrenncr el al [49] also showed a rapid translocation of the Ca2+ independent protein kinase 
C isozymes -0, -E and -( and of the Ca2+ dependent protein kinase e-a to the membrane 
occurring after a brief ischemic period. Prolongation of the ischemic period led to increased 
expression of Ca2+ independent [onns of protein kinase e-a and -E in the cytosol. Thus, in these 
shldies it appears that distribution of protein kinase C isozymes-a, -0, -E and -( was altered by 
briefi~chemia. On the basis afthe previously reported presence of these isozymes in the rat we 
have chosen to investigate myocardial protein kinase C isozymes-ct, -0, -€ and -( in classic 
ischemic preconditioning and cardioprotection by remote organ ischemia. For translocation 
measurements of protein kinase C isozymes from cytosol to membrane we have used two 
methods, both inlluunoblot analysis using protein kinase C isozyme-specific antibodies [28.49,50] 
and the assay of protein kinase C activity by Ca2+ and/or (1,2)DAG-dependent 32p incorporation 
from y32p labelled ATP into histon III-S 122,28,51, 521. 
On the basis of our inllllunoreactivity measurements we conclude that the cytosolic 
inmlUnoreactivity of protein kinase C isozyme-o in the CAO group was decreased but that the 
decrease was not accompanied by a rise in immunoreactivity in the membrane fraction. In 
addition it was also shown that the total immunoreactivity of the cytosolic and the membrane 
fraction is lower than in the Sham group. This could mean that a small part of protein kinase C-o 
is translocated e.g. to the myofibrils, mitochondria and the perinucJeus in which protein kinase 
C (immunore)activity could not accurately be measured (See Materials and Methods). A part of 
the activated (translocated) enzyme molecules in the membrane could also disappeared due to 
degradation. Although cytosolic protein kinase C-o decreased and so could first have been 
translocated (activated) by the ischemic preconditioning stimulus, the (in)direct involvement of 
this isozyme in the eventually protective effect is not proven by this finding. For the latter 
purpose it should become possible to specifically inhibit protein kinase C-O. At present no 
method is available. In the MAO group protein kinase C-o only tended to disappear from the 
cytosolic fraction. \Ve therefore tempt to conclude that protein kinase C isozymes-u, -0, -€ and 
-( are not involved in the mechanism of the cardioprotective effect of MAO. In the latter the 
cardioprotection could involve another pathway, which could directly interact with the commo.n 
protective pathway of ischemic preconditioning beyond the protein kinase C cascade or could 
be a totally different pathway besides the one of ischemic preconditioning leading to protection. 
The basal protein kinase C activity and the maximum excitable activity in the presence of 
Ca'" PtdSer and (1,2)DAG with histon lll-S as substrate were measured in the cellular 
subfractions. The protein kinase C activity measurements did not show any diHerences between 
the Sham, CAO and the MAO group. Thus, at least the observed changes in protein kinase C-o 
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by immunoreactivity in CAO have not led to changes in total protein kinase C activity by histon 
III-S phosphorylation. The 0 isozyme is not dependent on Ca2+ but even the Ca2+ and (l,2)DAG 
independent activities were showing no differences. It should be noted that the immunoreactivity 
measurements are reflecting the individual protein kinase C isozymes while the activity 
measurements are a sunullation of the activities of all protein kinase C isozymes together, a part 
being increased while another part being constant or decreased. It was also remarkable that there 
was virtually no Ca2t dependent activity in the membrane fractions, whereas the presence of the 
Ca2+ dependent isozyme a in this fraction was shown by immunoreactivity. 
Methodological considerations. 
The methods used for protein kinase C analysis may be limited in establishing which of the 
protein kinase C isozymes are translocated and definitively activated. Redistribution or 
inactivation (proteolysis) could have occurred during the preparation of subfractions and analysis 
of protein kinase C (immunore-)activity [281. It is also possible that the samples taken from the 
myocardium for measuring the activity were heterogenous in being preconditioned or not. The 
problem ofthe protein kinase C isozymes (immunore)activity measurement in the particulated 
fraction containing myofibrils, mitochodria, nuclei etc. could not be solved at this time. The 
material can be disolved at high ionic strength but the effect of this treatment on protein kinase 
C activity is not known. The interpretation of the immunoreactivity data of the protein kinase C 
isozymes applied on tissue fractions may be very preliminar, because generally spoken the 
antibodies do surely not distinguish between inactive and active form enzymes. (For further 
details see chapter 8) 
Conclusion 
After briefCAO cytosolic protein kinase C-O decreased. Thus, the cytosolic protein kinase 
C-O may be translocated to an unknown subcompartment, and was at least not kept in the 
membrane fraction. Tllis could mean that it is translocated to the myofibrils, nlitochondria and/or 
the peri nucleus. It may also be decreased due to partial degradation of the activated enzyme. 
Although protein kinase C-o was decreased in the cytosol by the ischemic preconditioning 
stimulus, its involvement in the eventually protective effect is far from proven. Specific 
inhibition of this isozyme is needed. Unfortunately, at present this is technically not possible. In 
the MAO group no alterations of protein kinase C-O were found to occur in this form of 
cardioprotection. Therefore, we conclude that protein kinase C-O may be involved in either 
ischemic preconditioning and that the cardioprotective effect of MAO likely involves another 
pathway, which could directly interact with the common protective pathway of ischemic 
preconditioning beyond the protein kinase C cascade or could be a totally different pathway 
besides the one of ischemic preconditioning leading to protection. 
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The original observation by Murry e/ al [IJ that in dogs myocardial infarct size produced by 
a 45-minutc coronary artery occlusion is reduced from 29% to 7% of the area at risk when the 
45-minute occlusion is preceded by four sequences of 5-minute occlusions and 5 minutes of 
reperfusion initiated numerous efforts for the search of the mechanism of cardioprotection by 
ischemic preconditioning and the description of the experimental conditions under which 
cardioprotection can be demonstrated. Major conclusions of these studies are that (i) ischemic 
preconditioning has been demonstrated in every species, including rat, rabbit and swine, in which 
the phenomenon has been investigated [21, (ii) the phenomenon is not restricted to the heart but 
also occurs in other organs such as kidney [3J, skeletal muscle [4], brain 15] , liver (6], lung P] and the 
intestine [8], although in these organs other endpoints than infarct size limitation have been used 
and (iii) the molecular mechanism leading to cardioprotection is still not fully understood 
although several hypotheses have been fonvarded based on endogenous production of adenosine, 
activation ofK+ATP channels and/or protein kinase C activation [9, W]. 
During the last number oryears we have investigated cardioprotection in a number of animal 
models in order to mimic the clinical situation more closely and to investigate whether stimuli 
which do not lead to myocardial ischemia can also protect the myocardium [11-11\. More 
specifically, we investigated whether partial coronary artery occlusions without intervening 
reperfusion, rapid ventricular pacing and brief ischemia in other organs alter myocardial infarct 
size produced by a prolonged coronary artery occlusion. Clinical parallels to the latter is stenosis 
ofthe renal artery or chronic reduced arterial circulation to the lower extremities (claudication). 
Furthermore the possible involvement of protein kinase C in ischemic preconditioning and 
remote cardioprotection was investigated. Experiments were perfonned in anesthetized pigs and 
rats, in which area at risk and in£1rct size were determined using established techniques. Pigs 
were used in those studies in which we also studied regional myocardial function and metabolism 
in detail. 
Ischemic pl'econditioning by partial coronary artery occlusion without intervening 
l'eperfusion 
In chapter 3 we addressed the possibility to precondition myocardium with partial occlusions 
without an intervening reperfusion period. This model is similar to the two-stage occlusion 
model used by Harris [181_ By occluding a coronary artery partially for 30 minutes prior to a 
complete occlusion, Harris showed that the incidence of ventricular fibrillation was markedly 
reduced. \Ve hypothesized that the reduction in ventricular fibrillation after the coronary artery 
was completely occluded might be the consequence of a preconditioning efiect during the partial 
occlusion [12, 131. In the clinical setting a brief abmpt total coronalY artery occlusion is usually not 
followed by complete reperfusion before that artery is occluded for a sustained period and an 
in£'1rction develops. If stringent conditions, such as abrupt brief total coronary artery occlusion 
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and intervening complete reperfusion, would be required to precondition the myocardium, it is 
very unlikely that ischemic preconditioning has a clinical analog (chapter 2). Several groups of 
investigators have investigated the requirements of brief total ischemia and complete reperfusion 
and shown that myocardium can also be protected by moderate partial coronary artery occlusions 
in the presence of adrenergic stimulation (demand ischemia) or endothelial injury [19, 20]. 
Furthennore, Ovize et al 12l ] showed that a sufficiently severe coronary artery occlusion can 
precondition the myocardium, provided that a period of complete reperfusion separated the 
partial and total occlusions. From their shIdy this group of investigators concluded that 
intervening complete reperfusion is a prerequisite of ischemic preconditioning by a partial 
occlusion. We have challenged the generalization of this conclusion because it is based on only 
one degree of flow reduction. \Ve hypothesized that partial occlusions might be able to 
precondition myocardium and limit infarct size during a subsequent complete occlusion without 
an intervening reperfusion period, but that the severity and the duration of the partial coronary 
occlusions could playa role. \Ve have investigated this hypothesis in open~chest anesthetized 
pigs which were instrumented for measurement of global and regional myocardial performance 
(chapter 3, figure I). 
In this ShIdy we revealed that flow reductions of 70% but not of30% were capable to reduce 
infarct size (chapter 3, figures 3 and 4). Because a flow reduction will affect perfusion of the 
inner half of the myocardium more severely than the outer half we hypothesized that the degree 
of protection could be different for the inner (endocardial) and outer (epicardial) halves of the 
myocardium. Analysis of our results showed that protection with the 70% flow reduction was 
more pronounced in the epicardial than in the endocardial half. Based on earlier observation with 
radioactive microspheres, we may assume that with the 30% flow reduction, the endocardium 
had at least become as ischemic as the epicardial half with the 70% flow reductions. Nevertheless 
we did not observe any protection in the endocardial half with the 30% flow reductions. The 
reason is yet unclear, but may be related to the lesser degree of ischemia during the 30% flow 
reduction thereby providing a subthreshold stimulus. Another explanation for this observation 
could be that the protection involves K+ ATP channels and that these channels are not 
homogeneously distributed throughout the myocardial wall but that they .are predominantly 
located in the epicardial layer of the myocardial wall. The latter is recently shown in a study by 
Miyoshi et al [22] in which they reported a different response of the epicardial and endocardial 
layers to K\TI' channel modulators which suggested a lower threshold for the activation and/or 
a denser distribution ofK+ AlP channels or other K+ chamlels at the epicardial layer . The finding 
that partial occlusions protect the myocardium against the development of irreversible damage 
during a subsequent total occlusion may be useful to the clinical condition that a coronary 
stenosis becomes totally occluded by a thrombus. The results of these shldies if applicable to 
man, imply that shIdies evaluating the effectiveness of pharmacological agents in thrombolysis 
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trials should take into account the existence and the severity of preexisting stenosis as ischemic 
preconditioning could be a confounding factor. In the present study we have only investigated 
partial occlusions which lasted 30 minutes or longer. It is of interest to study whether partial 
occlusions of much shorter duration can precondition the myocardium without intervening 
reperfusion period. 
Infarct size limiting effect of rapid ycntricular pacing 
From several studies it has become clear that a variety of stimuli, which do not produce 
myocardial ischemia, are also capable to limit infarct size during a subsequent sustained coronary 
artery occlusion. We further addressed this issue by applying rapid ventricular pacing (RVP) 
prior to a 60-l11inute coronary artery occlusion in anesthetized pigs. Ventricular pacing was 
chosen as a stimulus because ventricular pacing prior to a coronary artcry occlusion (CAO) 
reduces the incidence of ventricular arrhythmias and fibrillation [231. In that study it was assumed 
that ventricular pacing (at 300 bpm in dogs) produced myocardial ischemia in view of the 
occurrcnce ofST segment changes [23J. However, no attempts were made to confirm the presence 
of myocardial ischemia by abnonnalities in myocardial contraction and metabolism. In chapter 
4 we therefore first detailed the functional and metabolic changes that occurred in anesthetized 
pigs when the left ventricle was paced at 200 bpm [14] and concluded from these studies that 
ventricular pacing did not produce myocardial ischemia because (i) transmural myocardial blood 
flow remained equally distributed across the imler and outer layers of the left ventricular waU, 
(ii) the decrease in systolic shortening was entirely due to a decrease in end~diastolic length, (iii) 
postsystolic shOltening did not develop, and (iv) there were no changes in myocardial ATP and 
phosphocreatine levels, energy charge, and arterial or coronary venous pH concentrations. Other 
signs that ischemia did not develop during ventricular pacing were (v) the absence of reactive 
hyperemia aftcr pacing was stopped and (vi) the immediate recovery of systolic segment 
shortening indicating that post ischemic myocardial stunning did not occur. 
It proved that when 10-minute RVP and 60-minute CAO were separated by 15 minutes of 
normal sinus rhythm (NSR), infarct area over area at risk (IAlAR) was not different from the 
control group but when the duration ofRVP was extended to 30 minutes a small protection was 
obselved (chapter 4, figure 4). Without a period of normal sinus rh)1hm between the 30-minute 
RVP and the 60-minute CAO IAIAR was markedly limited but the protection was less than with 
ischemic preconditioning (chapter 4, figure 5). The finding that the 15 minutes ofNSR already 
attenuated protection by 30-minute RVP also implies that the time course of protection by 
ventricular pacing is different from that by ischemic preconditioning. K+ATP channel activation 
proved to play a role in the protection by rapid ventricular pacing as pretreatment with 
glibellclamide abolished the protection. The observation that administration of glibenclamide 
after the period of ventricular pacing was tcrminated did not attenuate the protection strongly 
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suggests that K+ AlP channels did not have to remain activated after the protective stimulus had 
been applied. TIlis is at variance with observations in ischemic preconditioning experiments as 
in these experiments glibenclamide abolished the protection independent whether administration 
occulTed prior or after the brief coronary artery occlusion (preconditioning stimulus). The results 
of this study confirm that myocardium does not first have to be ischemic for a brief period in 
order to increase its tolerance to the development of irreversible damage during a sustained 
coronary artery occlusion and suggests that the myocardium is able to protect itself against the 
development of irreversible damage by a large number of stimuli prior to sustained coronary 
artery occlusion and which mayor may not produce ischemia in the jeopardized myocardium. 
It remains of interest that the protection by RVP appears not only to be less potent than by 
ischemic preconditioning, but also that the protection has a much narrower time window. In some 
preliminary studies we have shown that RVP leads to activation of protein kinase C. In future 
studies it would therefore be interesting to relate the time course of protein kinase C activation 
to activation of K+AlP channels. 
Cardioprotection by brief ischemia in remote organs and the infarct size limiting effect 
of low body temperature 
In chapter 5 we hypothesised that brief ischemia in remote organs might also limit infarct 
size in the myocardium, because a brief coronary artery occlusion does not only linlit infarct size 
inside but also outside its distribution territory 1241. 
In the first series of experiments we investigated in anesthetized male \Vistar rats whether 
briefischemia in remote organs limited myocardial infarct size (chapter 5 figure 1). To this end 
rats were subjected to either a 15-minute (left) renal artery occlusion (RAO) or a I5-minute 
mesenteric artery occlusion (MAO) 10 minutes prior to a 60-l11inute left anterior descending 
coronary artery occlusion and 180 minutes of reperfusion. Experiments were performed at 
36.5°C-37.5°C (normothermia) and 30°C_31°C (hypothermia). Our study reveals that (i) in 
control animals the relation between IA and AR is llighly linear without a positive intercept on 
the AR-axis unlike in pigs in which there is a positive intercept on the AR-axis in the IA-AR-
relation 125J, (ii) in control animals development of the infarct areas was the same in the two 
temperature ranges (chapter 5 figure 4 and table 1). These data appear to contradict those 
reported for rabbits !26] and swine [27J. Thus, Chien el al [261 reported a steep relation between body 
core temperature in the Unonnothennicu range (35°_42°C) and myocardial infarct size in rabbits 
subjected to a 30-minute CAO and 3 hours of reperfusion, so that an increase of 1°C resulted in 
12% infarction of the area at risk with no infarction occurring at a body core temperature of 
34.SoC. Duncker el al l27J showed an even steeper relation between body core temperature and 
infarct size produced by a 45 minute coronary artery occlusion and four hours of reperfusion in 
swine as 20% ofthe area at risk became infarcted with a 1°C increase in temperature in the range 
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of 35°C to 39°C. However, in those last studies different temperature ranges were used, while 
the coronary artery occlusions were also shorter (30 min - 45 min). The importance of the 
duration of the coronary artery occlusion in studying the temperature-dependency of infarct 
development is supported by the study from McClanahan ef ai, who showed that the infarct area 
produced by a 60-minute CAO was not affected when body temperature was decreased from 
37"C to 35°C [281. We addressed this hypothesis in chapter 6 and demonstrated that the infarct 
size limiting effect ofhypothennia depends all the duration ofthe coronary artery occlusion. (For 
details see further). 
Our studies in chapter 6 also revealed that (iii) protection by 15-minute CAO was much more 
pronounced during hypothermia than normothermia, Because temperature had no effect on 
infarct area in the control animals, we conclude that the IS-minute CAO stimulus was morc 
effective during hypothermia than during normothermia, (iv) the IS-minute MAO limited 
myocardial infarct size both in the normothermic and hypothermic temperature ranges. The 
protection during hypothermia was, at variance with the classical ischemic preconditioning 
stimulus, only slightly larger than during normothermia, (v) the 15-minute RAO was not 
protective during normothermia but limited myocardial infarct size when experiments were 
performed during hypothermia (chapter 5 table I). We can only speculate on the reason why the 
IS-minute MAO was effective and the IS-minute RAO ineffective during nonnothennia. An 
argument could be that the IS-minute RAO produced less severe ischemia than the IS-minute 
MAO as only approximately 10% of renal artery flow (compared to 90% of mesenteric flow) is 
needed for nutritional flow. 1111.1s, the less severe ischemia produced by the IS-minute RAO may 
therefore 110t have been severe enough to trigger myocardial protection. 
In the following series of experiments we investigated whether the mechanism of 
cardioprotection by remote brief organ ischemia differed from that by brief myocardial ischemia. 
Because protection by IS-minute MAO occurr~d during normothermia as well as hypothermia 
we selected this stimulus for investigation of its mechanism. \Ve first evaluated whether a 
neurogenic mechanism could he involved in the protection by IS-minute lviAO. To this end 
infarct size was determined after neurogenic blockade with hexamethonium. \Ve showed that 
hexamethonium neither affected IAI AR in the control animals nor in the animals preconditioned 
with IS-minute CAO, regardless of whether the experiments were performed during 
normothermia or hypothermia. In contrast protection by IS-minute MAO was completely 
abolished after pretreatment with hexamethonium (chapter S figure 3 and S and table I). 
These data demonstrate that activation of the neurogenic pathway was involved in the 
protection by IS-minute MAO but not by IS-minute CAO. In the next series of experiments we 
investigated whether activation of the neurogenic pathway had occurred during early ischemia 
or during the 10-minute intervening reperfusion period, which separated the period from brief 
intestinal ischemia from the sustained coronary artery occlusion. \Ve therefore studied the effect 
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ofa pennanent mesenteric artery occlusion starting 25 min prior to the onset of the 60-minute 
CAO on myocardial infarct size. In these experiments, MAO failed to limit infarct size produced 
by 60-minute CAO and the neurogenic pathway appears therefore to be triggered during early 
reperfusion of the mesenteric artery (chapter 5 figure 3 and 6 and table I). In addition to these 
experiments we performed experiments to answer the question whether it is possible to protect 
the myocardium with MAO when the neurogenic pathway (and a possible downstream cascade) 
triggered during reperfusion of the intestinal bed arrived the myocardium after the onset of the 
long-tenn coronary artery occlusion. Thus in these experiments the mesenteric artery occlusion 
was terminated 1 minute after the onset of the long-term coronaty artery occlusion. It was 
revealed that, MAO failed to limit infarct size and it seemed that the stimulus via the neurogenic 
pathway (cascade) must arrive at the myocardium before the onset of the myocardial ischemic 
period. 
From our experiments we can not conclude that protection by IS-minute RAO also involves 
a neurogenic pathway. Furthermore, although protection by IS-minute MAO appears to differ 
from that by 1S-minute CAO we cannot exclude the possibility that these two approaches to 
cardiac protection have a conUllon endpoint such as the intracellular activation of protein kinase 
C (chapter 7 and 8). 
Thc myocardial infarct size limiting effect of low body tcmperature in rats depends on 
the duration of the coronary al'fcry occlusion. 
As already stated recently, Chien et at [26] and Dunckel' et at [27J showed a steep relation 
between body core temperature and myocardial infarct size. In contrast to these studies our study 
in rats described in chapter 6 did not show a protective effect of hypothermia on infarct size 
detemlined 3 hours after a 60-minute CAO [171. In chapter 6 we demonstrated that the infarct size 
limiting effect of hypothermia depends on the duration ofthe coronary artery occlusion. Thus, 
when in rats the coronary artery was occluded for 30 minutes, hypothennia was protective (5.2% 
of the area at risk per 1°C), but when the duration of the CAO was extended to 60 minutes the 
protective effect of hypothermia could not be detected (chapter 6 figure 4). 
There are several hypotheses by which hypothermia could exert protection. For instance a 
role myocardial oxygen demand at the onset of the coronary artery occlusion as a determinant 
ofinfarct size is postulated but is controversial. A positive correlation [29,30] as well as no relation 
[30-33} between the rate-pressure product and infarct size have been reported. Nienaber et at [341 
produced bradycardia in dogs with a synthetic opiate to lower the metabolic demand at the onset 
of a 24 hour coronary artery occlusion thereby producing a smaller infarction compared to a 
group of animals with a high metabolic demand at the onset of coronary artery occlusion. It 
cannot be excluded that the obtained protection by bradycardia was actually a direct result of fl-
opioid receptor stimulation [35J. In collateral deficient species such as rabbit and swine infarct size 
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does not appear to be cOlrelated with the ratcwpressure product [J2, 331, In the study by Duncker et 
al [27] univariate Of stepwise multivariate regression analysis did not reveal a significant 
cOlTclation between temperature and systemic hemodynamic variables at baseline or myocardial 
blood flow under baseline conditions, suggesting that temperature did 110t exert its effect by 
altering myocardial oxygen demand at the onset of occlusion. Similarly, in rabbit hearts [26] and 
rat hearts (chapter 6) the infarct size limiting effect of hypothermia was unmitigated when 
hypothermiawinduced bradycardia was prevented. It is likely that during coronary artery 
occlusion when contraction ceases, energy utilization is no longer reflected by the rateMpressure 
product. The present findings therefore lend further support to those studies that could not find 
a relation between the development of infarct size and energy demand at the time of occlusion 
as originally proposed. 
The role of protein kinase C in ischemic preconditioning and cal'diopl'otection by 
ischemia in other organs 
Activation of receptors by exogenously administered stimuli such as adenosine [36, 371, 
bradykinill138,39J, noradrenaline [40,41], acetylcholine [42,43], endothelinM! [44J or opiates {45] mimic 
myocardial protection by ischemic preconditioning. TIllS led to the hypothesis that intracellular 
signalling by these stimuli, via GTP-binding-protein-linked receptors and phospholipase Cop and 
possibly phospholipase D [46,47], leads to activation of one or more isozymes of the protein kinase 
C family which ultimately phosphorylate putative target proteins directly involved in 
cardioprotection {IO,48]. Consistent with the hypothesis is that direct activators of protein kinase 
C, phorbol esters, have been reported to mimic ischemic preconditioning [49] and inactivators of 
protein kinase C, such as staurosporin or chelerythrine can block ischemic preconditioning (49,50] 
(chapter 7). Possible target proteins of protein kinase C could be those that regulate opening of 
K+ ATr chatmels [51· 53J, activate ectoM5'Mnucleotidase [54] (during the first window of protection 
(F\VOP) [55}) or modulate transcriptional regulation of the expression of heat shock proteins [56, 
57} (during the second window of protection (SWOP) [SS.60}). For instance, K+ ATP chatmels are 
opened when atl ischemic preconditioning stimulus is applied, wIllIe blockade ofK+ATP channels 
prevents ischemic preconditioning ISI,52}, However, blockade of the action potential shortening 
by dofetilide does not abolish protection by ischemic preconditioning [61} therefore it is likely that 
modulation of K\w chatmels in the mitochondria, sarcoplasmic reticulum or the nucleus are 
involved in the mechanism of the protection. The presence of these channels in the mitochondria 
[62,63] or other types of K + channels in the sarcoplasmic reticulum [64,65] or the nucleus are shown 
[66] but their role in ischemic preconditioning is not yet investigated. 
Since protein kinase C can be activated via various receptors linked to phospholipase CM and 
possibly phospholipase D-mediated signalling pathways, these receptors may act synergistically 
[IO}, Opening ofK+ An' channels by pharmacological substances lowers the threshold for ischemic 
SUllunary, general discussion and future perspective 145 
preconditioning [67J, which is consistent with the hypothesis that K+ ATPchannels are target proteins 
for protein kinase C. Kltakaze e/ al [54J reported that ischemic preconditioning increased ecto-5'-
nucleotidase activity and that activation of protein kinase C increases ecto-S'-nucleotidase 
activity in isolated rat cardiomyocytes, supporting the candidacy of ecto-5'-nucleotidase as 
another target protein of protein kinase C. 
At present myristoylated-alanine-rich-C-kinase-substrate (MARCKS) is the only endogenous 
target protein for protein kinase C that has been shown to be phosphorylated in preconditioned 
rabbit myocardium. However, the fonner is believed to be an intracellular location site rather 
than a protein factor intimately involved in the protective response [68J. Irrespective of the target 
protein(s) we are dealing with or its (their) covalently bound phosphates must be relatively stable 
during the 2 to 3 hours in which the cardioprotection is present (F\VOP). Furthermore, the 
precise time point at which protein kinase C is maximally translocated (activated) during 
ischemia or reperfusion (preconditioning stimulus) is unknown and consequently also the time 
point at which the enzyme reaches the target proteins for catalysing their phosphorylation. It is 
quite feasible that protein kinase C is removed from its translocation site or proteolytic ally 
degraded after performing its action and thereafter the enzyme is not longer detectable by 
immunoreactivity or activity measurements. It is therefore mandatory to determine the time 
course of translocation/activation and subsequent relocalizationlinactivation or proteolytic 
degradation of the protein kinase C isozyme and the time course(s) of phosphorylation and 
dephosphorylation or prokolytic degradation of the target protein(s). Because the time course 
of weaning of the protective effect of the FWOP is roughly known, the time course of 
dephosphorylation/inactivation of the target protein could be correlated to the time course of 
weaning of protection. Candidate target proteins of protein kinase C involved in the F\VOP are 
e.g. the K+ATP charulel {51. 52} and/or the ecto-5'-nucleotidase [5-1J, but experimental evidence for 
phosphate incorporation into channel proteins and/or enzymes or regulating proteins is lacking. 
If the K\TP channel or the ecto-S'-nucleotidase are its targets the most likely translocation site 
for the protein kinase C isozyme(s) involved in the FWOP is the sarcolemma. 
Protein kinase C is involved in the agonist-receptor interaction induced changes in gene 
expression of many cells [41, 69.7~J. If we take into account the time required for inducing heat 
shock/stress proteins (56,57J the induced changes by protein kinase C may only playa role in the 
S\VOP. Therefore, a transcription factor involved in the regulation of expression of heat 
shock/stress proteins could be another potential target protein of protein kinase C. If true, the 
nucleus is the most likely translocation site for the protein kinase C isoZYl11e(s) in causing the 
protection. 
The protein kinase C isozymes can be divided into 3 subgroups. The classical protein kinase 
C-a is activated by phosphatidylserine (PtdSer), Ca" and (1,2)DAG. The novel protein kinases 
C-O and -E require PtdSer and (l,2)DAG for their activation but are Ca2+ independent and the 
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atypical protein kinase C-( only needs PtdSer, but no Ca" and (l,2)DAG. Weinbrelmer ef at [751 
showed that protein kinases C-a, -0, -E and -( are the most prom.inent isozymes in the rat heart 
which were also found in cultured neonatal (76) and adult rat cardiomyocytes [771, \VeinbrCIUlcr et 
at (75] also showed a rapid translocation afthe Ca2+ independent isozymes, namely protein kinases 
Cwo, -E and -( and the Ca2+ dependent protein kinase C-o: to the membrane after a brief ischemic 
period. An extension of the ischemia period led to increased expression of Ca2+ independent 
forms of protein kinases Cwo and -E in the cytosol. Thus, in these studies it appears that the 
distribution of protein kinase C isozymes-u, -0, -E and -( were altered. Therefore we 
investigated in chapter 8 myocardial protein kinase C isozymes-u, -0, -E and -( in classic 
ischemic preconditioning and cardioprotection by remote organ ischemia (chapter 8, figure 1). 
For the measurements of the translocation of protein kinase C isozymes from cytosol to 
membrane we have applied two methods, namely immunoblot analysis using protein kinase C 
isozyme-specific antibodies [69,75, 781 (chapter 8, table 1) and assay of protein kinase C activity by 
Ca'+ and/or (1,2)DAG-dependent phosphate incorporation into histonlIl-S [69.76.79. 8°1 (chapter 8, 
table 2). 
In the CAO cytosolic protein kinase C-o disappeared, but was not found back in the 
membrane fraction. It could mean that protein kinase C-O translocates to the myofibrils, 
mitochondria or the perinucleus and/or the activated enzyme is not detectable anymore due to 
degradation of the enzyme in the membrane fraction. Although protein kinase C-o was found to 
be decreased in the cytosol, the involvement of this event in the ultimate protective effect is not 
proven. Specific inhibition of protein kinase C-O is needed for the latter which is at present not 
possible. In the MAO group protein kinase C-O tended to disappear from the cytosolic fraction. 
Thus when it is concluded that protein kinase C-o is involved in ischemic preconditioning, 
the cardioprotective em~ct of MAO must involves another pathway, which could directly interact 
with the conunon protective pathway of ischemic preconditioning beyond the protein kinase C 
cascade or could be a totally different pathway besides the one of ischemic preconditioning 
leading to protection. 
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Future perspectives 
The neurogenic and other mediators of remote cardioprotection 
In chapter 5 the phenomenological characteristics of the myocardial infarct size limiting 
effect of ischemia in the small intestines were determined. Briefly, (i) infarct size limitation 
afforded by brief ischemia in the slllall intestines is temperature dependent, (ii) it involves a 
neurogenic pathway as it could be blocked by ganglion blockade (hexamethonium), (iii) tlus 
neurogenic pathway is activated during reperfusion of the ischemic small intestines, (iv) the 
signal must arrive in the myocardium before it becomes ischemic as the infarct size limiting 
effect could not be shown when reperfusion of the small intestines was induced 1 minute after 
the onset of the coronary artery occlusion (preliminary experiments not described in this thesis). 
TIle infarct size limiting effect of low body temperature depends on the duration of the coronary 
artery occlusion (chapter 6) and the infarct size limiting effect of prior brief ischemia in the 
kidney is temperature dependent; this implicates that the latter also depends on the duration of 
the coronary artery occlusion. The involvement of a neurogenic pathway which is activated 
during reperfusio~ of the ischemic small intestines and the observation that the signal must arrive 
before occlusion of the coronary artery suggests a two step mechanism in which a circulating 
mediator could be involved. It may be possible that autocoids trigger a neurogenic pathway 
during the intervening reperfusion of the small intestines and this neurogenic signal could trigger 
the release of a circulating mediator which reaches the myocardium during the intervening 
reperfusion period. Another possibility is that processing of the received signal by the 
myocardium that leads to the protective effect demands energy, which is only available during 
the intervening reperfusiog period. In future studies (i) the infarct size limiting effect of brief 
ischemia in other organs has to be further characterised by determining the window of protection 
(ii) the existence of a "second window of protectionu has to be investigated 24 hours after the 
stimulus has been given; (iii) the organ specificity of this phenomenon has to be studied and (iv) 
it has to be shown whether the infarct size limiting effect in the myocardium is also seen in other 
organs such as brains. In addition, (v) studies must be performed to detellnine more precisely the 
mechanism by investigating the role of substances such as bradykinin, oxygen radicals, and 
adenosine in the ischemic organ or the heart in a donor~recipient model i~ which the circulation 
of the organ that has to become ischemic is shunted to another animal so that the circulation of 
the heart and the target organ is separated from each other to permit specific application of 
pharmacological inhibitors/activators to the target organ or to the heart. 
The cellular mechanism of preconditioning 
In chapters 7 and 8 we already addressed the potential role of protein kinase C in the 
mechanisms of ischemic preconditioning. \Ve also delineated the limitations and the difficulties 
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of the procedures used. Thus interpretation of the data obtained must be done with caution. The 
role of protein kinase C in the mechanism of ischemic preconditioning remains therefore a 
controversial issue (see chapter 7). One afthe reasons is that protein kinase C represents multiple 
isozymes (more than 12). It is not possible to measure the translocation of each isozyme by 
activity individually. Thus, activity measurements show only the activity of protein kinase C 
isozymes all together. Moreover in all studies only one time point was chosen to determine 
translocation of (usually only a few) isozymes and activity of total protein kinase C. The time 
course of translocation is therefore still not known. Furthermore, measurements 
(phosphorylation/dephosphorylation/inhibiting) on potential target proteins have not yet been 
done. So in future studies the time course and the subcellular compartment to which several 
protein kinase C isozymcs translocates must be determined by isozyme and activity 
measurements in sequentiaVserial biopsies taken at different time points during the experiment. 
Furthermore, it will be necessary to develop specific blockers for isoZYl11cs of protein kinase C 
to see whether these can inhibit cardioprotection induced by CAO and/or MAO. In addition the 
place of the opening of the KATP chatmcl in the cascade of intracellular signal transduction 
pathway should be investigated by simultaneously inhibiting this channel by glibenciamide and 
protein kinase C isozyme protein and activity measurements. 
The mechanism of the infarct size limiting effect of low body temperature 
The infarct size limiting effect of low body temperature depends on the duration of the 
coronary artelY occlusion. Thus in rats for body temperatures around 30°C the protective effect 
could only be shown between 20 and 40 minutes of coronary artery occlusion. This implicates 
that the effect is only a delay in the infarct size development and not an absolute abolishment of 
infarction. Evidence suggests that myocardial cell death due to ischemia is mostly determined 
to be apoptotic cell death [81J (see below). This is rather unexpected because apoptosis is an 
energy dependent process. The enzymatic reactions involved are, as any other, temperature 
dependent. Thus, ill our experiments the lower body core temperature of the rats has reduced the 
rate of the genome~progral11med process of apoptosis. Another factor is the known effect of 
temperature changes on the membrane fluidity. Some enzymes involved in apoptosis, are 
membrane bound and so their catalytic function dependent on the fluidity of the membranes. 
The role of apoptosis in myocardial ischemia~rcperfusion injury and preconditioning 
The ultimate protection of the myocardium against ischemia is still the termination of 
ischemia by restoring the blood flow to the jeopardized myocardium. However, reperfusion after 
an infarction inducing ischemic period may act as a double edged sword as it will not only lead 
to salvage of jeopardized tissue but may also promote an extension of the infarcted area 181· 84] 
("reperfusioll iqjuryU [85,86]). In the setting with myocardial infarction as endpoint and reperfusion 
Summary, general discussion and future perspective 149 
injury thus refers to the,death of myocytes that are still viable at the onset of reperfusion. 
However "reperfusion injuri' has been questioned by several groups of investigators [87. 881. 
Jennings and Reimer have ascribed this extension to a "delayed ischemic injury" i.e. injury that 
is induced during the ischemic period but comes at first to expression during reperfusion [891. Pure 
ischemic injury and combined ischemic-reperfusion injury have different histological 
characteristics i.e. the wnount of coagulation necrosis and contraction band necrosis is different 
between the pure ischemic injury and the combined ischemic-reperfusion injury [90). In infarctions 
produced by an 8 hour coronary artery occlusion without reperfusion, 98% of the infarction 
consists of coagUlation necrosis. Tn contrast, the infarctions produced by a 1 hour occlusion 
period with I to 7 hours ofreperfusion show 30% contraction band necrosis and 70% coagulation 
necrosis. It is not known how the ratio between coagUlation necrosis and contraction band 
necrosis varies with the duration of the ischemic period. These different morphological 
characteristics could reflect a different modality of cell death and the mechanism in causing these 
different forms of cell death could be different. It is quite feasible that apoptosis plays a role in 
ischemic-reperfusioll injury. Apoptosis as a mode of cell death has been recognized in the mid 
70's and is currently acknowledged to exist in normal tissue to maintain balance between cell 
homeostasis and cell proliferation and differentiation. The characteristic events of apoptotic cell 
death which occur in a fixed sequence are cell shrinkage, loss of environmental contact of the 
cell, dense chromatin condensation of the nucleus, cellular budding and fragmentation, and rapid 
phagocytosis by macrophages or adjacent cells 191 , 921. Gottlieb et at [93) have recently shown that 
reperfusion injury induces apoptosis in rabbit eardiomyoc}1es. Apoptotic cells are programmed 
to die in a certain manner and the authors ascribed to the reperfusion after the ischemic period 
as the trigger because they could not detect any signs of apoptosis when the myocytes were 
subjected only to 30 min or 4.5 hours of ischemia. In this study there was no group which 
received a shorter period ofreperfusion after the ischemic period. More recently Kajstura et at 
{SII shows that apoptotic and necrotic myocyte cell deaths are independent contributing variables 
of infarct size in rats. In these experiments rats were subjected to 20 minutes to 7 days of 
coronruy artery occlusion. The contribution of myocyte necrotic and apoptotic cell death to the 
myocardial infarction was assessed. Apoptotic cell death represented the major independent form 
of myoc}1e cell death and peaked at 4.5 hours which is rather unexpected and difficult to 
understand because this genome directed progranuned process needs energy-rich phosphates at 
many reaction steps (e.g. transcription and translation). Therefore, programmed cell death 
occurring during reperfusion is more plausible, but even during this period myocardial energy 
charge will remain reduced for a long period. From these studies we conclude that ifapoptosis 
plays a major role in ischemic myocardial death it must be in the ischemia-reperfusion injury. 
The level of energYMrich phosphates is progressively reduced during ischemia. Furthermore, if 
apoptosis is responsible for the major part of the infarction, the infarct size limiting effect of 
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ischemic preconditioning and K+ All' channel activation may interfere with this form of 
myocardial cell death. It is of interest to know whether the infarct size limiting effect of these 
stimuli/strategies has its effect on ischemic injury or ischel11ia~reperfusion iqjury and whether 
apoptosis or necrosis is limited by these interventions. If apoptosis is involved we possibly could 
interfere in this active process of cell death once we know the mechanism of apoptosis. Because 
both apoptosis and preconditioning are biological processes, possibly existing in all tissues these 
two phenomena could be (inter)related. The aim of Ihture studies could be to attempt to 
distinguish reperfusioll iryury from delayed ischemic injury in an in-situ rat or porcine model for 
acute myocardial infarction and try to detect. quantify and localize apoptotic cardiomyocytes at 
the end of the induction of ischemic injury induced by a 1 hour period of ischemia and after a 1 
hour period of ischemia and 10 min or 3 hours of reperfusion. From the results of these 
experiments we hopefully can conclude whether apoptosis is involved in ischemic-reperfusion 
injury or whether this is a modality of its own. Ifapoptosis is involved. and if the extension of 
infarction during the reperfusion period could be ascribed to apoptosis or cell death induced 
during the ischemic period then the extension is delayed ischemic injury. If the extension could 
be ascribed to apoptosis induced during reperfusion the extension is indeed reperfusion injury. 
If the apoptotic cells lie beyond the "necrotic area" it is a modality ofits own. 
In view of the ischemic preconditioning phenomenon one should investigate whether infarct 
size limitation is due to limitation of ischemic injury, limitation of reperfusion injury ot a 
combination of both. In addition. one should also investigate whether the infarct size limiting 
effect of preconditioning could be ascribed to a limitation of cell death due to apoptosis. 
Concluding remarks 
In the effort to search for the ideal therapy to protect ischemic myocardium one should keep 
in mind that finally perfusion must be reinstalled. The current view is that the mechanism of 
myocardial cell death due to ischemia and reperfusion is multih'lctorial. Thus, during reperfush;m 
the myocardium is also injured, which therefore is another point to intervene and to protect t!le 
myocardium at risk. Ifprotection mechanisms in ischemic and ischemic-repcrfused myocardium 
act in a different way on the damaged myocardium, one could theoretically combine these 
protective interventions and create the best approach to save myocardium at risk. However. even 
when we are able to make the ideal anti-ischemic therapy, we should keep in mind that this will 
only be a delay tor myocardial death as long as we arc not able to reperfuse the myocardium at 
risk in time. 
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In ischemische preconditionerings studies word(en) een of meer korte, abruptc, tatale 
coronair artcrie occlusie - reperfusie peri odes gebruikt am het myocard te beschennen tcgen 
io'cversibele schade veroorzaakt door een langdurige coronair al1erie occlusie. Bewijs stapclt zieh 
llU op dat partif!ie coronair artcric occlusies, met ofZOllder cen toename in de zuurstofvraag, oak 
het myocard kan preconditioneren. Bovendien, in tegenstellillg tot wat er eerder werd 
gerapporteerd, blijkt cen particle coronaire arteric occlusie oak het myocard te kunnen 
preconditioneren, wanllcer er geen tussenliggende periode van reperfusie plaatsvilldt (hoofdstuk 
4). Echter de flow reductic moet ernstig genoeg zijn. De ernst van de flow reductie tijdens de 
eerste fase (preconditionerings stimulus) is kritieker voor de cardioprotectie tegen de tweede fase 
(langdurige occlusie) dan de duur van de flow reductie. In hoofdshlk 4 hebben we aangetoond 
dat zowel een 30 minuten als cen 90 minuten durende flow reductie van 30% faaide het myocard 
te prcconditioneren, maar dat zowd een 30 minuten als een 90 minuten durende flow reductie 
van 70% de infarctgrootte, veroorzaakt door een 60 minuten totale coronair arterie afsluiting, wei 
kon beperken. Daarentegen toonden Schulz et at aan dat in£1fcering, veroorzaakt door een 
langdurige periode van lage-flow ischemie, beperkt wordt \Vanneer het onmiddelijk wordt 
voorafgegaan door een korte totale occlusie zonder een tussenliggende peri ode van reperfusie. 
Deze partiele occlusie studies bootst meer de klinische oJUstandigheden na dan zo'n abmpte 
occ1usie-reperfusie prikkel in voorgaande studies. Een aantal observaties tonen aan die 
sllggereren dat myocardiale bescherming getriggerd kan worden door (patho)fysiologische 
stimuli welke zelf geen myocardiale ischemie veroorzaken. 
Przyklenk et at toonden in honden aan dat na een kortdurende coronair arterie occ1usie de 
infarctgrootte niet aIleen was afgellomen in het gepreconditioneerde myocard, maar ook in het 
aangrenzendc "virgin" myocard ("remote intracardiac preconditioning"). Hun sh.ldie was de 
eerste die stlggereerde dat het myocard niet direct aan ischemie bloodgesteld hoefde te worden 
0111 beschennd te raken tegen irreversibele schade veroorzaakt door een langdurige coronair 
arterie occlusie. 
De observaties van Pryklenk et at zijn de aanzet geweest voor verschillende shldies die de 
vraag ofhet myocard niet aIleen beschermd kan worden door remote il1tracardiac ischemische 
preconditionering maar ook door interorgan ischemische preconditionering praberen te 
beantwoorden. In een voorlopige studie toonden we aan in geanesthetiseerde ratten, dat na een 
15 minuten durende nier arterie occlusic en een 10 minuten durende tllssenliggende reperfusie, 
het in£1rct veraorzaakt door een 60 minuten coronair art erie occlusie kleiner is dan het contrale 
infarct. Kort hierna rees het vermocden, dat de resultatcn van onze laatste experimenten 
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waarschijn1ijk be'invloed zijn door de lichaamstemperatuur. Daarom hebben we in hoofdstuk 6 
onze experimenten herhaald onder strengere temperatuur controle. Nu hebben we gevonden dat 
een 15 minuten nier arterie occlusie voorafgaand aan de 60 minuten coronair arterie afsluiting, 
de infarctgrootte tot 30% wordt beperkt onder hypothennische olllstandigheden (30-31'C), maar 
dat het geen effect had op de infarctgrootte onder normothermische omstandigheden (36.5-
37.5'C). Een 15 minuten durende dann arterie afsluiting, had hetzelfde beperkende effect op de 
infarctgrootte als een 15 minuten coronair arterie afsluiting tijdens normothermie. 
In verschillende studies is aangetoond dat andere vonnen van stress het myocard kan 
beschennen tegen infarcering zonder dat ischemie eraan te pas moet komen. Ovize e/ al 
demonstreerde dat stretch en verhoging van de wand stress van de linker ventrikel door acute 
volume belasting ook infarctgrootte kon beperken. Deze observatie suggereert, dat stretch van 
de "remote" myocard veroorzaakt door dyskinesis in het ischemische myocard heeft meegewerkt 
tot het ontstaan van remote intracardiac preconditionering. Het mechanisme van interorgaan 
preconditionering is nag steeds speculatief, want myocard stretch lijkt een onwaarschijnlijke 
factor am bijdrage te geven in interorgan preconditionering. 
Ter ondersteuning van de observaties door Ovize el al dat niet-ischemische stimuli oak het 
myocard kan beschennen, hebben we in hoofdstuk 5 in varkens geobserveerd dat 30 minuten van 
ventrikel pacen op 200 slagen per minuut gevolgd door IS minuten van nonnale sinus ritme, dit 
oak de infarctgrootte, veroorzaakt door 60 minuten coronair arterie occlusie, kan beperken van 
84±7% (mean±SD) van de Area at Risk in de controle dieren naar 71±6%. Er werden zelfs 
kleinere infarctgroottes (63±13%) geobserveerd, wannccr 30 l11inuten van vcntrikel pacen 
omniddellijk wordt voorafgegaan aan de 60 minuten coronair occlusie zonder een tussenliggende 
periode van normale sinus ritme. Het beschennende effect van ventrikel pacen werd opgeheven 
door voorbehandcling met de K+ATP kanaal blokker glibenclamide. K\TP kanaal aktivatie trad niet 
op als gevolg van myocard ischemie welke aangetoond kon worden door metabole en 
contractiliteits (fullctionele) mctingen zoals de afwezigheid van post-systolische segment 
verkorting, cen norma Ie distributie van dc transl11urale bloeddoorstoming en de onveranderde 
myocardiale ATP-niveaus gedurende het ventrikel pacen en de afwezigheid van reactieve 
hyperemie en de olUlliddellijke hersteI van de systolische segment verkorting na het stoppen van 
het ventrikel pacen. Tocdiening van glibenclamide na de 30 minuten van ventrikel pacen op het 
moment van 15 minuten van normaal sinus ritme, kon niet de bescherming blokkeren, waamit 
we kUlUlen concluderen dat K+ ATP kanalen Iliet zelf een bijdrage leveren aan de beschenning, dat 
nag steeds aanwezig was 15 minuten na het stoppen van de ventrikel pacen. Dezc bevindingell 
wijzen erop dat K\TP kanaai aktivatie nodig was om de bescherming te triggeren, maar dat 
continuering van de activatie niet nodig was op het moment dat het myocard a1 in beschennende 
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staat verkeCli. Dit laatste is in tegenstrijd met wat in ischemische prcconditionering wordt gezicn. 
In tegen stelling tot Chien et al en Dllllcker et at vanden we in hoofdstuk 6 geen verschil in 
infarctgrootte tussen de lage temperatuufS groep (30°C-31°C) en de normale temperatuUfs groep 
(36.so C-37.5°C). \Ve verklaarden dit door het verschil in de duur van de periode Van coronaire 
atierie occlusie. In hoofdstuk 7 tcanden we aan dat het infarctgrootte beperkende effect van lage 
lichaamstemperaturen inderdaad afhangt van de duur van de cOIOnuire artcric occlusic. \Ve 
konden dit beschennende effect aileen maar aantonen walllleer de duur van de corona ire arterie 
occIusie tussen de 20 en de 40 minuten was. 
In hoofdstuk 8 beschrijven we de problematiek rondom de interpretatie van de studies die 
proberen de rol van de signaal transductie eiwit, protein kinase C, in de mechanismen van 
ischemische preconditionering aan te tonen of uit te sluitcn. In een paging am een bijdrage te 
leveren aan het antwoord voor deze vraagstelling hebben we in hoofstllk 9 protein kinase C 
isozymen~u, -0, -E en -C en de totale protein kinase C activiteit bepaald in mtte myocard welke 
onderworpen werden aan een controle stimulus, een peri ode van myocardiale ischemie en 
reperfusie en een peri ode van dUllne darm ischemie en reperfusie. Resultatcn van deze studie 
tonen aan dat er inderdaad een translokatie/activatie van het 0 isozyme van het cytosol 
plaatsvindt, echter deze is niet in de membraan fractic aan te tonen en de activiteits metingen 
kunnen deze bevinding ook niet ondersteunen. 
In conlusie kunnen we zeggen dat de huidige studies sllggereren dat het myocard beschennd 
kan worden door vonnen van stress auders dan myocardiale ischemie. Deze houden onder andere 
stimuli in welke stress van het hart veroorzaken, maar dat niet leidt tot ischemie (stretch, 
ventrikel pacen) en stimuli welke distress (ischemic) veroorzaken in andere organen andel's dat 
het hart. Ischemie in "remote orga1ls" zoals nier, hersens, skeletspier en lever, kunnen ook deze 
organen preconditioneren. Het is dllidelijk dat verschillellde vormen van stress of distress in staat 
zijn processen te triggeren, welke de organen kan beschennell die zowel hebbcn blootgestaan aan 
deze stimulus, maar ook andere organen op afstand. Het zou er dus op. kunnen lijken dat 
ischernische myocardiale preconditionering slechts een van de aspecten van een groter fenomcen 
is dat resulteert in orgaan beschenning. Toekomstigc studies moeten daarom het ontrafelen van 
het mechanisme dat leidt tot orgaan bescherming welke dan fannacologisch nagebootst kan 
worden als doel hebben. Het is ook belangrijk om in gedachte te houdcn, dat niet aile vonnen vall 
(dis)stress (myocardiale hibernation, rokell) resulteren in myocard bescherming. Ten slotte, 
zouden dezc nieuwe gevonden beschermende stimuli, samen met de problemen van 
infarctgrootte determinatie in patienten zoals ergens anders vermeld, verwarrende factoren 
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kunnen zijn in de het vinden van definitieve bewijs voor het voorkomen van ischemische 
myocardiale preconditionering in mensell. Ais laatste wii ik nog vennelden dat de beste 
beschenning van het ischemische myocard nog altijd de beeindiging is van de ischemisch 
toestand door reperfusie van het bedreigde myocard. 
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